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ABSTRACT
INTRODUCTION: Pre-exposure prophylaxis (PrEP) is a pill, taken orally, that
has been shown to be effective at reducing the chance that someone who is HIV-negative
and at-risk for HIV will contract the disease during sexual intercourse with someone who
is living with HIV. One demographic group that has been under-researched is Black
heterosexual men. This dissertation presents research on evaluating the heterosexual
Black men’s awareness of, prior use, and network of friends/family’s perceived interest
in learning more about PrEP.
METHODS: Two-hundred and six Black heterosexual men living in Brooklyn,
New York City, were surveyed about their sexual behaviors and PrEP use and interest at
their local barbershop in 2016. Another 505 Black heterosexual men were surveyed about
sexual behaviors and PrEP awareness of, use, and interest in Dar Es Salaam, Tanzania
during the baseline phase of a controlled-randomized trial surrounding HIV self-testing in
social camps in 2019.
RESULTS: In Brooklyn, 82% of men reported not having heard of PrEP and
55.3% of the 206 surveyed men reported not having used PrEP themselves or knowing
someone who had. Some 45.1% of men believed that their network of friends and family
would be somewhat interested in learning more about PrEP, while 28.2% believed their
friends and family would be very interested. In Dar Es Salaam, 85.6% of men reported
having never heard of PrEP prior to the survey. Still, 71.5% of men reported being likely
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to take PrEP if it were offered to them. Thirty-six percent of men reported that a reason
that would make other men not want to take PrEP is not knowing where to get it from.
Nearly 40% of men stated that they believed they would use PrEP before sexual
intercourse either every time or every other time.
CONCLUSION: Future research should explore intervention strategies for
increasing PrEP access and use for heterosexual Black men such as barbershops and
social camps as venues to raise awareness and for delivering PrEP. In tandem with
strategic partnerships among community-based organizations, health departments, health
clinics and hospital systems, both barbershops and social camps offer unique and useful
opportunities to reach heterosexual Black men and their peers.
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CHAPTER 1
INTRODUCTION
Though great progress continues to be made in the control of the HIV epidemic,
HIV remains a pertinent public health issue worldwide (WHO, 2021). HIV infections
have disproportionality affected men of color, specifically Black men, when compared to
other racial and ethnic groups (HIV.gov, 2017). Men who have sex with men (MSM),
who include gay and bisexual men, have the largest burden of new infections in the U.S.
followed by transgender women who have sex with men (HIV.gov, 2017). Injection drug
users (IDUs), referred to henceforth as people who inject drugs (PWID), also have an
elevated risk for HIV infection (HIV.gov, 2017). However, heterosexual men who
engage in risky sexual behaviors should also be included in HIV prevention measures
(Higgins et al., 2010; Leal et al., 2015).
Previous research has shown that approximately one third of non-Hispanic, Black
men 15–44 years of age have never been tested for HIV (Conserve et al., 2016), which is
the standard way of realizing one’s HIV status. Black men have also been found to
engage in high-risk sexual behaviors which put them at an increased risk for HIV and
other sexually transmitted infections (Millett et al., 2006). Black heterosexual men may
benefit substantially from innovative HIV preventative strategies such as pre-exposure
prophylaxis (PrEP), which first became available in mid-2012 but has yet to become
widely adopted by minority racial groups (Pingel et al., 2017).
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PrEP is an HIV prevention method, which uses antiretroviral (ARV) medications
as a preventative method for uninfected at-risk persons; the once-daily dosage is taken
orally and is a combination of ARV medications, which has been approved for use and is
marketed as the chemical compounds emtricitabine and tenofovir disoproxil fumarate
under the brand name Truvada (Gilead, 2019) and Descovy, which is a combination of
emtricitabine and tenofovir alafenamide (Gilead, 2020). Descovy is recommended for
persons who were not assigned a gender of female at birth and who may be at risk of
acquiring HIV from vaginal sex because its effectiveness has not been studied in women
(Gilead, 2020). The World Health Organization (WHO, 2019) has recommended that
PrEP be offered as an additional HIV prevention choice for persons who are at risk for
infection. PrEP has been found to be an effective HIV prevention method with very low
safety risks (Fonner et al., 2016). The Centers for Disease Control and Prevention (CDC)
(2019) recommends PrEP be offered to: sexually active MSM who are HIV-negative,
sexually active heterosexual individuals who are HIV-negative, sexually active
transgender individuals who are HIV-negative, PWID who are HIV-negative, and
individuals who have used multiple courses of post-exposure prophylaxis (PEP). CDC
(2019) also recommends PrEP be offered to sexually active adults and adolescents who
have engaged in anal or vaginal sex within the past 6 months and a known HIV-positive
sexual partner or who have recently had a bacterial STI or do not consistently use
condoms with their sexual partners. Persons who inject drugs (PWID) who have HIVpositive injecting partners or who share drug preparation or injecting equipment should
also be offered PrEP (CDC, 2019). PrEP also offers options for discordant couples who
desire to conceive children (WHO, 2012). However, a documented negative HIV test

2

result is required prior to the prescribing of PrEP in conjunction with no signs or
symptoms of acute HIV infection, normal renal functioning, and no contraindicated
medications (CDC, 2019) such as adefovir, orlistat, aminoglycosides, and atazanavir
(WebMD, 2021). PrEP has an effectiveness estimate of ~99% for sexual transmission and
an estimated effectiveness estimate of 74% - 84% among PWID (CDC, 2019). Recently,
studies have demonstrated the efficacy of PrEP to reduce the HIV incidence rates among
sexual minority populations such as MSM and transgender women (Buchbinder et al.,
2014; Donnell et al., 2014; Golub et al., 2013). MSM have been widely recruited,
represented, and retained in PrEP outreach (Kushwaha et al., 2017; Veronese et al.,
2019), trials (García & Harris, 2017; Wong et al., 2018), and other aspects of HIV
prevention.
To date, Black (including all members of the African diaspora), non-Hispanic
heterosexual men have been underrepresented in PrEP strategies, and as a result, little is
known about the awareness of, and willingness to use, nor the current usage rate and
adherence of PrEP among this group. In this dissertation, I aim to address this gap by
investigating these issues via cross-sectional data from heterosexual men in Brooklyn,
NYC, and Dar Es Salaam, Tanzania, and a systematic review of current research on PrEP
uptake and intervention strategies for heterosexual men, globally. The purpose of this
research inquiry is to highlight the need for heterosexual men to be included in future
research endeavors pertaining to PrEP to forge a well-rounded course of action for HIV
prevention going forward. The proposed research attempts to identify the factors
associated with the awareness of, willingness to use, and uptake of PrEP among
heterosexual men and how to theoretically apply the findings to multiple geographical
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settings in the contexts of different gender norms, cultural norms, expectations, risk
perceptions, and beliefs and how they are linked to PrEP. Findings from the research will
also provide guidance for other public health investigators who desire to work with PrEP
on a global scale by adding to their base of awareness regarding PrEP intentions among
heterosexual Black men.
Overall Purpose
The overall purpose of this dissertation is to explore the awareness of, willingness
to use, and uptake of PrEP among heterosexual Black men using cross-sectional surveys
from one sample of Black men who are patrons of barbershops in Brooklyn, New York
and another sample of men who are members of a social camp in Dar Es Salaam,
Tanzania as well as the identification of past research, that specifically included
heterosexual men regarding PrEP awareness, use, and access.
Research Questions
Overall Research Question:
What role do environmental and intrapersonal factors play in increasing heterosexual
Black men’s awareness of, willingness to use, and uptake of PrEP?
1. How aware are heterosexual Black men of PrEP as an HIV prevention method?
2. Does willingness to use PrEP increase after learning more about the drug?
3. What past intervention strategies have been used to increase men’s uptake of
PrEP?
4. What are the barriers and facilitators to uptake of PrEP among men?
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Hypothesis 1:
Most heterosexual Black men will report never having used PrEP due to a lack of
awareness and access to PrEP.
Hypothesis 2:
Most Black heterosexual men will report a willingness to use PrEP after receiving
more information about the drug.
Specific Aims
The goal of the proposed dissertation research is to investigate Black heterosexual
men’s awareness of PrEP, willingness to use PrEP, and use of PrEP among these men. To
achieve the overall goal, the following specific aims are proposed:
Aim 1: Evaluate heterosexual Black men’s awareness of, prior use, and
network of friends/family’s interest in learning more about PrEP.
Specifically, data from barbershop patrons in Brooklyn, New York will be used to
address questions pertaining to: 1) having heard of PrEP prior to the survey 2) having
known anyone who has used or is using PrEP and 3) their belief of their family and friends
being interested in learning more about PrEP.
Aim 2: Evaluate the awareness of and willingness to use PrEP among Black
heterosexual men who are members of a social camp and the interest of PrEP for their
close friends. Based on the results of a cross-sectional survey administered to men in Dar
Es Salaam, Tanzania who are members of a social camp, men’s self-reported personal
opinions regarding PrEP were investigated.
Aim 3: Investigate recently published literature to identify research which
focuses on heterosexual men and PrEP to inform future intervention strategies. All
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research published since 2011 until May 2021 that specifically focuses on heterosexual
men and PrEP was identified to investigate what previous research has uncovered
regarding PrEP awareness, access, and uptake among this population.
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CHAPTER 2
BACKGROUND & SIGNIFICANCE
Global Burden of HIV
The Human Immunodeficiency Virus (HIV) is a virus that is passed from person to
person via body fluids. According to The Joint United Nations Programme on HIV/AIDS
(UNAIDS), in 2018, approximately 37.9 million people were estimated to be living with
HIV globally, 23.3 million people were estimated to be using antiretroviral therapy
(ART), and 1.7 million were newly infected with HIV (UNAIDS, 2019). Since the
beginning of the epidemic, approximately 74.9 million people have been infected with
HIV and 32 million people have died from AIDS-related illnesses (UNAIDS, 2019). Of
people living with HIV (PLWH), 36.2 million persons were adults; however, only 79% of
infected persons were aware of their HIV status (UNAIDS, 2019). Since the peak of the
epidemic in 1997, the incidence rate of HIV has been reduced by 40% (UNAIDS, n.d.);
the global incidence rate of HIV is expected to continue a trend of decline since the
release of the ambitious plan to end the epidemic by UNAIDS:
•

Achieve 95% of all PLWH knowing their HIV status by 2030.

•

Achieve 95% of all diagnosed HIV infected persons receiving sustained ART by
2030.

•

Achieve 95% of all persons on ART achieving viral suppression by 2030
(UNAIDS, n.d.).
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To spread throughout the body, HIV attacks the immune system of an infected
person and takes over control of certain immune cells that are supposed to defend the
body. The HIV cell structure is made up of 5 parts: HIV envelope (the outer area of
HIV), HIV capsid (the core of HIV that encases HIV RNA), HIV enzymes (proteins),
HIV glycoproteins (spikes of protein that is embedded in the HIV envelope), and HIV
RNA (the genetic material of HIV) (German Advisory Committee, 2016). HIV attacks
the immune systems of persons by attaching themselves to CD4+ cells, which are a type
of white blood cell. The CD4+ cells help protect us from infection; HIV attacks the
immune system. kills CD4+ cells and mimics the process of CD4+ cells to multiply and
spread throughout the body. This is the beginning of the HIV life cycle. A major benefit
of antiretrovirals (ARVs) is two-fold – the medication regimen is protective to the
diagnosed person and allows their immune system to recover as well as helping to
prevent transmission of the virus to others once a low viral load is achieved. The
effectiveness of ARVs to prevent HIV transmission highlights the protective effect of
PrEP, which is taking of ARVs by HIV negative people in order to prevent HIV infection
(Abbas et al., 2013).
This research investigates PrEP among heterosexual Black men. In the U.S., it is
estimated that some 1.1 million individuals are HIV-infected, but 1 in 7 (15%) are not
aware of their HIV status (HIV.gov, 2020). Approximately 34,800 Americans are
believed to be newly infected with HIV in 2019 (HIV.gov, 2021). MSM share the
greatest burden of infection by risk group and represent 26,000 new infections annually
(HIV.gov, 2020). In 2019, an estimated 1.7 million individuals were believed to be living
with HIV in Tanzania; of which, the adult (ages 15-49) prevalence rate was estimated to
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be 4.8% (Avert, 2020). About 72,000 new infections occurred in 2018 alongside 24,000
AIDS-related deaths in 2018 (Avert, 2020). Heterosexual sex has been the most common
mode of HIV transmission in Tanzania (Avert, 2020).
Research on PrEP has been predominately focused on MSM in the U.S., for sex
workers in some countries, and by accessing heterosexual men through pregnant women
at antenatal clinics. There has been limited focus on accessing heterosexual black men as
a standalone demographic; this dissertation aims to address this gap. The impact of
heterosexual black men’s experiences and perspectives on sociocultural influences on
PrEP use, adherence, and access as well as key suggestions and/or insights for research,
interventions, and health communication strategies are worthwhile to increase PrEP
awareness and use among these men. Heterosexual Black men may provide key insights
into imperative social and cultural influences of PrEP interest and adherence, which may
differ from those of MSM, sex workers, or pregnant women with male partners.
HIV Prevention and Control Methods
There are multiple prevention and control methods that are associated with HIV
prevention and control such as antiretroviral therapy (ART), post-exposure prophylaxis
(PEP), condom usage, limiting concurrent sexual partnerships, prevention of, mother to
child transmission, viral suppression/treatment as prevention, test & treat, and PrEP.
Post-Exposure Prophylaxis (PEP)
Though only typically used following an emergency, PEP involves taking ART
after the event of potential exposure to HIV in order to prevent the acquisition of HIV
(CDC, 2019). PEP is recommended to be started within 72 hours following the possible
HIV exposure whether through sex, the sharing of needles, or due to sexual assault
9

(CDC, 2019). After a prescription has been obtained, persons must take PEP either once
or twice per day for up to 28 days (CDC, 2019). The use of PEP has been linked to a
substantial decrease in the risk of acquiring HIV following needle sharing and
condomless sex (Siedner et al., 2018). Persons who are prescribed PEP should also be
provided supportive care for other health risks (STI, injuries, hepatitis B & C, and
pregnancy) and be considered for PrEP (Marfatia et al., 2017). CDC (2019) has
recommended PrEP be offered to individuals who have recently been described nonoccupational PEP and who are at continued risk, or those individuals who have used
multiple courses of PEP.
Condom Use
Condom use is an integral part of HIV prevention strategies. Condoms have been
proven to be effective in reducing the risk of HIV infection, when used properly, and are
also inexpensive (Evans et al., 2019). In many countries, condoms are provided free of
charge through the public sector via donor support (Evans et al., 2019). Despite this, and
the fact that condom usage has prevented an estimated 50 million HIV infections since
the 1980s, condom use has either remained at a standstill or has decreased (Evans et al.,
2019). Multiple factors contributed to the stagnation of condom use, including branding
and distribution (Evans et al., 2019); study participants were less likely to pay for
condoms if they had a positive identification with the condoms which were offered and
provided for free (Evans et al., 2019). Furthermore, the elimination of the consumer costs
of condoms, by providing them for free, may increase condom use (Evans et al., 2019;
Ubrihien et al., 2016). Condoms are available as male and female types, though they both
provide the same health service – creating a barrier, which effectively blocks semen,
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other fluids, bacteria, and viruses. Male condoms fit over the penis of a user while female
condoms fit inside of a user’s vagina. Male condoms are available in different types:
latex, plastic, lambskin – and are often lubricated, include spermicide, or are textured
(WebMD, n.d.).
Limiting Sexual Partners
Limiting concurrent sexual partnerships is also pertinent to HIV prevention.
Concurrent sexual partnerships – having two or more sexual partnerships that overlap in
time – increases the risk of HIV for persons who engage in them and may increase the
speed of infection for populations when compared to serially monogamous relationships
(Mah & Halperin, 2010). Thus, limiting the number of partners a person has in each
amount of time may also reduce their risk of acquiring HIV. Approximately 11% of men
reported having had concurrent sexual partnerships (Adimora et al., 2007). Non-Hispanic
Black men reported more sexual partners throughout their lifetime than other ethnic
groups (Adimora et al., 2007). Past research has also documented a strong relationship
between concurrent sexual partnerships and primary HIV infection ( Eaton et al., 2011).
Antiretroviral Therapy (ART)
In its most basic explanation, antiretroviral therapy, also referred to as ART,
prevents HIV from making more copies of itself and infecting more cells. ART reduces
the amount of HIV that is present in the body. ART works by keeping the level of HIV in
the body low; this is also known as your viral load. Viral load is the measurement of the
amount of HIV that is in the body, mostly in the bloodstream, and is captured by the
number of virus particles are present in the blood per milliliter (CDC, 2019). The goal of
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ART is to keep the viral load of the user low so that the virus does not replicate and to
reduce the chance that the user will pass HIV on to others. ART is offered via
antiretroviral drugs (ARVs) in pill form; they are recommended to be taken in
combinations (Avert, 2015). Effective ARV drugs can control the virus and help prevent
HIV transmission so that people living with HIV and those at substantial risk can live
healthy, long, and productive lives (UNAIDS, 2019.). Global ART coverage for pregnant
and breastfeeding women living with HIV is currently 80% and. 21.7 million people
living with HIV were receiving ART globally in 2017 (UNAIDS, 2019). Due to the
success of ART uptake, new HIV infections were reduced by 36% from 2000 to 2017 and
HIV-related deaths were reduced by 38% with 11.4 million lives saved due to ART
adherence (WHO, n.d.).
Prevention of Mother to Child Transmission
It is possible for HIV to be transmitted from an HIV-positive mother to her baby
during pregnancy, labor, or while breastfeeding, this is called mother-to-child
transmission (WHO, n.d.). It is estimated that the transmission rates for mother-to-child
transmission hovers around 15% to 45% without intervention but may be reduced to 5%
with interventions during pregnancy and breastfeeding (WHO, n.d.). ART is typically
involved in these interventions for moms and at-risk babies. Almost 600,000 new
pediatric HIV infections, a total of 10% of new infections at the time, constituted motherto-child transmission (Cock et al., 2000). One study found that babies who were
exclusively breastfed by women with CD4-cell counts less than 200 per μL were twice as
likely to acquire HIV and nearly four times more likely to die before reaching 6 months
of age than were babies who were exclusively breastfed by women with CD4-cell counts
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above 500 per μL (Coovadia et al., 2007). This finding suggests that ART is beneficial to
both infected mom and baby (Siegfried et al., 2011). For HIV-positive pregnant mothers
who adhere to ART and HIV medication is provided to her baby some 4-6 weeks before
delivery, there is a reduced chance for risk of transmission (CDC, 2019).
Viral Suppression & Treatment as Prevention (TasP)
Treatment as prevention (TasP) is a term used to describe the use of ARV
medication to prevent the transmission of HIV. Through TaSP, persons living with HIV
(PLWH) are prescribed ARVs in an effort to reduce the amount of HIV that is detectable
in their blood (viral load) to undetectable levels in order to reduce their risk of
transmitting HIV to others to virtually no chance (CDC, 2019). Known as viral
suppression, this outcome is defined as having less than 200 copies of HIV per millimeter
of blood. Once viral suppression has been achieved and a person’s viral load is low
enough that tests cannot detect it, the individual has achieved an undetectable viral load
and thus cannot transmit HIV to others. Results of a past clinical trial revealed a 96%
reduction in risk of HIV transmission for viral suppression (The Lancet, 2011). The risk
of HIV transmission for persons who have achieved an undetectable viral load is 1% or
less for pregnant women, zero risk of transmission for all forms of sexual intercourse, and
a substantially reduced risk while breastfeeding (CDC, 2019). Recently, the public health
world as adopted the terminology ‘Undetectable=Untransmittable’ or ‘U=U’ in order to
establish the salience of ART adherence and its benefits (NIH, n.d.).
Achieving an undetectable viral load, or being virally suppressed is the goal of
ART. A person has an undetectable viral load when there are fewer than 200 copies of
HIV per milliliter of ? in their blood (<50 copies/mL) (CDC, 2019). In 2016, over 1
13

million people were living with HIV in the U.S. of which 76% of those persons were
linked to medical care within 1 month of their diagnosis (CDC, 2019). This is important
because people who have been diagnosed with HIV should be put on ART to treat their
HIV as soon as possible. Controlling the amount of HIV that is present in the body is the
best way for PLWH to stay healthy and help to prevent the transmission of HIV to others.
TasP is successful when a PLWH adheres to their ART regimen as prescribed,
consistently continue their follow-up care, and achieve an undetectable viral load
(HIV.gov, 2019).
Test & Treat
Test and Treat, like TaSP, uses ART to treat persons who are HIV-positive. The
major difference between the two approaches is that Test and Treat uses multiple HIV
testing strategies as a means of identifying those who are HIV-positive and immediately
linking them to care to begin ART with the aim of keeping their viral load low. Past
research has found that Test and Treat is an effective way to reduce new HIV infections
(NIH, n.d.). Using Test and Treat, a population-wide, home-based HIV testing campaign
and the offering of ART to newly diagnosed persons living with HIV may be
advantageous to assisting in controlling the epidemic in settings such as sub-Saharan
Africa where these intervention models have been used in the past.
HIV Testing
HIV testing is paramount for HIV prevention; the only way that PLWH can learn
their status is if they get tested. There are several types of HIV testing including: nucleic
acid tests (NAT), antigen/antibody tests, rapid antibody screening test, rapid
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antigen/antibody, and oral fluid antibody testing also known as self-testing (CDC, 2020).
Each test has a specified testing window, also referred to as an incubation period. The
various testing windows are specified time frame requirements, which must be met for
each test to properly detect the virus. Still, no HIV test has the ability to detect HIV
immediately following an infection (Prevention et al., 2018). In antigen/antibody tests, a
blood sample is used to search for antibodies, which are made by a person’s immune
system B-cells in defense against HIV; antigens are the toxins which causes an immune
response in the body. A majority of HIV tests are antibody test (HIV.gov, 2018). The
detection of antibodies in the blood confirms that HIV is present in the sample. The
window for antibody tests is typically 3-12 weeks. NAT also searches for an HIV
infection in the body via a blood sample; however, a key difference is that NAT targets
the presence of the virus and is not concerned with antibodies (HIV.gov, 2018). The
testing window for NAT is typically 7-28 days.
Rapid tests discover antibodies in blood samples and have a testing window of
three months. The greatest difference between rapid tests and other tests is that the results
are provided minutes after the test has been taken, usually within 20 minutes Avert,
2015). HIV self-testing (HIVST) is a testing method which allows users to test for HIV
discreetly and provides more privacy than traditional methods of testing. HIVST typically
involves the use of a rapid diagnostic test, which searches for HIV-1/2 antibodies or HIV1 p24 antigens in the sample specimen (WHO, n.d.). The objective of HIVST is to better
accommodate difficult-to-access persons who have not been reached by traditional testing
methods – including men, young persons, and key populations (Johnson et al., 2017).
Through HIVST, a user collects their own oral fluid or blood sample and then performs
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the test using a kit, and interprets the results either privately or alongside someone else
(WHO, 2015). The testing window for HIVST is three months and the results can be read
within 20 minutes (Avert, 2015). HIVST has been found to be both an acceptable and
feasible approach, which can be applied in various environments to the benefit of
multiple populations (Johnson et al., 2017). HIVST has also been shown to increase
testing frequency among men (Johnson et al., 2017; Katz et al., 2018). Overall, HIVST
provides privacy, confidentiality, and reduced stigma for persons who face such barriers
to traditional testing. Still, a confirmatory HIV test is required for HIVST which are
returned positive.
HIV testing is important for us to locate as many people as possible who are atrisk for HIV and who may have already been infected. Though there are multiple ways
that people can be tested, these methods most be used in combination to reach all persons
who are at-risk for HIV. Rapid testing and HIV self-testing have the benefit of being able
to reduce the barriers that are associated with traditional testing. Once these persons are
confirmed positive, they must be linked to care and placed on ART immediately. Once on
ART, these persons must achieve viral suppression so that they are less likely to transmit
HIV to others. It is through these efforts that the HIV epidemic will be better controlled
and the incidence rates for HIV can be 0, globally. Simultaneously, there must also be a
focus on HIV-positive individuals achieving a durable viral load; this requires consistent
ART adherence. More programs are needed that focus on linkage to care and ART
adherence. It is not enough that HIV-positive persons are linked to care, they also must
be retained in care. Through testing, linkage to care, and retaining those who are in care
efforts, the HIV burden can be significantly lessened. These efforts may also benefit from
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pre-exposure prophylaxis (PrEP) programming alongside condom distribution to prevent
HIV-negative persons who are at-risk from becoming infected.
Pre-Exposure Prophylaxis (PrEP)
Pre-Exposure Prophylaxis (PrEP) is a preventive medication regimen for persons
who are at risk HIV and who are interested in preventing acquiring HIV from behaviors
such as sexual intercourse or injection drug use. PrEP is a prescribed medication and has
been proven to be safe and effective at preventing HIV (CDC, 2021). PrEP has been
found to reduce the risk of acquiring HIV via sexual intercourse by 99% when it is taken
as prescribed (CDC, 2021); PrEP also reduces the risk of persons who inject drugs (PWI)
by 74% when it is taken as prescribed (CDC, 2021). For full effectiveness, PrEP reaches
maximum protection at seven (7) days of daily use for receptive anal sex and twenty-one
(21) days for receptive vaginal sex and injection drug use (CDC, 2021). It is important
that PrEP be taken as prescribed for it to reach maximum effectiveness, otherwise, there
may not be enough medicine in the bloodstream to block the virus (CDC, 2021). There
are currently two medications that have been approved for daily use as PrEP: Truvada,
which is prescribed for persons at risk of HIV through sexual intercourse or injection
drug use and Decovy, which is prescribed for persons at risk of HIV through sex but who
were not assigned female at birth (CDC, 2021). A PrEP regimen consists of an individual
taking one pill per day prior to sexual contact. Minor side effects have been reported with
PrEP use including diarrhea, nausea, headache, fatigue, and stomach pain (CDC, 2021).
PrEP is available to persons who test negative for HIV, have engaged in anal or
vaginal sex in the past six months, have a sexual partner with HIV, have had any
unprotected sex, and who have been diagnosed with an STD in the past six months
17

(CDC, 2021). PrEP is also available to PWID, persons who have an injection partner with
HIV, and persons who share needles, syringes, and other instruments used to inject drugs
(CDC, 2021). Persons who have been prescribed post-exposure prophylaxis (PEP), have
continued risk behavior, and who have taken multiple courses of PEP should also use
PrEP as well as women who have a partner with HIV and would like to become pregnant
(CDC, 2021).
To get started on PrEP, interested persons must first discuss their interest in PrEP
with their healthcare provider; a negative HIV test must then be returned prior to the
beginning of PrEP. After the return of a negative HIV test, the healthcare provider will
then assess the person’s self-reported risk of HIV and if appropriate, the provider will
prescribe PrEP. While taking PrEP, persons are expected to meet with their healthcare
provider every three months for a follow-up visit, HIV test, and for refills of PrEP (CDC,
2021). However, it is possible for persons to start or continue taking PrEP without inperson visits with their provider via telemedicine and mail-in self-testing (CDC, 2021).
Most insurance plans cover medication, lab tests, and clinic visits for PrEP and state
Medicaid programs also cover PrEP (CDC, 2021). Still, there are also multiple programs
such as co-pay assistance programs, PrEP assistance programs, and Ready, Set, PrEP
which assist persons with the costs of PrEP (CDC, 2021).
CDC (2021) has proposed a PrEP care system for delivery models for assessment
and monitoring which presents a system of both prevention and support services for
persons who are HIV-negative but who are at risk for acquiring HIV. The PrEP care
system includes engaging persons at risk for HIV, assessment of indication for PrEP use,
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laboratory and testing services, risk-reduction support, adherence support, and
encompasses three phases: screening, PrEP initiation and follow (CDC, 2021).
Delivery models for PrEP include health departments, community-based
organizations (CBOs), and healthcare organizations (CDC, 2021); these entities may play
a role in clinic-based model or a collaborative model. In the clinic-based model, a full
range of services within the PrEP care system are provided at a single location (CDC,
2021). In a collaborative model (see figure below), local health departments, CBOs, and
clinics collaborate with one another to provide PrEP services.
Key Populations & HIV
Key populations are defined as groups of people who are at an increased risk of
acquiring HIV and have been designated as persons who belong to the following groups:
MSM, transgender persons, sex workers, and people in prison (The Global Fund, 2020).
These populations are deemed as being at greater risk for HIV and AIDS acquisition than
other populations around the world. Approximately 40 to 50% of all new HIV diagnoses
occur among persons in key populations and their intimate partner(s) (UNAIDS, n.d.).
The risk for acquiring HIV is significantly heightened for key populations (Brown
& Peerapatanapokin, 2019). MSM and PWID have a 22 times higher risk of acquiring
HIV while sex workers have a 21 times higher risk and transgender individuals have a 12
times higher risk of acquiring HIV when compared to all adult men (UNAIDS, 2019).
Key populations and their sexual partners are estimated to contribute upwards of 95% of
new HIV infections occur in Eastern Europe and Central Asia (AmfAR, 2019). The trend
continues in regarding new HIV infections in the Middle East and Northern Africa for
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key populations, which account for 95% of those new infections (UNAIDS, n.d.). Key
populations contribute 88% of new HIV infections in Western and central Europe and
North America (UNAIDS, n.d.). Key populations comprised some 78% of new HIV
infections in Asia and the Pacific and 65% of new HIV infections in Latin America
(UNAIDS, n.d.). In Western and Central Africa, key populations accounted for 64% of
new HIV infections and 25% of new infections in southern Africa (UNAIDS, 2019).
Lastly, key populations comprised approximately 47% of new HIV infections in the
Caribbean (UNAIDS, 2019).
The reach of timely testing, linkage to care, and other services have been limited
due to the difficulty of accessing key populations (Laar & DeBruin, 2017). Due to this,
underreporting of HIV incidence and prevalence often occurs (Rao et al., 2018). Barriers
such as HIV-related stigma and discrimination exacerbate this issue. The global rates of
access and uptake of safe and effective HIV services are low for key populations (Laar &
DeBruin, 2017). In contrast, the barriers are high and include gender-based violence
(Leddy et al., 2019). Furthermore, harassment, by peers, law enforcement, and others
may work together to prevent key populations from accessing and utilizing critical health
services (Logie et al., 2017).
Key Populations & PrEP
MSM & PrEP
In 2017, 67% of new HIV diagnoses were MSM, of which Black and Hispanic
MSM were disproportionately affected (Kanny et al., 2019). PrEP may reduce the risk of
acquiring HIV for many at-risk populations, including MSM and Transgender persons. It
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has been reported that PrEP reduces the risk of sexual HIV transmission by
approximately 99% (Kanny et al., 2019). Yet, PrEP uptake has been slow for both MSM
and Transgender persons (Chakrapani et al., 2020; Kirby & Thornber-Dunwell, 2014;
Pingel et al., 2017). Still, PrEP was found to be acceptable for these populations (Hosek
et al., 2017). Research inquiries involving PrEP and MSM and Transgender persons have
been well documented in the literature (Braksmajer et al., 2020; L. A. Eaton et al., 2017;
Kahle et al., 2020; Lelutiu-Weinberger et al., 2020; McMahan et al., 2019; Phillips et al.,
2020; Rael et al., 2018; Wilson et al., 2015). Throughout a four-year period, awareness of
PrEP among MSM hovered between 60% to 90% for MSM (Finlayson, 2019), while
PrEP use increased from 6% to 35% for MSM in that same period (Finlayson, 2019).
PrEP usage increased among all demographic subgroups in the past few years but
remained lower among Black and Hispanic MSM (Finlayson et al., 2019).
In 2017, one-third of MSM reported using PrEP (Kanny et al., 2019). Another
report indicated a 500% increase in PrEP use among MSM between 2014 and 2017
(Ward, 2019). PrEP use was 3.8% in 2014 for Black MSM and increased to 30% in 2017
(Ward, 2019). In London, MSM who were age 35 or younger reported interest in future
PrEP use (Aghaizu et al., 2013). In Thailand, MSM were willing to use PrEP regardless
of inconvenience or expense (Wheelock et al., 2013). In one study, MSM who
experienced emotional intimate partner violence were less likely to take PrEP than MSM
who did not report having had that experience (Braksmajer et al., 2020).
There are no significant differences in adherence to PrEP between MSM and
Transgender persons (Hassan et al., 2019). Some 90% of MSM and Transgender persons
had either adequate or perfect adherence to PrEP (Hassan et al., 2019). Adequate
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adherence to PrEP was defined as having dried blood spot tenofovir diphosphate levels of
>719fmol/punch (≥4 doses/week) and perfect if >1246fmol/punch (7 doses/week) with
thresholds verified previously (Hassan et al., 2019).
PWID & PrEP
PrEP has also been recommended as a HIV prevention method for adult people
who inject drugs (PWID) (Mermin et al., 2013). In 2010, PWID contributed an estimated
500,000 new HIV cases in the U.S. (Mermin et al., 2013). Multiple studies have
investigated PrEP uptake for PWID (Alistar et al., 2014; Baral et al., 2012; Bazzi et al.,
2018; Bernard et al., 2017; Bositis & Louis, 2019; Choopanya et al., 2013; Fu et al.,
2018; Martin et al., 2015; Picard et al., 2020; Richert et al., 2015; Roth et al., 2018;
Strathdee et al., 2012). In one study, PrEP reduced HIV infections by nearly 50%
(Choopanya et al., 2013). In another study, an 84% adherence rate was achieved (Martin
et al., 2015) . Still, uptake of PrEP among PWID remains low due to low awareness and
awareness of PrEP, access, and cost constraints, even though many PWID are eligible for
PrEP because of their injection and/or sexual practices (Roth et al., 2018). Yet, for PWID
recruited in Boston, MA, and Providence, RI, two urban centers in the US Northeast, a
vast majority reported never having heard of PrEP (Bazzi et al., 2018). Limited
awareness and mixed interest in PrEP was reported among PWID (Bazzi et al., 2018).
Despite this, PrEP has found to be cost effective if provided in tandem with other
interventions, such as needle exchange programs, and when PrEP is strategically targeted
towards PWID who are at high risk for HIV (Alistar et al., 2014; Bernard et al., 2017).
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Sex Workers & PrEP
Past research has investigated PrEP knowledge, usage, barriers, challenges and
preferences for female ?sex workers (FSW) (Becquet et al., 2020; Eakle, Bourne, et al.,
2018; Eakle, Mutanha, et al., 2018; Emmanuel et al., 2020; Footer et al., 2019; Glick et
al., 2019; Lancaster et al., 2019; Restar et al., 2017; H. Zhang et al., 2020). Among FSW,
PrEP was deemed an acceptable HIV prevention method (Eakle, Bourne, et al., 2018).
Past investigations have also included male sex workers (MSW) (Biello et al., 2017;
Cremin et al., 2017; Oldenburg et al., 2014; Restar et al., 2017; Underhill et al., 2015;
Zablotska et al., 2016). While awareness and awareness of PrEP was low for MSW,
many found it acceptable (Restar et al., 2017; Underhill et al., 2015). Through the
assistance of peer educators, willingness to use PrEP increased among MSW (Oldenburg
et al., 2014). In Mexico, MSW reported that their interest in PrEP was associated with
their not wanting to expose their non-paying intimate partners to HIV (Edeza et al.,
2019).
Significance
This research is significant in many ways. Firstly, since the 1980s, HIV/AIDS
prevention has been a pertinent public health issue that researchers and practitioners
vigorously continue to advocate for (Mutchler et al., 2011). Even though many lives have
been lost since the beginning of the epidemic and when it reached its peak in the late
1990s, much progress has been made in both prevention and treatment (Yehia & Frank,
2011). Still, in the U.S., most of HIV prevention efforts have been geared towards MSM,
transgender women, and PWID (CDC, n.d.). In sub-Saharan Africa, research endeavors
have mostly focused on mother to child transmission, couples, and sex workers (Belato et
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al., 2017; Grabbe & Bunnell, 2010; Matovu, 2010; Ramjee & Daniels, 2013). While
these efforts are commendable and much needed, heterosexual men, specifically Black
men, have not received as much attention nor service offerings (Leal et al., 2015).
Globally, approximately 37.9 million people living with HIV in 2018, of which some 1.7
million became newly infected in that same year (HIV.gov, 2019). In the U.S.,
heterosexual contact accounted for 9% of new HIV diagnoses among men in 2017 (CDC,
2019), and heterosexual men accounted for 7% of HIV diagnoses in 2018 (HIV.gov,
n.d.). The issue at hand, however, is that heterosexual Black men worldwide should be
targeted for HIV prevention efforts alongside their MSM, transgender, and PWID
counterparts because the incidence rates of HIV span across both domestic and
international borders and from both developing and developed nations (Higgins et al.,
2010). Therefore, it is imperative that heterosexual Black men of all countries where
there is an elevated incidence of HIV be provided both health education and
programming as well as health services. Considering that only 79% of infected persons
were aware of their HIV status globally (HIV.gov, n.d.), it is imperative that HIV
prevention targets all persons who are at risk for infection and not just those who fit into
specific demographics. A holistic perspective is necessary for strengthening the offerings
of HIV prevention methods. With the inclusion of heterosexual Black men, a wider net
may be cast for HIV testing, PrEP adherence, and linkage to care.
Innovation
This research is innovative in three ways. First, it focuses on the inclusion of
heterosexual Black men in HIV prevention efforts, specifically with PrEP. This group has
not received much attention in past research (Bowleg & Raj, 2012); therefore, with their
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inclusion, a richer narrative as well as an increased capacity for developing new and
informative interventions is realized regarding HIV prevention, outreach, and services.
Secondly, a showing of what past research has already been produced benefits future
research by providing best practices as well as lessons learned that may be used to guide
future work. Through this, we can identify an effective way forward without having to
recreate the wheel or rehashing past mistakes. Third, the results of all three studies allows
us to be able to identify effective strategies for PrEP uptake and adherence that have
worked in different regions around the world and conceptualize as to how to implement
these strategies in various settings. Since regional customs differ by country and region,
and gender norms differ in these places as well, the results of the three proposed papers
will provide an opportunity to put into place strategies, which consider these differences
and align them with a universal PrEP intervention, which can work in multiple settings
for heterosexual black men.
While the two included original empirical studies are able to stand alone on their
own merit, and it may be argued that the inclusion of both is unnecessary for this
dissertation because a direct comparison of the two samples cannot be made, the rationale
for including both is that by triangulating the two studies alongside the systematic review,
a more comprehensive understanding of past successes, so far, for PrEP interest and
uptake in heterosexual Black communities will be realized.
Barbershops are relevant to Black men all over the world, and while social camps
may be unique to the African continent and other places outside of the U.S., the two share
the commonality that they are structured places where Black men often congregate and
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are venues where information and products, such as PrEP, may be advertised and
delivered among these men.
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CHAPTER 3
METHODS
Theoretical Background
The theoretical background for this dissertation has been developed from the
combination of two theories: Social Cognitive Theory and the Protection Motivation
Theory. Both theories included an individual’s social environments and peer norms can
play in the adoption of behaviors. The overarching reasoning for including these theories
is because they allow for the inclusion of one’s social environment to potentially guide
health behaviors.
Social Cognitive Theory
In the Social Cognitive Theory, a person’s social environment could reinforce the
uptake or rejection of a behavior via personal and environmental factors (UPenn, n.d.).
SCT includes an individual’s past lived-experiences and ultimately factors into whether
or not a behavioral change will occur (Lamorte, 2019). It is noted that “these past
experiences influences reinforcements, expectations, and expectancies, all of which shape
whether a person will engage in a specific behavior and the reasons why a person
engages in that behavior” (Lamorte, 2019). SCT features six constructs: reciprocal
determinism, behavioral capability, observational learning, reinforcements, expectations,
and self-efficacy. This research focuses on the constructs of behavioral capability,
observational learning, reinforcements, and self-efficacy.
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Behavioral capability alludes to an individual’s ability to successfully adopt a
behavior via their awareness and skills. The key to behavioral capability is for an
individual to be aware of what to do as well as how to do it. Observational learning is
completed through the successful demonstrations of a behavior by others and then an
individual reproduces the behavior for themselves. Sometimes referred to as “modelling”
– individuals who witness successful adoptions of a behavior can learn how to adopt that
behavior as well (Lamorte, 2019). Reinforcement occurs after a behavior is being adopted
and the internal or external responses to the behavior is either positively or negatively
reinforced. Reinforcement determines whether an individual will continue or discontinue
a behavior. Self-efficacy is an individual’s belief of their capability of successfully
adopting the behavior. Furthermore, “people form beliefs about what they can do, they
anticipate the likely consequences of prospective actions, they set goals for themselves,
and they otherwise plan courses of action that are likely to produce desired outcomes”
(Bandura, 1991). The SCT has been applied to the exercise of control over HIV infection
(Bandura, 1990), the testing of a social-cognitive model of HIV transmission risk
behaviors in HIV-infected MSM with and without depression (Safren et al., 2010), and
the disclosure of HIV seropositivity to sexual partners (Semple et al., 1999).
Protection Motivation Theory
The Protection Motivation Theory (PMT) was originally constructed to
investigate the fear appeals on health attitudes and behaviors and has been applied to
many topics, health promotion and disease prevention being a main point of application
(Floyd et al., 2006). The concept of PMT may best be summed up as involving any threat
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that has a recommended response that an at-risk individual may act upon or carry out
(Floyd et al., 2006).
In the model, persons assess “threat” by weighing the benefits of a risk behavior
via intrinsic rewards and extrinsic rewards while considering the perceived severity of
their behavior. Individuals also assess their “coping” response via their response efficacy
and self-efficacy minus the response cost. Threat appraisal involves an individual’s
assessment of a health threat based on their environmental and personal factors combined
and includes four factors: intrinsic and extrinsic awards, severity, and vulnerability
(Rogers, 1983). Intrinsic and extrinsic awards increase the likelihood of an individual
selecting a maladaptive response; severity and vulnerability decreases the likelihood of
the selection of a maladaptive response (Prentice-Dunn & Rogers, 1986). An
individual’s coping options that are a direct result of their perceived efficacy as well as
the cost of the social/personal factors, which contribute to and influence their ability to
prevent the health threat is the coping appraisal process (Li et al., 2011). Three factors
make up the coping appraisals process: self-efficacy, response efficacy, and response
cost. Self-efficacy refers to an individual’s belief of having the ability to carry out the
adaptive response; response efficacy is the belief that the adaptive response will result in
an effective outcome. Both response efficacy and self-efficacy increase the likelihood of
an individual utilizing an adaptive response and the response cost decreases the
likelihood of an individual selecting that same response – these two processes combined
results in protection motivation (Li et al., 2011). The appraisal processes and the coping
responses interact to increase an individual’s intention of performing an adaptive
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response to prevent the health threat and thus promotes behavior change through further
action by individual.
For this dissertation the threat is the risk of HIV infection; the recommended
response is the increased awareness of, willingness to use, or uptake of PrEP. The inputs
of PMT model include environmental sources and intrapersonal sources. Environmental
sources consist of written or verbal communication and observational learning, while
intrapersonal sources include personality aspects and prior lived experiences with
targeted maladaptive and adaptive responses (Floyd et al., 2006). PMT prioritizes the
cognitive process of individual behavior change and presents threat and coping appraisals
which are include weighing the threat appraisal (e.g., intrinsic, and extrinsic rewards,
minus the perceived severity and vulnerability) versus the coping appraisal (e.g., response
and self-efficacy minus response cost) to reach a decision regarding risk behavior (see
figure 4 below). The Protection Motivation Theory (PMT) is a SCT that was used by
Stanton & Li (2014) to investigate HIV prevention programming among youth.
A revised model of PMT was modified by Chamroonsawasdi et al. (2017) (see
figure 5) for the development and validation of a questionnaire assess knowledge, threat
and coping appraisal, and intention to practice health behaviors and includes three stages
of behavior uptake: source of information, mediation process, and coping mode.
Chamroonsawasdi et al. (2017) applied PMT to identify modifiable risks of
noncommunicable diseases including social cognitive domain which included
knowledge, affective domain comprised of threat appraisal and coping appraisal, and
behavioral domain of practicing healthy behaviors.
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In summary, PMT involves a threat appraisal, which includes an individual’s
perceived severity plus their perceived vulnerability combined with coping appraisal,
which is an individual’s perceived response efficacy plus their perceived self-efficacy. In
tandem, the two processes result in behavioral intention (protection motivation), which
then ultimately leads to uptake of the actual behavior (coping response).
Conceptual Model
The conceptual model used in this dissertation used a conceptual framework that
was das developed from a modified PMT conceptual model (Chamroonsawasdi et al.,
2017) (see figure 6). Using the SCT and PMT, the conceptual model aims to provide a
sequence of how PrEP intent to use, and its uptake may be increased by heterosexual
Black men. The model theorizes that a person’s intent to use is directly related to their
source of information, mediation process, and coping mode. The source of information
includes individual’s being introduced to PrEP via an environmental source such as
written or verbal communication and observational learning. The environmental source is
coupled with an individual’s intrapersonal factors such as an individual’s attitude towards
HIV prevention and their past sexual experiences. In the mediation process, heterosexual
Black men gauge their perceived severity (e.g., their personal concern of acquiring HIV),
and their perceived vulnerability (e.g., their personal belief that they are at risk of
acquiring HIV), which leads to their threat appraisal. During this process, HBM also
gauge their response efficacy (e.g., their personal belief that PrEP is a worthy investment)
and their personal belief that they are capable of properly using PrEP, which is their
coping appraisal. Both HBM’s threat and coping appraisals lead to their protection
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motivation (willingness to use PrEP) and ultimately creates the health behavior of uptake
and adherence to PrEP.
The developed conceptual model presents the progression of heterosexual Black
men’s progression from their source of information (e.g., where their personal feelings
and beliefs regarding HIV originate) to the mediation process which includes both their
threat and coping appraisal, to their ultimately deciding that they are willing to use PrEP
and then actually using it.
Settings
The two studies took place in urban areas in Brooklyn, NYC and Dar Es Salaam,
Tanzania. Cross-sectional data with heterosexual Black men living in these two areas was
be used. Participants in Brooklyn, NYC were approached at participating barbershops in
2016. Participants from Dar Es Salaam, Tanzania were members of social camps in two
districts in June 2019. Research staff in both sites administered surveys via electronic
tablets. All surveys were conducted in English in Brooklyn, while all surveys were
conducted in Kiswahili in Dar Es Salaam. Heterosexual Black men were recruited to
participate by barbers or research staff in Brooklyn and by nominated camp leaders in
Dar Es Salaam.
Sample
A total of 206 participants were recruited for the barbershop study in Brooklyn,
and 505 men were recruited via social camps in Dar Es Salaam. The decision to sample
only heterosexual Black men was for the inclusion of perspectives and sexual health
experiences/factors of these men regarding HIV prevention methods such as PrEP.
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In the Brooklyn study, Black men who patronized selected barbershops in the
Brooklyn area, and who identified as heterosexual, were recruited to participate in a selfguided interview using an electronic tablet. In the Tanzania study, men who resided in
two identified wards in Dar Es Salaam were recruited and screened for participation in a
randomized control trial focused on HIV self-testing because a high proportion of men in
those wards had not tested for HIV in the past 12 months and did not provide blood for
HIV testing at the endline of a previous trial (R01MH098690-01 PI: Maman).
Instrumentation and Measurement
Cross-sectional surveys were developed for one-on-one interview administration
by trained research staff. The surveys consist of both dichotomous response options and
multiple response options. The survey questions requested information pertaining to the
sexual behaviors of the men (number of partners, condom use, etc.), their awareness of
PrEP, intent to use, and their perception of PrEP. The surveys openly address the
perceptions of PrEP and its current accessibility. Survey questions also include whether
the men are willing to recommend PrEP to their family and friends.
The sources of information include friends, family, and barbers for the Brooklyn
study and family and other social camp members for the Tanzania study. Regarding the
mediation process, threat appraisal (e.g., personal concern of acquiring HIV) was
assessed via cross sectional survey in both studies which specifically asks men questions
pertaining to their sexual behaviors including use of condoms, number of sexual partners
etc. Coping appraisal (e.g., attitudes towards HIV prevention, self-efficacy for taking
PrEP, etc.) was investigated via survey questions which asked the opinions and beliefs of
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participating men regarding issues such as determining PrEP to be a worthwhile health
investment.

Figure 3.1 The Social Cognitive Theory. The Social Cognitive Theory (SCT), created
by Albert Bandura in the 1960s, suggests that “learning occurs in a social context with a
dynamic and reciprocal interaction of the person, environment, and behavior” (Lamorte,
2019).

Figure 3.2 Diagram of PMT. Diagram of PMT (Rogers, 1983). PMT puts forward as
basis of fact that individuals must balance the threat appraisal pathway and the coping
appraisal pathway when they are making decisions whether to engage in a risky behavior
of which is influenced by one’s environment (e.g., cultural and family influences).
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Figure 3.3 Modified Protection Motivation Theory. Modified Protection Motivation
Theory (Chamroonsawasdi et al., 2017) depicting the PMT modified to show the
progression from awareness to behavioral uptake. The diagram breaks the PMT into three
sections: source of information, mediation process, and coping mode of which provides
the sequential pathway to behavioral uptake.

Figure 3.4 Conceptual Model. Conceptual Model using the SCT and PMT as anchors to
provide a sequence of how PrEP intent to use and its uptake may be increased by
heterosexual Black men.
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CHAPTER 4
RESULTS

Study 1: Awareness of, Prior use, and Network of Friends/Family’s Perceived
Interest in Learning more about Pre-exposure Prophylaxis among Heterosexual
Black Male Barbershop Patrons and their Social Networks in Brooklyn, New York 1

1

Hamilton, A. To be submitted to AIDS Patient Care and STDs.
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ABSTRACT
Background: Heterosexual Black men who engage in high-risk sexual behaviors
are at increased risk for HIV infection. Pre-exposure prophylaxis (PrEP) has been
demonstrated to reduce HIV incidence rates among sexually active individuals. However,
there is limited research on PrEP among Black heterosexual men. We assessed the
awareness of, prior use of, and interest in PrEP among Black heterosexual men and their
social networks.
Method: Data were collected as part of the Barbershop Talk with Brothers
(BTWB) project, a cluster randomized controlled trial designed to evaluate the effect of a
community-based HIV prevention intervention to reduce HIV risk among Black
heterosexual men in high-risk areas in Brooklyn for HIV infection.
Results: Two-hundred and six Black men participated. Thirteen percent of them
had never been tested for HIV, 55.8% reported having spoken to their friends about HIV,
and 25.7% of men used health education materials provided by their barbershop. Thirtytwo percent of men had engaged in sex with a partner of unknown serostatus or who was
HIV-positive. Eighty-two percent of men reported not having heard of PrEP. Over half
(55.3%) of the men reported not having used PrEP themselves or knowing someone who
had; 37.4% of men reported being unsure. Nearly three out of four men (73.3%) believed
that their network of friends and family would be somewhat or very interested in learning
more about PrEP.
Conclusion: More community-based health programming and awareness
education to increase awareness and use of PrEP are needed. Barbershops are potential
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venues for practitioners to partner with to increase awareness and uptake of PrEP among
heterosexual Black men.
Keywords: HIV prevention, Pre-exposure Prophylaxis, Heterosexual men, Barbershops
Introduction
In 2018 over one million people were living with HIV (PLWH) in the United
States (U.S.) (CDC, 2021) of which approximately 42% of all new infections were among
Black persons (CDC, 2021). Estimates suggest that 32% of non-Hispanic, Black males
aged 15–44 years have never been tested for HIV (Conserve et al., 2017).
Simultaneously, 68% of Black men engaged in high-risk sexual behaviors, such as having
at least two concurrent sexual partners, that increase their risk for HIV and other sexually
transmitted infections (Taylor et al., 2014). Antiretroviral medications (ARV) were
initially developed to reduce the morbidity of HIV and slow disease progression in
PLWH, but a novel use of the drugs has been identified with pre-exposure prophylaxis
(PrEP).
PrEP is an HIV prevention method, where a combination of ARV medications,
most notably under the brand name Truvada, is used to limit transmission to uninfected
at-risk persons. Truvada is a single pill with once-daily dosage, taken orally (Truvada,
2020). PrEP has been found to be an effective and highly tolerable HIV prevention
method (Grant et al., 2014) with very low safety risks (Fonner et al., 2016). PrEP first
became available in mid-2012, however, national adoption has not yet occurred (Liu et
al., 2014). The World Health Organization (WHO) has recommended that PrEP be
offered as an additional HIV prevention option for persons who are at high risk for
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infection (WHO, 2020). In addition to preventing HIV transmission, the use of PrEP by
persons not living with HIV may be anxiety reducing for PLWH who worry about
transmission of HIV to their partners (Grant & Koester, 2016) and provides an option for
serodiscordant couples to conceive together (Lampe et al., 2011). Recently, studies have
demonstrated the impact of PrEP in reducing the HIV incidence rates among sexual
minority populations such as men who have sex with men (MSM) and transgender
women Elion et al., 2019).
Previous research has examined PrEP interest within a heterosexual population at
a sexual transmitted infection clinic (Khawcharoenpow et al., 2012); however, Black men
were not the focus of the analysis. Khawcharoenpow et al. (2012) found that of the 83%
of participants who expressed interest in PrEP, there was no difference in willingness to
take oral PrEP across genders. Baeten et al. (2012) measured PrEP efficacy among
heterosexual women and men with a partner known to have HIV in Uganda and Kenya
and found that PrEP was associated with increased risk reduction when provided
concurrently with HIV prevention services. Additional research, mostly conducted in
sub-Saharan Africa has also assessed PrEP interest, use, and adherence among serodiscordant heterosexual couples, of which women often comprised a greater proportion of
participants (Fowler et al., 2015; Gilbert et al., 2019; Haberer et al., 2013; Ngure et al.,
2016; Psaros et al., 2015).
Several published systematic reviews have investigated the awareness (Spinner et
al., 2016), values, and preferences of PrEP among various populations (Koechlin et al.,
2017; Riddell et al., 2018). However, these reviews yielded limited literature regarding
PrEP for heterosexual men (Koechlin et al., 2017); suggesting that Black, non-Hispanic
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heterosexual males in the U.S. have been underrepresented in PrEP research. As a result,
little is known about the awareness of, and willingness to use PrEP within this group.
To address this gap in evidence on PrEP among Black heterosexual men, our
study assessed the awareness of and prior use of PrEP among Black non-Hispanic male
barbershop patrons, as well as their interest in learning more about PrEP among their
networks of family and friends, as part of the Barbershop Talk with Brothers (BTWB)
program (Wilson et al., 2019).
Methods
Setting and Participants
The study was conducted in Brooklyn, New York, specifically targeting the
neighborhoods of Flatbush, East Flatbush, Crown Heights, Brownsville, BedfordStuyvesant, and East New York. It is estimated that 31% of New York City residents live
in Brooklyn (New York City Department of Health and Mental Hygiene, 2019). Around
29% of new HIV diagnoses were reported in Brooklyn in 2018 (New York City
Department of Health and Mental Hygiene, 2018) and almost 24% of people living with
HIV in New York City resided in Brooklyn that same year (New York City Department
of Health and Mental Hygiene, 2018). The Crown Heights neighborhood in Brooklyn has
been identified as having one of the highest HIV diagnosis rates in New York (New York
City Department of Health and Mental Hygiene, 2018). Between 2014 and 2018, the
number of new HIV diagnoses involving heterosexual contact decreased by 31% (New
York City Department of Health and Mental Hygiene, 2019); however, in 2018, Black
persons aged 20-59 comprised the largest proportion (22%) of new HIV diagnoses in

40

Brooklyn (New York City Department of Health and Mental Hygiene, 2019).
Furthermore, the HIV diagnosis rate for Black men was five times higher than White
men, three times higher than multiracial men, and one and a half times higher than Latinx
men citywide (New York City Department of Health and Mental Hygiene, 2018).
The BTWB project was designed to reduce sexual risk behaviors and HIV
transmission for Black heterosexual men in neighborhoods with high prevalence in
Brooklyn, NY (Taylor et al., 2014; Wilson et al., 2019). Data for this analysis were
collected as part of the BTWB assessment and evaluation activities for the project.
BTWB was a cluster randomized trial that used a community-based participatory
research (CBPR) approach (Wilson et al., 2019). The barbershops selected had a
predominately Black male clientele. Fifty-three barbershops were randomized to either
receive a group-based HIV prevention intervention or group-based prostate cancer
education as the control (Wilson et al, 2019). Participating men were individually
approached by a member of the research team while awaiting service at a participating
barbershop. The participants were recruited at barbershops during daytimes, evenings,
weekdays, and weekends to ensure that recruitment periods were equally covered
throughout the study period (Gousse et al., 2018). Potential study participants were
screened using the following study inclusion criterion: self-identification as Black and
male, being 18 years or older, able to read and understand English, have had at least two
female sexual partners and at least one unprotected sexual encounter in the last three
months. The methods and results from the BTWB study are presented elsewhere (Wilson
et al., 2019).
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Variables
In the BTWB study, audio computer-assisted self-interview (ACASI) technology
was used to screen potential participants and collect data at baseline and at three and sixmonth follow-up intervals. Eligible participants who provided informed consent were
administered a questionnaire which included socio-demographic factors, HIV testing
history, and various perceptions pertaining to HIV. Response options varied across all
measurement items. Survey questions on PrEP were included only during the six-month
follow-up data collection from July-December 2016. Three variables that specifically
focused on PrEP awareness and willingness to use are presented in Table 1.1 and
included the following: 1) ‘have you ever heard of PrEP before today’; 2) ‘have you or
anyone that you know ever used PrEP’; and 3) ‘how interested do you think people in
your network of friends and family would be in learning about PrEP.’ The first two
questions had response options of yes, no, or I don’t know. The final question had
response options of not, somewhat, or very.
In this study, demographic characteristics of participants were included (see Table
4.1) to describe the characteristics of the sample and summarize the results regarding
HIV risk, knowledge, and prior use of PrEP. Selected variables included: race & ethnicity
(Black, non-Hispanic; Black, Hispanic), born in the U.S. (yes/no), age (20-29, 30-39, 4049, 50-65), income (less than $10k; $10k or higher), residence (rural/urban), currently
living with sexual partner (yes/no), education (did not complete HS, completed HS or
equivalent or trade school, college or higher), currently enrolled in school (yes/no), ever
spent at least one night in jail or prison (yes/no), ever been tested for HIV (yes/no), any
sex with partner of unknown serostatus or is HIV-positive (at least one partner/no), have
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any one-time partners (yes/no), any unprotected sex (yes/no), how many women did you
have sex with in the past 90 days (none, one, two or more, refuse to answer), talked with
sexual partner about HIV (yes/no), talked with friends about HIV (yes/no), talked with
barber about HIV (yes/no), used health education materials provided by your barbershop
(yes/no). Variables focused on participants’ attitudes toward HIV were also included:
HIV is a problem in my community (agree, disagree, not sure), people in my
neighborhood are at risk for HIV (agree, disagree, not sure), Black men and women are at
risk of HIV (agree, disagree, not sure), I am worried that I might get an HIV infection
(agreed, disagree, not sure), HIV is not that serious anymore (strongly agree, agree,
disagree, strongly disagree), people like me do not get HIV infections (strongly agree,
agree, strongly disagree, disagree).
Statistical Analysis
The analysis for this paper only included participants (n=206) who provided
responses for the PrEP survey questions for the BTWB study. All variables of interest
were included in the calculation of frequencies and percentages (see Table 4.1).
The main outcome variable was “How interested do you think people in your
network of friends and family would be in learning more about PrEP?” Bivariate
associations among selected variables and men’s friends and family’s perceived interest
in PrEP were performed (see Table 4.2) before ordinal logistic regression was performed
(see Table 4.3). In ordinal logistic regression, sometimes referred to as ordered logit
model or proportional odds model, the coefficients on the log-odds scale are used to
quantify how well an explanatory variable differentiates the lowest versus all higher
categories of the response (outcome) variable, the two lowest versus all higher categories,
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etc. under the assumption that the relationship with explanatory variables at each level is
the same (Harrel, 2015). The odds ratios from the exponentiated coefficients quantify the
odds of higher interest in PrEP compared to lower interest in relation to the explanatory
variables. Selected dependent variables were categorized with ordered responses or
values. The outcome variable or the response variables are ordered and necessitated the
application of ordinal logistic regression. Sociodemographic variables were selected to
account for the diversity of factors among the men including age, income, and education.
Other variables were selected due to their relevance to the reported environmental and
intrapersonal factors related to participating men in relation to men’s ability to properly
gauge how interested their friends and family may be in learning more about PrEP.
Odds ratios and p-values were calculated to present the strength and confidence in
the associations, and c-statistics were calculated to quantify model fit. C-statistics varied
between 0.5 (chance) to 1.0 (perfect fit), similar to the area under the receiver operating
characteristic curve, and were used to calculate the proportion explained of all possible
pairs in which participants reported on the variable “How interested do you think people
in your network of family and friends would be in learning more about PrEP?” (e.g., a cstatistic of 0.8 corresponds to three-fifths of the distance from 0.5 to 1.0). Statistical
significance was set at p ≤ 0.05. Analyses were preformed using SAS statistical software
version 9.4 (SAS Institute Inc., Cary, NC).
Results
The descriptive statistics for participants included in the analysis are presented in
Table 1. The sample of 206 participants had a mean age of 32.9 years (sd= 1.15). The
study sample was skewed toward younger ages, with only 20.4% of participants aged 5044

65 years. Black, non-Hispanic men comprised 82.5% of the sample, and 15% of
participants identified as Black Hispanic men. Most participants (78.2%) were born in the
U.S and reported not to be living with a sexual partner. Approximately two-thirds
(66.5%) of the men reported an income of less than $10,000 annually. Approximately
68% of participants reported completing at least a high school education, and 27.7% were
currently enrolled in school. Nearly 39% were employed either full-time or part-time,
60.2% were unemployed, and 63.6% reported having ever spent at least one night in jail
or prison.
HIV-Risk and Beliefs
Most participants (86.9%) reported ever having been tested for HIV, while 32.5%
of participants engaged in sex with a partner known to be HIV positive. Over one-third
(36.9%) of participants reported having one-time sexual partners; and 27.3%% reported
sometimes wearing a condom during any sex with casual sex partners. Furthermore,
51.5% of men reported having had sex with two or more women in the past 90 days.
Over one-third (39.3%) reported having talked with their sexual partners about HIV in
the last 90 days, 43.2% had spoken to their friends about HIV, 36.1% had spoken to their
family about HIV, and 21% had spoken to their barber about HIV in that same period.
About one-quarter (25.7%) of the respondents reported having used the health education
materials provided by their barbershop in the last 90 days.
Two-thirds of participants (68.9%) believed that Black men and women are at risk
for HIV. Most participants agreed that people in their neighborhood are at risk for HIV
(65.5%) and believed HIV is a problem in their community (65.5%). Still, 60.7%
reported not being worried that they might get an HIV infection. Many participants
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(87.7%) disagreed that HIV/AIDS is not that serious anymore and 74.7% disagreed that
people like them do not get HIV infections.
PrEP Knowledge, Use, and Friends and Family’s Willingness to Use
Most participants (82%) had never heard of PrEP prior to their participation in the
survey. Approximately 55.3% of men reported never having used PrEP or knowing
anyone that had, 37.4% of participants were not sure, and only 6.8% reported PrEP use
by them or someone that they knew. When asked how interested they believe people in
their network of friends and family would be in learning more about PrEP, 45.1% of men
reported somewhat interested while 28.2% reported very interested, and 26.7% not
interested. Due to the high proportion of men who were unaware of PrEP or had ever
used it.
The results of the ordinal logistic regression found only one of the variables in the
model reached significance. The sole significant variable was found for men who
reported talking with their family about HIV; these men were three times as likely to
report perceiving their friends and family as being likely to be interested in learning more
about PrEP (OR 3.219; 95% CI 1.113-9.305). However, the direction of association
shows men in the 30-39 age group were almost three times more likely to perceive their
friends and family to be interested in learning more about PrEP (OR 2.757; 95% CI
0.835-9.096), and men in the 40-49 age group were more likely (OR 1.497; 95% CI
0.552-4.062), compared to men in the 50-65 age group. Men who reported having
completed high school, college or higher were more likely to report perceiving their
friends and family as having an interest in learning more about PrEP (OR 1.030; 95% CI
0.484-2.194, OR 1.426; 95% CI 0.525-3.873) compared to men who did not complete
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high school. Men who reported living with their sexual partner were less likely to
perceive their friends and family as being interested in learning more about PrEP (OR
0.823; 95% CI 0.332-2.039) than men who reported not living with their sexual partner.
Men who reported having ever tested for HIV were less likely to perceive their friends
and family as being interested in learning more about PrEP (OR 0.857; 95% CI 0.3142.340) than men who had not tested for HIV. Men who reported talking with their barber
about HIV were less likely to perceive their friends and family would be interested in
learning more about PrEP (OR 0.638; 95% CI 0.252-1.617) compared to men who had
not talked with their barber about HIV. Men who reported talking with friends about HIV
were less likely to perceive that their friends and family would be interested in learning
more about PrEP (OR 0.605; 95% CI 0.218-1.683) compared to men who did not talk
with their friends about HIV. There was nearly no association among men who reported
talking to their sexual partners about HIV perceiving their friends and family as being
interested in learning more about PrEP (OR 1.005; 95% CI 0.386-2.621) compared to
men who did not talk with their sexual partners about HIV.
Discussion
The present findings demonstrate that high proportion (82%) of participating
Black heterosexual men had never heard of PrEP nor had ever used PrEP or known
anyone who had ever used PrEP (55.3%). Our results are supported by other studies that
have found low awareness of and prior use of PrEP among Black men who have sex with
men (MSM) in the U.S. (Cohen et al., 2015; Eaton et al., 2015) and multiple populations
in the Deep South (Elopre et al., 2017). Still, nearly two-thirds of participants reported
believing people in their social network would be somewhat or very interested in learning
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about PrEP. These findings support evidence for the need to target this population for
PrEP and other HIV prevention awareness campaigns and services. The findings of this
study also highlight the need for Black heterosexual men to be more engaged with HIV
prevention information and services, especially PrEP. Since PrEP was only approved for
use by the Food & Drug Administration (FDA) in 2012 (AIDSinfo, 2012), and its uptake
has been slow (Wuet al., 2017), the relative newness of the drug may explain in part the
high proportion (82%) of men who had never heard of PrEP in our study. In addition,
advertisements for PrEP in the U.S. have been predominately marketed towards MSM
persons and communities (Thomann et al., 2018).
This study is one of the first to assess PrEP awareness among a group of Black,
heterosexual men regarding the potential interest in PrEP among their friends and family.
Past research has investigated awareness and willingness to use PrEP among MSM in the
U.S. A study featuring single young MSM’s awareness of PrEP found only 27% of the
men had heard of PrEP (Bauermeister et al., 2013). Other research found that 96.1% of
MSM reported being aware of PrEP but only 14.4% of the men had ever used it (Halkitis
et al., 2018). Another study found that PrEP awareness increased from 2011-2014 among
MSM in Washington, D.C. and Miami-Dade County, FL. (Patrick et al., 2017); however,
only a small proportion of the men reported being very likely to use PrEP in 2014 vs.
2011(Halkitis et al., 2018). Overall, national trends for PrEP awareness among MSM in
the U.S. increased between 2013-2017 from 47.4% to 80.6% (Sullivan et al., 2020):
while willingness to use PrEP increased from 43.9% to 59.5% (Sullivan et al., 2020).
Additionally, several studies investigated oral PrEP in the U.S. among serodiscordant
heterosexual couples (Gallagher et al., 2014; Lampe et al., 2011; McMahon et al., 2014);
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however, research focusing on heterosexual Black men, their friends/family, and PrEP in
the U.S. were not found.
One promising finding in this study was that 73.3% of men reported that their
network of friends and family would be somewhat interested or very interested in PrEP;
suggesting that these groups perceived the need for and willingness to use PrEP. The
findings of men who talked to their family about HIV being almost three times as likely
to report perceiving their network of friends and family of being interested in learning
more about PrEP shows the importance of targeting the at-risk friends and families of
heterosexual men to increase PrEP awareness and uptake among all three groups. Future
research should include the development of culturally tailored programming that targets
heterosexual Black males, their friends, and their families in community-embedded
locations such as barbershops. Encouraging from both a public health perspective and as
a reinforcement that barbershops can effectively share health information, was that 25.7%
of the respondents reported having used the health education materials provided at the
barbershop that they patronize. Barbershops should continue to be used to recruit
heterosexual Black men and their friends/family to participate in other programming for
PrEP. Researchers should seek out partnerships with local barbershop owners and
provide training to barbershop staff regarding service referrals.
Since this study successfully used barbershops as venues for PrEP research, future
outreach and advertisements for PrEP should consider targeting common high foot traffic
areas such as shopping areas, bus/metro stops, coffee shops, and bodegas and should
highlight the importance of friends and family supporting and encouraging one another to
not only use PrEP, but also using condoms and getting tested for HIV regularly. Places
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and venues of high patronage from heterosexual Black male consumers and their
networks of family and friends, night club/bar bathrooms for example, should be high
priority places for the advertisement of PrEP. With slightly over half of the men reporting
their belief that people in their social network would not be interested in PrEP, there is
room for improvement regarding the marketing and availability/access of PrEP for
heterosexual Black males and their networks of family and friends. Because few men
reported knowing about PrEP, surveying participating men of their friends and family’s
interest in learning more about a drug they do not know much about is not advantageous
and provides evidence that more promotions of PrEP must occur to increase uptake.
Lastly, medical service providers should be trained to educate patients on and
offer PrEP as an option for their heterosexual Black male clients, particularly those who
engage in high-risk sexual behaviors. Heterosexual Black men and their social networks
should be engaged in the development of messaging, advertisements, and service
offerings geared towards them. Input from the priority audience is invaluable to
understanding how to engage these men and their social networks in HIV prevention
efforts. One of the most salient programming and awareness needs for heterosexual Black
males, as well as their friends and family, regarding PrEP is to increase perceived need
for PrEP. Future programming and advertisements for PrEP should highlight that the
drug is necessary for all persons who are engaging in risky sexual behaviors. Much of the
literature surrounding PrEP has focused on MSM (Gallagher et al., 2014; LelutiuWeinberger & Golub, 2016; Mantell et al., 2014) and less research focusing on
heterosexual men. Developing programming and health education materials for the
partners of heterosexual Black men and their friends and family is also necessary to
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increase PrEP use among this population as friends and family’s interest in learning more
about PrEP may help to motivate men to both try and adhere to PrEP.
Limitations
This study is subject to limitations, first, the timing of the data collection is a
limitation as numerous PrEP advertising campaigns have been launched in NYC since
2016; thus, increasing the need for the study to be repeated to assess the current
awareness of, use, and social network interest in PrEP. Another limitation is the small
sample size for a large number of variables which rendered the analysis underpowered.
Also, data collection for this study relied solely on a convenience sample of men who
were walk-in clients of the participating barbershops. Information of persons who refused
to participate was not collected and thus restricted the estimation of the participation
profile. Lastly, only Black heterosexual males living in Brooklyn, NY were recruited; the
generalizability of the findings to non-urban Black heterosexual males may be limited
from this study. A further limitation to this study is that participating men were not
surveyed about their own potential interests in PrEP and thus leaves this information
unknown while having participants guess whether their friends would be interested in
learning more about PrEP even though most participants reported having never heard of
it.
Conclusion
This study explores the knowledge, use, and interest of PrEP among Black
heterosexual men living in Brooklyn, NY who solicited services from participating
barbershops and their networks of friends and family. The results of the analysis indicate
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that, at the time of data collection, most Black heterosexual men in the sample had never
heard of PrEP and had never used PrEP. However, most of the men reported having the
belief that their network of friends and family would be interested in learning more about
PrEP. The findings indicate a need for more community-based health programming and
awareness education to increase awareness and use of PrEP and that barbershops may be
an effective environment for public health practitioners to increase awareness of PrEP
and the dissemination of information pertaining to PrEP education and access among
heterosexual Black men.
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Table 4.1 Demographic Characteristics of Participants in Brooklyn PrEP study,
(N=206)

Variables
Have you ever heard of PrEP?
No
Yes
Have you or anyone that you know of ever used PrEP?
No
Yes
I Don’t Know
How interested do you think people in your network of
family and friends would be in learning more
about PrEP?
Not
Somewhat
Very
Race & Ethnicity
Black, non-Hispanic
Black, Hispanic
Born in the U.S.
No
Yes
Income
Less than 10k
10k or higher
Age
20-29
30-39
40-49
50-65
Education
Did not complete HS
Completed HS or equivalent or trade school
College or higher
Currently enrolled in school
No
Yes
Currently employed full or part-time
No
Yes
59

SurveyWeighted
Frequency

%

169
37

82
18

114
14
77

55.3
6.8
37.4

55
93
58

26.7
45.1
28.2

170
31

82.5
15

45
161

21.8
78.2

137
53

66.5
25.7

72
41
49
42

35
19.9
23.8
20.4

65
100
41

31.6
48.5
19.9

148
57

71.8
27.7

124
80

60.2
38.8

Currently have health insurance
No
Yes
Ever spent at least one night in jail or prison
No
Yes
Ever been tested for HIV?
No
Yes
Living with a sexual partner
No
Yes
Any sex with partner of unknown serostatus
or is HIV-positive
At least one partner
No
Have any one-time partners
No
Yes
Any unprotected sex with casual sexual partners
Condoms always
Condoms almost always/sometimes/never
No casual partners
HIV is a problem in my community
Agree
Disagree
Not Sure
People in my neighborhood are at risk for HIV
Agree
Disagree
Not Sure
Black men & women are at risk of HIV
Agree
Disagree
Not Sure
I am worried that I might get an HIV infection
Agree
Disagree
Not Sure
HIV is not that serious anymore
Strongly Agree

60

50
152

24.3
73.8

73
131

35.4
63.6

27
179

13.1
86.9

168
36

82.3
17.6

76
94

36.9
45.6

94
76

45.6
36.9

35
56
114

17.1
27.3
55.6

135
65
6

65.5
31.5
3

135
68
3

65.5
33
1.5

142
62
2

68.9
30.1
1

79
125
2

38.3
60.7
1

6

2.9

Agree
Disagree
Strongly Disagree
People like me do not get HIV infections
Agree
Disagree
I Don’t Know
How many women did you have sex with in the
past 90 days?
None
One
Two or More
Refuse to Answer
In the last 90 days have you used health education
materials provided by your barbershop?
No
Yes
In the last 90 days did your barber talk with you about
HIV?
No
Yes
In the last 90 days, did you talk with your family
about HIV?
No
Yes
In the last 90 days, did you talk with your friends
about HIV?
No
Yes
In the last 90 days, did you talk with your sexual
partner about HIV?
No
Yes

61

19
87
92

9.3
42.6
45.1

50
154
2

24.3
74.7
1

36
55
106
9

17.5
26.7
51.5
4.4

152
53

74.2
25.8

162
43

79.02
20.98

131
74

63.90
36.10

115
89

55.8
43.2

123
81

59.7
39.3

Table 4.2 Bivariate Analyses: How interested do you think people in your network
of family and friends would be in learning more about PrEP? by Demographic and
Self-Reported Behaviors in Brooklyn. (N=206)

Not
n
(%)

Variables

55
(26.7)

Total
Age Group (Years)

Friends/Family Interest in
PrEP (N=206)
Somewhat
Very
n
n
(%)
(%)
p-Value
93
(45.15)

58
(28.16)
0.3062

27
(13.24)
5
(2.45)
11
(5.39)
11
(5.39)

20-29
30-39
40-49
50-65
Income

25
(12.25)
24
(11.76)
26
(12.75)
17
(8.33)

20
(9.80)
12
(5.88)
12
(5.88)
14
(6.86)
0.2309

39
(20.53)
12
(6.32)

Less Than $10K
Greater Than $10K
Education
Did not complete HS

63
(33.16)
23
(12.11)

35
(18.42)
18
(9.47)
0.7849

Completed HS or Equivalent or Trade
School

College or Higher
Living with Partner

18
(8.74)

31
(15.05)

16
(7.77)
12
(5.83)

28
(13.59)
9
(4.37)

42
(20.39)
20
(9.71)

47
(23.04)
8
(3.92)

75
(36.76)
16
(7.84)

46
(22.55)
12
(5.88)

8
(3.88)
47
(22.82)

11
(5.34)
82
(39.81)

8
(3.88)
50
(24.27)

12
(5.83)
0.3926

No
Yes
Ever Tested for HIV

0.9132

No
Yes

62

In the Last 90 Days, Did You Talk to
Your Barber About HIV?

0.5159
42
(20.49)
13
(6.34)

No
Yes
In the Last 90 Days, Did You Talk with
Your Friends about HIV?

79
(38.54)
14
(6.83)

41
(20)
16
(7.80)
0.5527

33
(16.18)
22
(10.78)

No
Yes
In the Last 90 Days, Did You Talk with
Your Family about HIV?

51
(25)
41
(20.10)

31
(15.20)
26
(12.75)
0.0692

40
(19.51)
15
(7.32)

No
Yes
In the Last 90 Days, Did You Talk with
Your Sexual Partner about HIV?

59
(28.78)
34
(16.59)

32
(15.61)
25
(12.20)
0.4815

34
(16.67)
21
(10.29)

No
Yes

63

58
(28.43)
35
(17.16)

31
(15.20)
25
(12.25)

Table 4.3 Ordinal Logistic Regression of how interested do you think people in your
network of family and friends would be in learning more about PrEP? (N=206)

Variables
Age Group (Years)
20-29
30-39
40-49
50-65
Education
Did Not Complete HS
Completed HS or Equivalent or Trade
School
College or Higher
Ever Tested For HIV
No
Yes
Living with a sexual partner
Yes
No
In the Last 90 Days, Did You Talk to
Your Barber About HIV?
No
Yes
In the Last 90 Days, Did You Talk
with Your Friends about HIV?
No
Yes
In the Last 90 Days, Did You Talk
with Your Family about HIV?
No
Yes
In the Last 90 Days, Did You Talk
with Your Sexual Partners about
HIV?
No
Yes

Friends/Family interest in PrEP (N=206)
Adjuste
95% CI
d Odds
Lower
Upper
Ratio
Limit
Limit
p-Value
0.600
2.757
1.497
1.00

0.250
0.835
0.552

1.436
9.096
4.062

0.251
0.096
0.428

1.030
1.426

0.484
0.525

2.194
3.873

0.939
0.486

1.00
0.857

0.314

2.340

0.764

1.00
0.823

0.332

2.039

0.675

1.00
0.638

0.252

1.617

0.344

1.00
0.605

0.218

1.683

0.336

1.00
3.219

1.113

9.305

0.031

1.00
1.005

0.386

2.621

0.991

1.00
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Table 4.4 Proportional Odds Assumption of How interested do you think people in
your network of family and friends would be in learning more about PrEP?
(N=206)

Variables
Age Group (Years)/Response Level
20-29 vs 50-65/somewhat or very
20-29 vs 50-65/not
30-39 vs 50-65/somewhat or very
30-39 vs 50-65/not
40-49 vs 50-65/somewhat or very
40-49 vs 50-65/not
Education
Completed HS or Equivalent vs Did not
complete HS/somewhat or very
Completed HS or Equivalent vs Did not
complete HS/not
College or higher vs Did not complete
HS/somewhat or very
College or higher vs Did not complete
HS/not
Income
10k or higher vs less than 10k/somewhat
or very
10k or higher vs less than 10k/not
Living with Sexual Partner
Yes vs No/somewhat or very
Yes vs No/not
In the past 90 days, have you talked to
your barber about HIV?
Yes vs No/somewhat or very
Yes vs No/not
In the past 90 days, have you talked to
your friends about HIV?
Yes vs No/somewhat or very
Yes vs No/not
In the past 90 days, have you talked to
your family about HIV?
Yes vs No/somewhat or very
Yes vs No/not

Network of family and friends (N=206)
Adjuste
95% CI
d Odds
Lower
Upper
Ratio
Limit
Limit
p-Value
p=0.107
0.735
0.030
1.801
0.683
0.281
1.664
0.914
0.333
2.509
2.681
0.797
9.025
0.744
0.272
2.034
2.077
0.713
6.053
p=0.924
1.77
1.066

0.524

2.643

0.482

2.359

0.408

3.189

0.526

4.459

1.140
1.531
p=0.593
1.500
1.117

0.689
0.471

3.270
2.647
p=0.517

0.632
1.051

0.265
0.411

1.504
2.688
p=0.186

1.554
0.640

0.645
0.243

3.743
1.718
p= 0.478

0.628
0.573

0.229
0.209

1.718
1.571
p= 0.049

2.102
3.768
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0.768
1.251

5.755
11.348

In the past 90 days, have you talked to
your sexual partners about HIV?
Yes vs No/somewhat or very
Yes vs No/not

p= 0.966
1.124
1.060

66

0.470
0.426

2.687
2.642

Study 2: Awareness of and Willingness to Use PrEP among Heterosexual Men in
Dar es Salaam, Tanzania2

2
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ABSTRACT
Background: HIV remains a significant public health issue in Tanzania. In 2018,
there were an estimated 1.6 million people living with HIV (PLWH) in Tanzania with an
HIV incidence rate of 1.41% and a 5.1% prevalence rate among all ages. Some 78% of
PLWH are aware of their status; the main route of HIV transmission in Tanzania is
heterosexual transmission. A pertinent strategy for reducing HIV infections is PrEP, a
once-daily tablet taken by HIV-negative persons before they engage in potentially risky
behaviors that leave them susceptible to possible HIV exposure. There are no published
studies regarding awareness and/or willingness to use PrEP for heterosexual men in
Tanzania.
Design: This study used a cross-sectional survey design embedded into a
randomized control trial. Participating men completed a behavioral survey administered
by a data collector at baseline. The surveys assessed participants’ awareness of and
attitude towards PrEP, as well as HIV risk behaviors, social network characteristics, and
other variables.
Setting: Two wards in Dar es Salaam, Tanzania – Manzese and Tandale.
Results: Data collection occurred in June 2019 and included 506 men. Most men,
433 (85.6%) reported having never heard of PrEP prior to the survey. Still, 71.5% of men
reported being likely to take PrEP if it were offered to them. Nearly 40% of men stated
that they believed they would use PrEP before sexual intercourse either every time or
every other time. Thirty-six percent of men reported that a reason that would make other
men not want to take PrEP is not knowing where to get it from.
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Conclusion: PrEP was acceptable among this group as a large majority of them
men reported their willingness to use it if it were to become available. More research is
required to determine the best methods of promotion, delivery, and distribution of PrEP
among heterosexual males. Still, the results of the men’s willingness to use PrEP is
encouraging and provides evidence that there is interest in the drug among this
population.
Introduction
In 2018, approximately 37.9 million people around the world were living with
HIV/AIDS and an estimated 1.7 million persons worldwide had been newly infected in
the same year (HIV.gov, 2019). Yet only an estimated 79% of persons, globally, who are
HIV-positive were aware of their status in 2018 (HIV.gov, 2019). The African-region
accounted for slightly more than one-quarter (25.7%) of all people living with HIV in
2018 (WHO, 2019).
A strategy for reducing HIV infections that has been recommended by WHO is
pre-exposure prophylaxis (PrEP) (WHO, 2015). Oral PrEP is a once-daily tablet taken by
HIV-negative persons before they engage in potentially risky behaviors which leave them
susceptible to possible HIV exposure. Oral PrEP functions as a barrier to acquiring HIV
for HIV-uninfected individuals (WHO, 2015). PrEP was approved by the Food & Drug
Administration in 2012 under the brand-name Truvada in the U.S. and was found to be an
effective HIV prevention method. Research suggests that interest in PrEP is high among
certain demographics such as young Black MSM (Rolle et al., 2017). However, barriers
to PrEP, such as included costs, rigid adherence regimens, and access (Perez-Figuerora et
al., 2015) persist, and uptake of PrEP for at-risk populations such as MSM is low (Kirby
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& Thornber-Dunwell, 2014). Furthermore, in South Africa, one of the few countries in
Sub-Saharan Africa where PrEP is currently available, uptake of PrEP was 7% for HIVnegative men (Schwartz et al., 2017).
In 2020, there were an estimated 1.7 million people living with HIV (PLWH) in
Tanzania with an HIV incidence rate of 1.26 and a 4.7% prevalence rate among adults
aged 15-49 (UNAIDS, 2021). Some 78% of PLWH are aware of their status, 71% are on
treatment, and 62% are virally suppressed (UNAIDS, 2019). The main route of HIV
transmission in Tanzania is heterosexual transmission (Mpondo et al., 2017);
consequently, HIV remains a significant public health issue in Tanzania. Although few
articles have been conducted to explore the feasibility and acceptability of PrEP in
Tanzania, they have mostly focused on adolescent girls and young women and/or
provider perspectives (Marthur et al., 2016; a,bPopulation Council, 2017; Pilgrim et al.,
2018). There are no published studies regarding awareness and/or willingness to use
PrEP for heterosexual men in Tanzania. In this paper, we address this gap by presenting
research that was conducted among this population.
Methods
Parent study
Data for this project were collected as part of a R00 Phase II study entitled
“Acceptability and Feasibility of Unsupervised HIV Self-Testing among Networks of
Men: Tanzania Self-Testing Education and Promotion Project (STEP)” which assessed
the outcomes of two HIV testing strategies among heterosexual men living in Dar Es
Salaam, Tanzania. The STEP project builds on the idea that it is feasible to identify and
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engage leaders within their camps to promote HIV self-testing and confirmatory HIV
testing with men in their social networks. Camps are fixed venues where young men meet
up and socialize during prearranged dates and times in Dar es Salaam, Tanzania and offer
social support to one another (e.g., emotional, informational, and instrumental). Camps
generally have a democratic system that often includes the structure of having a
chairperson, a secretary, and a treasurer at the minimum. Membership dues are often
paid for members to remain in good standing. The objective of the study was to train men
as HIV self-testing (HIVST) educators to promote HIVST in their networks and assess
the effect of two different testing approaches on HIV testing uptake among men.
Study Design and Method
This study used a cross-sectional survey design embedded into the STEP project.
Camp members were recruited from two wards in Kinondoni municipality in Dar Es
Salaam, Tazania, Manzese and Tandale. Eleven camps in Manzese and 7 camps in
Tandale were included in the STEP project. The 18 camps were deemed eligible due to
their reported median member size of 20 and high levels of participation among
members.
Camp Recruitment, Screening and Eligibility
Men from two out of four wards (Manzese and Tandale) were selected to be
assessed for eligibility. Camp members who resided in the two wards were recruited and
screened for participation in the study. These two wards were selected due to data
showing a high proportion of men in those wards who have not tested for HIV in the past
12 months and did not provide blood for HIV testing at the endline of a previous trial
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(R01MH098690-01 PI: Maman). Eighteen camps were assessed for eligibility. Camps
had to meet several requirements to be eligible for selection into the study. Camps not
meeting criteria were eliminated from the sampling frame. Eligibility criteria included:
having 20 members or more, having less than 70 members, and 80% of camp members
having not been tested for HIV in the past 6 months.
Participant Inclusion & Exclusion
Camp members were eligible to participate in the study if they were male, at least
15 years old, had been member of camp for at least 3 months, visited the camp at least
once a week, owns a cellular phone, and were willing to provide their personal contact
information and the contact information of a relative or friend. Camp members were
excluded from participation if they did not meet all the inclusion criteria and if they were
unable to participate due to psychological disturbance, cognitive impairment, or
threatening behavior. At enrollment into the study, staff members recorded locator
information (name, telephone number, typical place of residence or sleeping location)
and names of contacts who usually know where to find the participant.
Behavioral Survey
After providing written consent, participating men completed a behavioral survey
administered by a data collector who used a Samsung tablet to record the participant
responses. Participants completed a behavioral survey at baseline and one-month followup. The surveys assessed the participants’ HIV risk behaviors, social network, collective
efficacy, knowledge/attitude towards PrEP, and other points of interest. Eligible and
consenting camp members in the selected camps participated in the survey assessing
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socio-demographic and outcome variables. The questionnaires were administered by
trained interviewers who are not intervention facilitators. The questionnaires took 40
minutes to an hour to complete. At one-month follow-up, a behavioral assessment was
conducted among eligible and consenting participants to assess outcome; the same
procedures described for the baseline assessment were used. All surveys were conducted
in Kiswahili, the predominant language in Tanzania.
Participant Compensation
Participants received monetary compensation of TSH 10,000 (4.29 USD) for
travel expenses to the site where interviews take place for completing the baseline and
follow-up survey; however, survey items regarding PrEP were only included at baseline
assessment.
Variables
Variables related to PrEP are presented in table 4.5. Nine survey items were
administered to participating men focused on PrEP with various response options: how
much do you know about PrEP (nothing at all, not much, some information, a lot of
information), have you ever heard of PrEP before today? (yes/no), if you were offered
PrEP, how likely are you to take it? (very likely, likely, neutral, unlikely, very unlikely),
how likely are you to inform your sexual partner that you are using PrEP (very likely,
likely, neutral, unlikely, very unlikely), how do you think your sexual partner would react
if you told them that you were using PrEP? (positively, neutral, negatively), how likely
are you to discuss PrEP with other camp members? (very likely/likely, neutral,
negatively), how often do you think you would use PrEP before sexual intercourse?
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(every time, every other time, neutral, sometimes, almost never), how likely are you to
use a condom during sexual intercourse while using PrEP (very likely, likely, neutral,
unlikely, very unlikely), what do you think are reasons that would make other men not
want to use PrEP? (they are not interested, they do not know where to get PrEP, I am not
sure/none of the above).
Sociodemographic variables for participating men included: age (20-29, 30-39,
40-49, 50-65), education (standard 1-4 or less/no formal education, standard 5-7, form 14/greater than form 4), marital status (single, monogamous marriage, cohabitating,
divorced/separated/widowed), do you have at least one close friend in the camp?
(yes/no), have you ever tested for HIV (yes/no), has your close friend encouraged you to
get an HIV test? (yes/no), do you think you close male friend has ever had an HIV test?
(yes/no), where did you learn about HIV self-testing? (this research project, peer educator
from camp, other), do you currently have a sexual partner? (yes/no), have you gone to the
HIV testing clinic with your sexual partner and tested? (yes/no), is your current sexual
partner male or female? (female, male), do you know your current partner’s HIV status?
(yes/no), does your current sexual partner know your HIV status? (yes/no), have you ever
sent text messages to your friends in the camp about HIV testing? (yes/no).
Statistical Analysis
The analysis for this paper included participants (n=505) who responded to survey
items related to PrEP during the baseline assessment of an HIV self-testing randomized
controlled trial in June 2019 in Dar Es Salaam, Tanzania. All variables of interest were
used to compute frequencies and percentages. Bivariate associations were performed
between willingness to take PrEP, sociodemographic variables, behavioral variables, and
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attitudes towards PrEP variables with the main outcome variable being “If you were
offered PrEP, how likely are you to take it?” Ordinal logistic regression was then
performed. Sociodemographic variables were selected to account for the diversity of
factors among the men including age, income, marital status, and education. Other
variables were selected due to their relevance to the reported environmental and
intrapersonal factors related to participating men in relation to men’s interest in PrEP.
In ordinal logistic regression, also known as cumulative logit regression or
proportional odds regression, the coefficients on the log-odds scale are used to quantify
how well an explanatory variable differentiates the lowest versus all higher categories of
the response (outcome) variable, the two lowest versus all higher categories, etc. under
the assumption that the relationship with explanatory variables at each threshold is the
same (Harrell, 2015). The odds ratios from the exponentiated coefficients quantify the
odds of higher interest in PrEP compared to lower interest in relation to the explanatory
variables.
Odds ratios and p-values were calculated to show the strength and confidence in
the associations, and c-statistics are reported to quantify model fit. The c-statistic ranged
from 0.5 (chance) to 1.0 (perfect fit), analogous to the area under the receiver operating
characteristic curve and was used to compute the proportion explained (e.g., a c-statistic
of 0.8 corresponds to three-fifths of the distance from 0.5 to 1.0). Statistical significance
was set at p ≤ 0.05. Analyses were preformed using SAS statistical software version 9.4
(SAS Institute Inc., Cary, NC).
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Ethical Oversight
This study was reviewed and approved by the institutional review boards of
University of South Carolina (IRB approval number: Pro00072005) and the National
Institute of Medical Research of Tanzania (NIMR/HQ/R.8c/Vol.I/1170).
Results
In June 2019, a total of 505 men were recruited with the assistance of peer
educators and camp leaders; men were surveyed from 18 camps. Table 4.5 presents the
demographic characteristics of camp members included in the study. The sample skewed
relatively younger with men aged 20-29 making up 39.6%, men aged 30-39 making up
26.73%, men aged 40-49 making up 22.77%, and men aged 50-65 making up 10.89% of
the sample. The highest level of school completed was secondary school education
(forms 1-4/greater than form 4), with 46.73% of men reporting this level of education.
Some 47% of men reported having completed up to primary school level of education
(standard 5-7) and 3.96% of men reported an education of standard 1-4 or less or no
formal education. Most men (60.2%) self-reported their marital status as single; 26.93%
reported being in a monogamous marriage, 9.31% reported cohabitating, and 3.56% were
either divorced, separated, or widowed. Overwhelmingly, all but one man reported
having at least one close friend in the camp; while 72% of men reported that their close
male friend has encouraged them to get an HIV test. A vast majority of men (90%) had
ever been tested for HIV, 64.48% believed that their close male friend had ever had an
HIV test, and 22.18% of men reported having ever sent text messages to their friends in
the camp about HIV. Approximately 80% of men reported learning about HIVST via a
peer educator from their camp.
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A large portion of men (83.96%) reported that they currently had a sexual partner.
All men reported that their current sexual partner was female and 45.99% reported having
gone to the HIV testing clinic with their sexual partner and tested. Still, over half of men
(58.25%) reported knowing their current partner’s HIV status, and 59.67% of men
reported that their current sexual partner knew of their HIV status.
PrEP
Table 1.5 presents the frequencies of survey items regarding PrEP for camp
members. When surveyed about how much they knew about PrEP, most men reported
knowing nothing at (86.34%) or not much (13.07). Most men (85.74%) reported having
never heard of PrEP prior to the survey. The same number of men (85.6%) reported
knowing “nothing at all” regarding PrEP. Still, 64.54% of men reported being very likely
to take PrEP if it were offered to them; however, 36% of men reported that a reason that
would make other men not want to take PrEP is not knowing where to get it from. Nearly
40% of men stated that they believed they would use PrEP before sexual intercourse
either every time or every other time, while a combined more than half of men (53.84%)
reported being very likely or likely to inform their sexual partner that they were using
PrEP. Slightly over one-third of men (36.44%) believed that their sexual partner would
react positively if they were informed that they were using PrEP, and a combined 59.21%
reported being very likely or likely to use a condom during sexual intercourse while using
PrEP. Lastly, almost three-fourths of men (74.46%) reported that they are very likely or
likely to discuss PrEP with other camp members.
Table 4.7 presents the bivariate analyses of “If you were offered PrEP, are you
likely to take it?” by demographic self-reported behaviors between variables of interest.
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Only two variables reached statistical significance, “how likely are you to discuss PrEP
with other camp members?” (p<.0001) and “how do you think your sexual partner would
react if you told them that you were using PrEP? (p<.0001). However, due to past
research’s inclusion of age, education, marital status, and having ever tested for HIV,
these variables were selected for the final regression model (Conserve et al., 2013;
Conserve et al., 2016). One variable concerning whether close male friends had tested
was also included in the model due to its high relevance to the outcome variable and the
study setting. Three variables of interest: “How do you think your sexual partner would
react if you told them that you were using PrEP?”, “Have you ever gone to the HIV
testing clinic with your sexual partner and tested?”, and “Do you know your current
partner’s HIV status?” were omitted from the final model due to an exorbitant amount of
missing data.
Table 4.8 presents the results of the ordinal logistic regression; “If you were
offered PrEP, are you likely to take it?” was the outcome variable. The results of the
ordinal logistic regression found that a few variables reached statistical significance.
“How likely are you to discuss PrEP with other camp members?” was statistically
significant (p<0.001), with men who reported being very likely or likely to discuss PrEP
with other camp members being thirty-two times more likely (OR 32.412; 95% CI
15.863-66.225) to report being willing to use PrEP if it were offered to them compared to
men who reported being very unlikely or unlikely to discuss PrEP with other camp
members. Men who reported a neutral response (p=.001) were three-times more likely to
report being likely to take PrEP if offered it compared to men who reported being very
unlikely or unlikely to discuss PrEP with other camp members (OR 3.392; 95% CI 1.603-
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7.178). “How do you think your sexual partner would react if you told them that you
were using PrEP?” also yielded a statistically significant result. Men who reported
believing that their sexual partner would react negatively were less likely (p<0.0001) (OR
0.206; 95% CI 0.122-0.347) to report being likely to take PrEP if offered it compared to
men who reported believing their sexual partner would react neutrally. Men who reported
believing their sexual partner would react positively if they told them that they were
using PrEP were more likely (p=0.517) (OR 1.225; 95% CI 0.662-2.268) to report being
likely to take PrEP if it were offered to them compared to men who reported believing
their sexual partner would be neutral, though no statistical significance was found.
Furthermore, men who reported having no formal education or having completed
standard four or less were four times as likely (p=0.018) (OR 4.147; 95% CI 1.26613.586) to report being likely to being likely to take PrEP if it were offered to them
compared to men who reported having secondary education or higher. Men who reported
a primary education were almost twice as likely (p=0.008) (OR 1.921; 95% CI 1.1843.119) to report being likely to take PrEP if it were offered to them compared to men who
reported secondary education or higher.
Though not statistically significant, the regression also found that as men increase
in age, they are less likely to respond being likely to take PrEP if offered when compared
to men aged 18-24. Men aged 25-31 (p=0.964) (OR 0.987; 95% CI 0.551-1.768), aged
32-39 (p=0.306) (OR 0.708; 95% CI 0.365-1.373), and aged 40 or older (p=0.155) (OR
0.551; 95% CI 0.242-1.254) were all less likely to reporting being willing to take PrEP if
it were offered to them. Men who reported being single were more likely to report being
likely to take PrEP if it were offered to them (p=0.325) (OR 1.331; 95% CI 0.753-2.353)
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compared to men in a monogamous marriage, as were men who reported being divorced,
separated, or widowed (p=0.534) (OR 1.442; 95% 0.454-4.575) compared to men in
monogamous marriages. Men who reported cohabitating were likely to report being
willing to take PrEP if it were offered to them (p=0.904) (OR 1.050; 95% CI 0.474-2.37)
compared to single men. Men who reported having ever been tested for HIV were less
likely to report being likely to take PrEP if it were offered to them (p=0.208) (OR 0.789;
95% CI 0.356-1.749) compared to men who had never been tested for HIV. Men who
reported not knowing if their close male friend has ever had an HIV test were two-times
as likely to report being likely to take PrEP if offered it (p=0.071) (OR 2.224; 95% CI
0.934-5.298) compared to men who reported no; men who reported thinking their close
male friend had ever had an HIV test were more likely to report being likely to take PrEP
if it were offered to them (p=0.208) (OR 1.701; 95% CI 0.744-3.893) compared to men
who reported no.
We opted to use the ordinal logistic regression based on the nature of the outcome
variable (assessed using an ordinal scale of ordered categories) and because such model
has more power to detect effect by producing a single coefficient. However, it is
performed under the proportional odds assumption. The proportional odds assumption
means that for each exposure variable included in the model, the coefficient estimate
between each pair of outcomes across two response levels are assumed to be the same.
This means for example, in examining the association between Willing to Use PrEP if
Offered and age, the effect of age on Willing to Use PrEP if Offered is constant across
the response scale. To test if the proportional odds assumption is met, we re-run the
ordinal regression model by specifying that the assumption that the effect (coefficient) is
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equal does not apply. This was done by adding unequal slopes in the model statement and
testing if the produced coefficients (slopes) for each response value of the outcome are
significantly different. Table 8 presents results of the proportional odds assumption test.
Based on this model we found that the proportional odds assumption was met for age
(p=0.341), ever tested for HIV (p=0.0527), and close male friend has ever had an HIV
test (p=0.540). The assumption was not met for marital status (p=0.006), education
(p=0.045), how likely are you to discuss PrEP with other camp members (p=0.040) and
how do you think your sexual partner would react if you told them that you were using
PrEP (p=0.022). Considering, the proportional odds assumption was not met for some
variables we have included in the supplementary material that depicts separate ORs for
all explanatory variables at different response levels of outcome (Willing to Use PrEP if
Offered).
Discussion
A previous research inquiry investigated PrEP interest among female bar workers
in Dar es Salaam (Harling et al., 2019), but no research has been published regarding
willingness to use PrEP among heterosexual men in Tanzania. Since PrEP has not been
marketed in Tanzania, it is unsurprising that most men reported not having heard of it.
However, it is encouraging, from a public health perspective that almost three-fourths of
men reported that they would be willing to take PrEP if it were offered to them. These
results indicate that there is great room for the promotion of PrEP for heterosexual men
not only within the camps, but perhaps all over Tanzania. Wide-scale marketing of PrEP
would address the beliefs of men that a barrier to its uptake would be men not knowing
where to find the drug, among other consideration to keep in mind regarding a roll-out of
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PrEP (Amico & Bekker, 2019). It is also encouraging that a portion of men reported
believing they would use PrEP often prior to sexual intercourse; past research has found
that PrEP use has been associated with feeling safe during sex and is able to create a
sense of control over vulnerabilities associated with HIV risks (Grant & Koester, 2016).
Interestingly, more men reported being willing to tell their partner that they were using
PrEP than the number of men who reported knowing their partner’s HIV status. An
explanation for this may be that the men feel more comfortable openly discussing HIV
prevention methods such as PrEP because there is no stigma associated with it yet due to
it being relatively unknown and supports the belief of one-third of men that their partner
would react positively to such news. However, past research, which included men and
women from Kenya and Namibia and 424 men in Tanzania found that 80% of
participants had disclosed their status to their partner and 64% knew their partner’s status
(Bachanas et al., 2013). With roughly half of men reporting that they were not aware of
their sexual partner’s HIV status and vice versa, interventions to increase couple’s HIV
testing and reducing HIV stigma may benefit the men and their partners as well. Still,
since almost three-fourths of men reported having been encouraged to test by a close
male friend in the camp, it is reasonable to believe that camps and their members are
good conveyors of health education and uptake for PrEP. Camps and other social clubs
could be used as ways to promote and disseminate PrEP, of which a strong
recommendation for PrEP uptake in Sub-Saharan Africa has been to reduce stigma
associated with PrEP and the normalization of its use (O’Malley et al., 2019); camps
could be used a strategic venue for both once PrEP widely available for use in Tanzania.
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The results of the final regression model revealed that men who believed their
sexual partner would react negatively were less likely to report being willing to take PrEP
if it were offered to them. This result is expected as it justifies a reason for why men may
not be interested in using PrEP and exposes another perspective that must be kept into
consideration for future research and PrEP uptake campaigns. The regression model also
revealed that men who reported being very likely or neutral to discuss PrEP with other
camp members were thirty-two times more likely to report being willing to take PrEP if it
were offered to them. This finding is encouraging because it provides evidence that both
men and their peers should be targeted for PrEP. Through the tailoring of heath
messaging to include the importance of peer support, future projects surrounding PrEP
intake should utilize this strategy. Also, in the final model, men who reported standard
four, less, or no formal education were four times as likely to report being willing to take
PrEP if it were offered to them compared to men with secondary education or higher and
provides evidence that lower educated men should be targeted for PrEP uptake.
Partner distributions of PrEP may, perhaps, also be a worthwhile strategy for
heterosexual men that is worth pursuing and may interest them and their female partners
as well. In tandem with multiple strategies, the positive effects of partner distribution
may be realized and may combat past findings of gay and bisexual men believing PrEP to
be only moderately important and moderately willing to convince their partner to use
PrEP (John et al., 2018). This method would allow men to be trained as health educators
and empower them to discuss the use of PrEP with their partners along with encouraging
HIVST and other HIV prevention methods. For such strategies to be successful, Tanzania
needs governmental policies which support, promote, and advocate for PrEP distribution
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and use. These policies must promote access to PrEP in all communities in the country
and provide guidelines and recommendations for healthcare professionals to adhere to.
Proper advertising and adequate rolling out of PrEP are also needed at the governmental
level. PrEP campaigns via interventions and advertisements should aim to increase
perceived susceptibility among men. PrEP should be offered in a combination of HIV
prevention strategies via behavioral, biomedical, structural approaches to maximize the
reach of HIV prevention and reducing HIV infection rates. PrEP is merely one part of the
prevention toolkit that should be used in conjunction with others to address HIV risk.
Interventions pertaining to PrEP should be effective, cost-effective, sustainable and easily
disseminated in other developing country settings as well. Although adolescent girl and
young women have been identified as key populations for HIV epidemic control in subSaharan Africa due to the incidence of new HIV infections being higher for this group
than men (Dellar et al., 2015), HIV remains a major public health issue for both men and
women in the region since most HIV transmission occurs through heterosexual sex (Cork
et al., 2020), and there are limited strategies that have proven effective at targeting men
(Sharma et al., 2017). Per the results of this research, men with memberships in social
camps expressed both an interest in learning more about PrEP and using it; these results
may have widespread application in other settings, outside of Dar Es Salaam and
Tanzania.
The strengths of this paper are numerous. First, because PrEP had not been rolled
out in Tanzania at the time of the survey administration, this paper is one of the first to
assess awareness of, interest in, and willingness to use PrEP among heterosexual men in
Tanzania. This paper is also the first study to use social camps to investigate PrEP in any
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capacity among men who are members of social camps. Thus, this paper provides
evidence that social camps may be a suitable place to provide HIV education and
prevention methods for heterosexual Black men in Tanzania.
This paper is also subject to limitations. First, because the design of this research
was cross-sectional, the results present data that was collected at a single point in time,
thus, it impossible to analyze the intentions, beliefs, and behaviors of participating men
over time. Secondly, the data provided was self-reported and all responses may not have
been truthful due to social desirability biases. The data presented also does not determine
cause and effect of PrEP use among participating men. Furthermore, the results of the
data may not be representative of other heterosexual men in different settings. The survey
instrument was translated from English to Kiswahili and there is a possibility that some
survey items were not accurately translated.
Lastly, considering that surveyed men are active members in camps and share
social spaces with the other participants, there is a potential risk of social desirability
bias. Lastly, key sociodemographic data that would have strengthened the understanding
of participants’ self-reported sexual behaviors and risk for HIV, such as frequency of
condom use and other preventive behaviors, were not included in the survey instrument.
Conclusion
PrEP was unknown to almost all heterosexual men surveyed in Dar es Salaam,
Tanzania. Still, after being explained what it is, PrEP was acceptable among this group as
a large majority of them men reported their willingness to use it if it were to become
available. More research is required to determine the best methods of promotion,

85

delivery, and distribution of PrEP among heterosexual males in Dar Es Salaam. Still, the
results of the men’s willingness to use PrEP is encouraging and provides evidence that
there is a market for the drug among this population in Dar Es Salaam.
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Table 4.5 Demographics and Characteristics Regarding HIV for Camp Members in
Dar Es Salaam, (N=505)
Frequency
%
Variables
Age
200
20-29
39.60
135
30-39
26.73
115
22.77
40-49
55
50-65
10.89
Education
20
Standard 1-4 or less/no formal education
3.96
247
Standard 5-7 (Primary)
47.13
236
Form 1-4/Greater than form 4 (Secondary)
46.73
Marital Status
304
Single
60.20
136
Monogamous Marriage
26.93
47
Cohabitating
9.31
18
Divorced/Separated/Widowed
3.56
Do you have at least one close friend in the camp?
504
Yes
99.80
1
No
0.20
Has your close male friend encouraged you to get an HIV
test?
141
No
27.98
363
Yes
72.02
Have you ever been tested for HIV?
49
No
9.70
Yes
Do you think your close male friend has ever had an HIV
test?
No
Yes
I don’t know/I don’t think so
Where did you learn about HIV self-testing?
This research project
Peer educator from camp
Other
Do you currently have a sexual partner?
No
Yes

90

456

90.30

33
325
146

6.55
64.48
28.97

23
172
20

10.70
80.00
9.30

81
424

16.04
83.96

Have you gone to the HIV testing clinic with your sexual
partner and tested?
No
Yes
Is your current sexual partner male or female?
Female
Male
Do you know your current partner’s HIV status?
No
Yes
Does your current sexual partner know your HIV status?
No
Yes
Have you ever sent text messages to your friends in the
camp about HIV testing?
No
Yes

91

229
195

54.01
45.99

424
0

100
0.00

177
247

41.75
58.25

171
253

40.33
59.67

393
112

77.82
22.18

Table 4.6 Frequencies of Survey Items Regarding PrEP for Camp Members in Dar
Es Salaam, (N=505)
%
Frequency
Variables
How much do you know about PrEP?
Nothing at all
Not much
Some information
A lot of information
Have you ever heard of PrEP before today?
No
Yes
If you were offered PrEP, how likely are you to take it?
Very Likely
Likely
Neutral
Unlikely
Very Unlikely
How likely are you to inform your sexual partner that you
are using PrEP?
Very Likely
Likely
Neutral
Unlikely
Very Unlikely
How do you think your sexual partner would react if you
told them that you were using PrEP?
Positively
Neutral
Negatively
How likely are you to discuss PrEP with other camp
members?
Very Likely/Likely
Neutral
Very Unlikely/Unlikely
How often do you think you would use PrEP before sexual
intercourse?
Every time
Every other time
Neutral
Sometimes
Almost Never

92

436
66
2
1

86.34
13.07
0.40
0.20

433
72

85.74
14.26

331
30
46
78
20

65.54
5.94
9.11
15.45
3.96

199
88
93
72
53

39.41
17.43
18.42
14.26
10.50

184
183
138

36.44
36.24
27.33

376
65
64

74.46
12.87
12.67

182
18
76
36
193

36.04
3.56
15.05
7.13
38.22

How likely are you to use a condom during sexual
intercourse while using PrEP?
Very Likely
Likely
Neutral
Unlikely
Very unlikely
What do you think are reasons that would make other men
not want to use PrEP?
They are not interested
They do not know where to get PrEP
I am not sure/None of the above

93

120
179
75
88
43

23.76
35.45
14.85
17.43
8.51

54
182
269

10.69
36.04
53.27

Table 4.7 Bivariate Analyses: If you were offered PrEP, are likely are you to take it?
by Demographic and Self-Reported Behaviors Dar Es Salaam. (N=505)
Willing to Use PrEP if
Offered (N=505)

Variables

Very
Unlikely
n
(%)

Total

3.96
(20)

Un- Neutr
Likely al
n
n
(%)
(%)
9.11
15.45
(46)
(78)

Likel
y
n
(%)
30
(5.94)

Very
Likel
y
n
(%)
331
(65.54
)

0.152
9

Age Group (Years)

18-24

25-31

32-39
40+
Education
Standard 1-4 or less/no formal
education

Standard 5-7 (Primary)
Form 1-4/Greater than form 4
(Secondary)
Marital Status

Single

Monogamous Marriage
Cohabitating
Divorced/Separated/Widowed

pValue

9
(1.78)

26
(5.15)

3
(0.59)

22
(4.36)

4
(0.79)
4
(0.79)

20
(3.96)
10
(1.98)

0
(0)

6
(1.19)

8
(1.58)

39
(7.72)

12
(2.38)

33
(6.53)

18
(3.56)

8
(1.58)

13
(2.57)

10
(1.98)

8
(1.58)

6
(1.19)

7
(1.39)

6
(1.19)

0
(0)
20
(3.96)

1
(0.20)
18
(3.56)

26
(5.15)

11
(2.8)

139
(27.52
)
87
(17.23
)
77
(15.25
)
28
(5.54)
13
(2.57)
162
(32.08
)
156
(30.89
)
0.257

9
(1.78)

40
(7.92)

9
(1.78)
2
(0.40)
0
(0)

24
(4.75)
9
(1.78)
5
(0.99)
94

25
(4.95)

17
(3.37)

13
(2.57)

7
(1.39)

7
(1.39)
1
(0.20)

5
(0.99)
1
(0.20)

213
(42.18
)
83
(16.44
)
24
(4.75)
11
(2.18)

Ever Tested for HIV
No

Yes
Do you think your close male
friend has ever had an HIV
test?
I Don’t Know/Think So
No

Yes
How likely are you to discuss
PrEP with other camp
members?

Very Likely/Likely
Neutral
Very Unlikely/Unlikely
How do you think your sexual
partner would react if you told
them that you were using
PrEP?

0.502
2
(0.40)
18
(3.56)

8
(1.58)
70
(13.86
)

1
(0.20)
29
(5.74)

35
(6.93)
296
(58.61
)

15
(2.98)

9
(1.79)

5
(0.99)
26
(5.16)

3
(0.60)
18
(3.57)

95
(18.85
)
18
(3.57)
217
(43.06
)

0.562
5
(0.99)
1
(0.20)

22
(4.37)
6
(1.19)

14
(2.78)

50
(9.92)

<.000
1
6
(1)
6
(1.19)
8
(1.58)

18
(3.56)
13
(2.57)
47
(9.31)

22
(4.36)

21
(4.16)

18
(3.56)
6
(1.19)

6
(1.19)
3
(0.59)

309
(61.19
)
22
(4.36)
0
(0.00)

<.000
1

Positively

2
(0.40)

4
(0.79)

Neutral

1
(0.20)

15
(2.97)
59
(11.68
)

Negatively

3
(0.59)
43
(8.51)

17
(3.37)

95

8
(1.58)

10
(1.96)

28
(5.54)

10
(1.98)

10
(1.98)

10
(1.98)

160
(31.68
)
129
(25.54
)
42
(8.32)

Table 4.8 Ordinal Logistic Regression of If you were offered PrEP, are likely are
you to take it? (N=505)
Willing to Use PrEP if Offered (N=505)
Adjuste
95% CI
d Odds
Lower
Upper
Ratio
Variables
Limit
Limit
p-Value
Age Group (Years)
1.00
18-24
0.987
25-31
0.551
1.768
0.964
0.708
32-39
0.365
1.373
0.306
0.551
40+
0.242
1.254
0.155
Education
Form 1-4/Greater than for 4
1.00
(Secondary)
1.921
Standard 5-7 (Primary)
1.184
3.119
0.008
4.147
Standard 4 or less/no formal education
1.266
13.586
0.018
Marital Status
1.331
Single
0.753
2.353
0.325
1.00
Monogamous marriage
1.050
Cohabitating
0.474
2.327
0.904
1.442
Divorced/separated/widowed
0.454
4.575
0.534
Ever Tested for HIV
1.00
No
0.789
Yes
0.356
1.749
0.559
Do you think your close male friend
has ever had an HIV test?
1.00
No
1.701
Yes
0.744
3.893
0.208
2.224
I Don’t Know/I Don’t Think So
0.934
5.298
0.071
How likely are you to discuss PrEP
with others camp members?
32.412
Very likely/likely
15.863
66.225
<.0001
3.392
Neutral
1.603
7.178
.001
1.00
Very unlikely/unlikely
How do you think your sexual partner
would react if you told them that you
were using PrEP?
1.225
Positively
0.662
2.268
0.517
1.00
Neutral
0.206
Negatively
0.122
0.347
<.0001

96

Table 4.9 Proportional Odds Assumption of If you were offered PrEP, are likely are
you to take it? (N=505)
Willing to Use PrEP if Offered (N=505)
Adjuste
95% CI
d Odds
Lower
Upper
Ratio
Variables
Limit
Limit
p-Value
Age Group (Years)/Response Level
p=0.341
1.028
25-31 vs 18- 34/very unlikely
0.525
2.016
1.060
25-31 vs 18- 34/unlikely
0.504
2.229
0.930
25-31 vs 18- 34/neutral
0.381
2.267
4.644
25-31 vs 18- 34/likely
0.849
25.387
0.869
32-29 vs 18-24/very unlikely
0.381
1.982
0.674
32-39 vs 18-24/unlikely
0.234
1.940
0.331
32-39 vs 18-24/neutral
0.094
1.170
1.623
32-39 vs 18-24/likely
0.264
9.983
0.353
40-66 vs 18-24/very unlikely
0.130
0.963
0.562
40-66 vs 18-24/unlikely
0.166
1.906
0.692
40-66 vs 18-24/neutral
0.160
2.986
0.726
40-66 vs 18-24/likely
0.097
5.402
Education
p=0.045
3.546
No Formal vs Secondary/very unlikely
0.654
19.224
5.940
No Formal vs Secondary/unlikely
0.494
71.442
0.185
No Formal vs Secondary/neutral
0.004
8.374
2.238
No Formal vs Secondary/likely
0.081
62.156
1.352
Primary vs Secondary/very unlikely
0.713
2.565
3.978
Primary vs Secondary/unlikely
1.685
9.396
1.494
Primary vs Secondary/neutral
0.669
3.340
4.283
Primary vs Secondary/likely
1.193
15.372
Marital Status
p=0.006
Cohabitating vs Monogamous
0.226
Marriage/very unlikely
0.085
0.602
Cohabitating vs Monogamous
2.067
Marriage/unlikely
0.619
6.905
Cohabitating vs Monogamous
3.739
Marriage/neutral
0.962
14.533
Cohabitating vs Monogamous
2.262
Marriage/likely
0.327
15.666
Divorced/Separated/Widowed vs
Monogamous Marriage/very unlikely
2.487
0.428
14.453
Divorced/Separated/Widowed vs
Monogamous Marriage/unlikely
1.396
0.211
9.223
Divorced/Separated/Widowed vs
Monogamous Marriage/neutral
0.277
0.040
1.933
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Divorced/Separated/Widowed vs
Monogamous Marriage/2
Single vs Monogamous Marriage/very
unlikely
Single vs Monogamous
Marriage/unlikely
Single vs Monogamous
Marriage/neutral
Single vs Monogamous Marriage/likely
Ever Tested for HIV
Yes vs No/very unlikely
Yes vs No/unlikely
Yes vs No/neutral
Yes vs No/likely
Do you think your close male friend
has ever had an HIV test?
Yes vs No/very unlikely
Yes vs No/unlikely
Yes vs No/neutral
Yes vs No/likely
I Don’t Know/Think So vs No/very
unlikely
I Don’t Know/Think So vs No/unlikely
I Don’t Know/Think So vs No/neutral
I Don’t Know/Think So vs No/likely
How likely are you to discuss PrEP
with others camp members?
Very Likely/Likely vs Unlikely/very
unlikely
Very Likely/Likely vs Unlikely/unlikely
Very Likely/Likely vs Unlikely/neutral
Very Likely/Likely vs Unlikely/likely
Neutral vs Unlikely/very unlikely
Neutral vs Unlikely/unlikely
Neutral vs Unlikely/neutral
Neutral vs Unlikely/likely
How do you think your sexual partner
would react if you told them that you
were using PrEP?
Negatively vs Neutral/very unlikely
Negatively vs Neutral/unlikely
Negatively vs Neutral/neutral

2.061
0.598

0.40

107.243

0.289

1.239

0.520

3.122

0.248
0.445

2.065
11.342

1.274
0.716
2.247

p=0.052
7
0.177
0.361
1.941
1.008

0.046
0.087
0.418
0.171

0.675
1.494
9.010
5.952
p=0.540

1.938
0.983
0.375
0.722
2.293
1.01
0.807
1.097

0.644
0.275
0.079
0.071

5.835
3.509
1.775
7.325

0.740
0.308
0.166
0.097

7.104
3.939
3.916
12.33
p=0.040

28.741
44.826
32.279
2.353
2.601
2.173
2.839
0.351

5.769
14.353
11.309
0.556
0.435
0.632
0.912
0.084

143.178
139.990
92.131
9.954
15.536
7.466
8.832
1.457

p=0.022
0.222
0.252
0.060
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0.118
0.127
0.025

0.417
0.500
0.142

0.047
1.419
1.737
0.973
2.999

Negatively vs Neutral/likely
Positively vs Neutral/very unlikely
Positively vs Neutral/unlikely
Positively vs Neutral/neutral
Positively vs Neutral/likely
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0.007
0.733
0.698
0.242
0.062

0.323
2.750
4.320
3.914
144.052

Study 3: PrEPping for Inclusion: a systematic review of pre-exposure prophylaxis
research among heterosexual men3

3

Hamilton, A. To be submitted to Sexual Health.
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ABSTRACT
Background: In 2019, an estimated 38 million people were living with HIV
worldwide; however, recent successes in HIV prevention and treatment have been
variable by region, country, and population because of differing access to HIV testing,
treatment, and care. HIV prevention research and programming has typically focused on
men who have sex with men (MSM), a demographic that in many geographic areas such
as the USA comprise the highest incidences of HIV. Yet, heterosexual men are a key
demographic that should also be targeted for HIV prevention. PrEP, which has been
proven effective to prevent HIV infection among multiple groups, is an important tool for
heterosexual men to reduce HIV incidence. To investigate the current literature
surrounding heterosexual men, we completed a systematic review to synthesize papers
that discuss PrEP and heterosexual men without including serodiscordant couples. We
aimed to gain the clearest view of what research has been conducted explicitly for
heterosexual men.
Methods: We used a systematic approach to survey literature published using
electronic databases (through a database search which including PubMed, Embase,
Scopus, Global Health, Google Scholar, and a manual search). The literature search was
completed in May 2021. No publication date parameters or geographic restrictions were
set for the search. Both quantitative and qualitative articles that focused on PrEP,
included heterosexual men, articles that were peer reviewed, and were written in English
were included in this review.
Results: A total of twenty-one articles matched the inclusion criteria and were
sorted into five themes: awareness, acceptability & willingness to use,
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uptake/adherence/maintenance, facilitators & barriers, and PrEP efficacy. Eleven articles,
with extracted data matching more than one theme, were sorted into each category of
which they fit. PrEP awareness was low at 4.9% for heterosexual men. Low risk
perception was the most common reason for lack of willingness to use. Fear of becoming
infected with HIV (32%) was the greatest reason for male PrEP initiation; having
multiple partners (18%), not knowing the HIV-status of a sexual partner (15%) and living
in a serodiscordant relationship (14%) were other reasons for PrEP initiation.
Heterosexual men believed HIV testing to be a major limitation to accessing PrEP
regardless of participants’ HIV risk perception. Regarding participant attitudes towards
PrEP, 83% reported that they would not feel anxious about using PrEP and 87% reported
that they would not feel embarrassed about using PrEP.
Conclusion: Our findings from this systematic review reflect a dearth of literature
focused on heterosexual men regarding PrEP awareness, willingness to use, and uptake.
Our findings demonstrate that few studies have been published pertaining to PrEP uptake
and adherence for heterosexual men. Results from our review show that PrEP awareness
is very low for heterosexual men while uptake and adherence are even lower. Still, of the
relevant articles found for PrEP and heterosexual men, it is encouraging that when
surveyed, most heterosexual men report being willing to use PrEP, providing ample
opportunities for researchers to develop and implement programming and interventions
targeted at heterosexual men along the entire PrEP continuum of care.
Keywords: HIV; preexposure prophylaxis; PrEP; men, heterosexual men
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Introduction
In 2019, an estimated 38 million people were living with HIV worldwide (WHO,
2021); however, new HIV infections have fallen by 39% and HIV/AIDS related deaths
have fallen by 51% between 2000 and 2019 (WHO, 2021). Although much progress has
been made, reducing the number of new infections for HIV infections remain a pertinent
global health concern. Recent successes in HIV prevention and treatment have been
variable by region, country, and population because of differing access to HIV testing,
treatment, and care (WHO, 2021). Sub-Saharan African countries, specifically Southern
African countries have been a high priority region for HIV prevention and care (Vermund
et al., 2015). In 2018, it was estimated that about one out of five adults were living with
HIV in South Africa (UNAIDS, 2019). In the same year, heterosexual persons comprised
24% of all new HIV infections in the U.S., of which heterosexual men accounted for 8%
of those new infections (HIV.gov, 2021). However, HIV prevention research and
programming have typically focused on men who have sex with men (MSM), a
demographic thatcomprise the highest incidences of HIV (Sullivan et al., 2020). Yet,
there are regions, such as in sub-Saharan Africa, where most HIV infections occur among
opposite-gender partners (Dwyer-Lindgren et al., 2019). PrEP programming,
interventions, and strategies for serodiscordant MSM are abundant in the literature
(Brooks et al., 2020; Dubov et al., 2018; Garcia & Harris, 2017) and little is known about
PrEP uptake for heterosexual men because past research has mostly focused on
serodiscordant couples (Haberer et al., 2018; Irungu et al., 2019; Musinguzi et al., 2020).
PrEP, which has been proven effective to prevent HIV infection among multiple
groups (Fonner et al., 2016), is a worthwhile strategy for at risk heterosexual men. PrEP
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is an important tool for heterosexual men to utilize to reduce HIV incidence among this
population. Heterosexual men are a key demographic targeted for HIV prevention in
geographic locations such as sub-Saharan Africa (Cork et al., 2020). However, because
heterosexual men have not been a high priority population for HIV prevention in
locations such as the U.S., it is imperative to be aware of what is both known and has
been done regarding PrEP offerings for heterosexual men in all geographic locations.
Furthermore, identifying awareness of, willingness to use, access, stigma, barriers to
uptake, and adherence of PrEP is of equal importance. To investigate the current
literature surrounding heterosexual men, we completed a systematic review to synthesize
papers that discuss PrEP and heterosexual men without including serodiscordant couples
to screen out research that typically included heterosexual men but are more focused on
their female counterparts. We aimed to gain the clearest view of what research has been
conducted explicitly for heterosexual men. We also aimed to identify pertinent research
gaps and key concepts regarding PrEP and heterosexual men to inform future research
and address research gaps.
Methods
Chosen Methodology
A systematic review approach was selected to present the results of the review.
Systematic reviews allow for a thorough overview of the current literature surrounding
PrEP for heterosexual men and allows for the description and appraisal of previous
studies (Temple University Libraries, 2021). The results of the review are presented in a
narrative synthesis format to convey what is known about and what has been investigated
regarding PrEP for heterosexual men which includes a synthesis of the findings presented
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via words and text to summarize and explain the findings (Popay et al., 2006). The aim of
this paper is to compile all relevant research on PrEP research for heterosexual men and
provide recommendations for future PrEP research. The decision to restrict the inclusion
of serodiscordant couples is a result of the vast amount of literature that has been
published featuring heterosexual serodiscordant couples. Simply put, there are far too
many heterosexual serodiscordant articles to be presented in one paper and while
valuable to the literature, these papers often exclude single and/or unmarried heterosexual
men. To narrow the scope of this review, we opted to omit these studies. Also, many
studies that included serodiscordant couples reached heterosexual men via their female
counterparts and were typically more focused on using women as a means of getting men
to participate in the research. Because of this, the decision was made to not include these
studies. This systematic review includes studies that have focused solely on heterosexual
men.
Search Strategy
This systematic review was conducted through a database search in May 2021 and
included PubMed, Embase, Scopus, Global Health, Google Scholar, and a manual search.
No publication date parameters or geographic restrictions were set for the search. We
used combinations of specified search terms across all databases such as: (Pre-Exposure
Prophylaxis[mesh] OR pre-exposure prophylaxis[tw] OR Pre-Exposure Prophylaxi[tw]
OR preexposure prophylaxis[tw]) AND (heterosexuality[mesh] OR heterosexuality[tw]
OR heterosexual[tw] OR heterosexuals[tw] OR heterosexually[tw] OR straight[tw])
AND (men[mesh] OR men[tw] OR man[tw] OR male[tw] OR males[tw]).
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Study Selection
This review utilized the guidance of the Preferred Reporting Items for Systematic
Reviews and Meta Analyses extension for Systematic Reviews (PRISMA-ScR). The
selection of articles for inclusion was completed in multiple stages. First, search yields
from all databases were compiled in an Endnote file; titles were then scanned, and
duplicate titles were removed. Following the removal of duplicate titles, relevant articles
were screened via their abstracts. Articles were then selected for full-text review and their
references were inserted into to an Excel spreadsheet. Following full-text review, a final
sample of studies meeting eligibility criteria was compiled and data from each article was
extracted and compiled.
Study Selection/Inclusion Criteria
Studies included in this review were limited to search results which highlighted
HIV chemoprophylaxis, most referred to as PrEP, and heterosexual men. If the article
title and/or abstract included PrEP but was unclear or did not specify if heterosexual men
were included, those articles were also reviewed for inclusion. Both published
quantitative and qualitative articles that met the below inclusion criteria underwent fulltext review: article focused on PrEP, included heterosexual men, article was peer
reviewed, and was written in English. Titles were then excluded if they: did not discuss
PrEP for heterosexual men (e.g., did not focus solely on or include heterosexual men or
serodiscordant couples), the article was not peer-reviewed, the article was written in a
language other than English, or due to the article publication type (e.g., review article,
meta-analysis, editorial, unpublished poster abstract, commentary).
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Data Extraction & Analysis
A single coder (A.H.) completed the individual screening of articles and made
final decisions for article inclusion or exclusion based on the above criteria. A.H.
extracted relevant information from each article including study characteristics,
participant sample demographics, and article study design. A.H. reconciled the results
and conducted a final review of the yielded literature. Extracted data from each included
article was then summarized in a table that highlighted the publication authors, year of
publication, country where the research was conducted, study population, and the main
study findings (see Table 4.10). Data was collated in an Endnote file. Data were grouped
according to their theme; included articles’ methods, country of investigation, study
design, and results were charted.
Results
A total of 865 records were identified using electronic search strategies; 362
duplicates were then removed. After removal, 458 relevant titles/abstracts were then
screened; 381 titles/abstracts were excluded for reasons such as: study did not discuss
PrEP for heterosexual men, article was not peer reviewed, paper was not written in
English, or the paper fell into one an exclusionary category (e.g., review article, metaanalysis, editorial case report, etc.). Thirty-six articles were selected for full-text review
after which 15 articles were excluded because of their focusing on serodiscordant
couples, paper not focused on heterosexual men, PrEP not discussed, poster presentation,
only an abstract provided, or article focused on an animal model. A total of twenty-one
articles matched the inclusion criteria and were sorted into five themes: awareness,
acceptability & willingness to use, uptake/adherence/maintenance, facilitators & barriers,
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PrEP efficacy. Eleven articles, with extracted data matching more than one theme, were
sorted into each category of which they fit. Each theme and its included articles are
presented below.
Awareness
Five articles discussed PrEP awareness (Jones et al., 2021; Leonardi et al., 2011;
Ojikutu et al., 2018; 3Roth et al., 2019; Zhang et al., 2019). In the United States, PrEP
awareness was lowest among heterosexual persons (7%), highest among men who have
sex with men (85%), and 26% among persons who inject drugs (Jones et al., 2021). Out
of 256 participants, very few (11.7%) men reported awareness of PrEP (Leonardi et al.,
2011). In the same study, more MSM (14.1%) were aware of PrEP than heterosexual men
(4.9%) (Leonardi et al., 2011). Findings from one article found that 14.5% of all survey
participants reported being aware of PrEP; awareness of PrEP was higher among high
risk than lower risk participants (19.8% vs 11.4%) (Ojikutu et al., 2018). Further,
reported PrEP awareness was low at 4.9% (95% CI 1.9% to 7.9%) for men in another
study (3Roth et al., 2019). Among participants who reported having had a health care visit
in the past 12 months, reported PrEP awareness was lowest when compared to
participants who had no health care visits (OR 0.09; 95% CI 0.03-0.32) (3Roth et al.,
2019). Participation in an HIV prevention intervention (e.g., conversations with HIV
prevention professional or receiving free condoms) was associated with increased PrEP
awareness (3Roth et al., 2019). Participants who had participated in an intervention were
5.53-fold more likely to be aware of PrEP (95% CI 1.55-19.7) compared to those had not
participated in an intervention (3Roth et al., 2019). No statistical difference in PrEP
awareness was reported by gender, race/ethnicity, or having tested for HIV in the past 12
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months (3Roth et al., 2019). One article reported more than one-third (38%) of 138
participants being aware of PrEP (Zhang et al., 2019). MSM reported significantly
greater odds of reporting being aware of PrEP compared to other respondents (OR, 5.6,
95% CI, 2.5–13.1) than their heterosexual male counterparts (Zhang et al., 2019). Being
male, having a non-heterosexual orientation, health insurance status, and having tested
for HIV in the past were significantly associated with greater odds being aware of PrEP
(Zhang et al., 2019). Participants who believed that HIV is treatable (OR, 2.2, 95% CI,
1.0–5.1) or that condoms reduce the risk of acquiring HIV (OR, 2.7, 95% CI, 0.9–8.8)
were more likely to report being aware of PrEP (Zhang et al., 2019). Participants who
reported believing stigma affects HIV testing (OR, 2.1, 95% CI 0.9–4.8) or that stigma
affects HIV treatment (OR, 2.6, 95% CI, 1.1–6.3) were also more likely to report being
aware of PrEP (Zhang et al., 2019). No significant association between self-reported
awareness of how to protect oneself from HIV with being aware of PrEP (OR 1.8, 95%
CI, 0.7–4.8) was found (Zhang et al., 2019).
Acceptability & Willingness to use
Nine articles discussed PrEP acceptability and willingness to use (Govender &
Karim, 2018); Hannaford et al., 2020; Kumar et al., 2013; Leonardi et al., 2011; Martin et
al., 2017; Ojikutu et al., 2018; 1Roth et al., 2019; Schneider et al., 2010; Schneider et al.,
2012). Most men reported not being in support of PrEP use and expressed that a
justification of vulnerability or exposure to risk of HIV infection for their women must be
present to accept product use (Govender & Karim, 2018). Urban men who support PrEP
use reported that PrEP use is limited to “vulnerable rural women” but not their female
romantic partners (Govender & Karim, 2018). In another study, participants reported
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being willing to take PrEP to protect themselves as well as their sexual partner amidst
anticipated stigma and structural barriers (Hannaford et al., 2020). PrEP had an
acceptance rate of 87% among truck drivers and driver apprentices (Kumar et al., 2013).
When asked if they would accept taking a pill soon once daily to prevent HIV infection,
87.3% truckers reported being likely to get more information; 84.3% of truckers reported
an interest in obtaining the medication if it were provided free of cost over the next 3
years by a healthcare provider (Kumar et al., 2013). However, 75.8% of truck drivers
reported being likely to pay for PrEP. Of truckers who were likely to consider PrEP,
42.3% were likely to consider taking a pill once a day without planning to have sex
afterwards and 57.7% were likely to consider a pill one day before sex and then for 28
days afterwards (Kumar et al., 2013). Most truckers, 87%, were likely to recommend it to
their friends, if necessary (Kumar et al., 2013). Participant willingness to consider PrEP
use was high and associated with high-risk activities such as having multiple sexual
partners (Leonardi et al., 2011). Identifying as MSM was strongly associated with PrEP
awareness (odds ratio [OR] 3.55; 95% CI: 1.03, 12.28) (Leonardi et al., 2011). Variables
associated with ‘definitely’ or ‘maybe’ being willing to use PrEP included MSM status
(OR 1.90, 95% CI: 1.06, 3.41), more than one sexual partner in the preceding six months
(OR 2.43, 95% CI: 1.27, 4.66 for those with 2–4 partners; OR 2.11, 95% CI: 1.08, 4.10
for those with 5 or more partners) and unprotected anal sex in the past six months (OR
2.02, 95% CI: 1.19,3.42) (Leonardi et al., 2011).
Among PWID, findings support the belief that a great proportion of PWID who
are aware of PrEP may be interested in taking it; most eligible Bangkok Tenofovir Study
(BTS) participants (Martin et al., 2017). However, 26.0% of participants reported being
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willing to use PrEP (Ojikutu et al., 2018). Among high-risk participants, willingness to
use PrEP was higher than among lower risk (35.1% vs 20.5%) (Ojikutu et al., 2018). Low
risk perception was the most common reason for lack of willingness to use PrEP [lower
risk (76.8%), high risk (65.1%)] (Ojikutu et al., 2018). One-half of participants reported
willingness to take PrEP even though only 25% of participants reported believing they
were at-risk for HIV (1Roth et al., 2019). Participants who perceived themselves to be atrisk for HIV had 2.2-fold likelihood of being willing to take PrEP 95% confidence
interval (CI):1.12–4.35] compared to participants with no perceived HIV risk (1Roth et
al., 2019). In another study, truck-drivers reported low initial commitment to PREP
Schneider et al., 2010). Also, a large majority (85.9%) of participants reported being
likely to accept PrEP; however, a pericoital option (used at the time of intercourse) was
preferred to a once-daily PrEP option among 57.5% of participants likely to accept PrEP
and 97.4% of participants unlikely to accept PrEP (Schneider et al., 2012). One-quarter of
respondents reported intercourse with female sex workers (FSW) and 5% with men
(MSM). Participants reporting prosocial network characteristics demonstrated variable
PrEP acceptability (AORs 0.08–2.22; p < 0.001) (Schneider et al., 2012). Ages ranging
from 20-24, current alcohol use, alcohol use prior to sex, current drug use, multiple sex
partners in the past 6 months, extramarital sexual partner at last sex, history of sex with
men, and friend closeness were significantly associated with increased odds of accepting
PrEP (p < 0.05) in bivariate analyses (Schneider et al., 2012). Conversely, low-middleand high-income levels, traveling on a southeastern route, having many friends, daily
communication with a friend, and closeness of friend to respondent’s family, were
associated with decreased odds of accepting PrEP (Schneider et al., 2012).
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Uptake, Adherence & Maintenance
Six articles discussed uptake, adherence, and maintenance of PrEP (BernerRodoreda et al., 2020; Cheng et al., 2016; Choopanya et al., 2013; Leonardi et al., 2011;
Martin et al., 2017; Wu et al., 2017). PrEP uptake skewed predominantly towards
participants aged 26-35 with this group accounting for 43.1% of total PrEP initiation and
43.8% for men (Berner-Rodoreda et al., 2020). Fear of becoming infected with HIV
(32%), according to risk assessment forms, was the greatest reason for male PrEP
initiation; having multiple partners (18%), not knowing the HIV-status of a sexual partner
(15%) and living in a serodiscordant relationship (14%) were other reasons for PrEP
initiation (Berner-Rodoreda et al., 2020). Men who continued PrEP and who also had an
HIV-positive partner on anti-retroviral treatment (ART) reported coordinating the times
for taking PrEP and ART pills as a useful adherence tool (Berner-Rodoreda et al., 2020).
Heterosexual men believed HIV testing to be a major limitation to accessing PrEP
regardless of participants’ HIV risk perception (Berner-Rodoreda et al., 2020). In another
article, nearly half (48%) of participants reported preferring long acting injectable (LAI)
PrEP, while 33% and 20% preferred oral PrEP and condoms, respectively (Cheng et al.,
2016). Being a parent and having children (marginal effect = 0.22; 95% CI [0.01, 0.44])
or reporting higher risk attitude scores (marginal effect = 0.03; 95% CI [0.01, 0.06]) was
significantly associated with a choice of LAI PrEP (Cheng et al., 2016). Participants who
had engaged in unprotected anal intercourse (marginal effect = − 0.42; 95% CI [− 0.57, −
0.27]) and those who were concerned with protection against other sexually transmitted
infections over HIV (marginal effect = − 0.42; 95% CI [− 0.60, − 0.24]) were less likely
to prefer LAI PrEP (Cheng et al., 2016). Men who have children were associated with a
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higher likelihood of choosing LAI PrEP compared to childless men, which yielded a
likelihood increase of 22% (marginal effect = 0.22; 95% CI [0.01, 0.44]) (Cheng et al.,
2016). However, it was found that neither MSM nor heterosexual men participants
reported PrEP usage (Leonardi et al., 2011).
In a study focusing on PrEP for HIV infection in injecting drug users, participants
took PrEP an average (mean) of 83.8% of days (SD 23.0, median 94.1%, IQR 79.2–
98.7); participant adherence did not differ by treatment group (assigned to tenofovir and
included in the intention-to-treat analysis) (p=0.16) or by time on study (p=0·22)
(Choopanya et al., 2013). Participants aged 40 years and older adhered better (median
98.2%, 93·5–99·5) than younger participants (92.3%, 75.5–98.2; p<0.0001) (Choopanya
et al., 2013). Women (95.6%, 81.1–98.9) adhered better than men (93.8%, 78.8–98.7%;
p=0.04) (Choopanya et al., 2013). Seventeen participants met the adherent criteria (e.g.,
took the study drug for 71% or more of days and did not miss more than 2 consecutive
days of study drug)—five in the tenofovir group and 12 in the placebo group, yielding an
efficacy estimate of 55.9% (95% CI, –18.8 to 86.0; p=0.11) (Choopanya et al., 2013).
Martin et al (2017) found that 61% of participants opted to start open-label PrEP;
participants who were 30 years or older (odds ratio [OR] 1·8, 95% CI 1·4–2·2;
p<0·0001), injected heroin (OR 1·5, 1·1–2·1; p=0·007), or had been in prison (OR 1·7,
1·3–2·1; p<0·0001) during the randomized trial were more likely to choose PrEP than
participants without these characteristics (Martin et al., 2017). Participants who reported
injecting heroin or being in prison during the 3 months before open-label enrolment were
more likely to return for at least one open-label follow-up visit than those who did not
report injecting heroin (OR 3·0, 95 % CI 1·3–7·3; p=0·01) or being in prison (OR 2·3,
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1·4–3·7; p=0·0007) (Martin et al., 2017) Participants who injected midazolam or were in
prison during open-label follow-up were more likely to be greater than 90% adherent
than were those who did not inject midazolam (OR 2·2, 95% CI 1·2–4·3; p=0·02) or
were not in prison (OR 4·7, 3·1–7·2; p<0·0001) (Martin et al., 2017).
In an article reporting on PrEP among commercially insured persons in the U.S.
in a five-year period, male PrEP users increased from 82.0% in 2010 to 97.5% in 2014
(Wu et al., 2017). Throughout the 5-year study period, participants who reported living in
the West showed an increasing trend in PrEP uptake and accounted for >40% of PrEP
users in 2014 (Wu et al., 2017). Each year, most participants (>97% of PrEP users) lived
in a metropolitan area (Wu et al., 2017). The weighted prevalence of persons prescribed
PrEP among the US population with commercial health insurance increased significantly
from 3.3 per million in 2010 to 75.4 per million in 2014 (Wu et al., 2017). When
stratified by sex, male PrEP prevalence increased significantly overtime; the largest
increase occurred in 2014 with 151.2 persons prescribed PrEP per one million (Wu et al.,
2017).
Facilitators & Barriers
Nine articles discussed facilitators and barriers to use PrEP (Berner-Rodoreda et
al., 2020; Govender & Karim, 2018; Hannaford et al., 2020; Kumar et al., 2013; Ojikutu
et al., 2018; 1Roth et al., 2019; 2Roth et al., 2019; Schneider et al., 2010; Smith et al.,
2012; Toledo et al., 2015. Heterosexual men believed men usually test when sick or did
not test at all due to an assumption that their HIV status was the same as their partner’s or
because they feared going to a clinic to test (Berner-Rodoreda et al., 2020). Still, men
who had begun using or continued using PrEP reported that taking a pill daily worried
114

them at first but proved manageable after initiation (Berner-Rodoreda et al., 2020).
Heterosexual men reported heightened stigma of PrEP due to their confusion about the
difference between PrEP and ARVs; heterosexual men also reported PrEP pills rattling in
the container, having only one line at health facilities for prevention and treatment, and
evading close-by facilities to avoid being recognized by family and peers as barriers to
PrEP adherence (Berner-Rodoreda et al., 2020). Heterosexual men also reported concerns
about PrEP education and subsequent service delivery in health clinics because these
placed are typically avoided by men (Berner-Rodoreda et al., 2020). Heterosexual men
recommended PrEP education be implemented in the community at various venues (e.g.,
chief’s residence, schools, taxi ranks and bus stations, bars, churches, soccer matches,
etc.) to raise awareness, especially using flyers or other health education materials
(Berner-Rodoreda et al., 2020). Heterosexual men suggested the use of advertising about
PrEP through printed media, radio, and television (Berner-Rodoreda et al., 2020).
Men desired information pertaining to the added product benefit for both women
and men, suggesting a level of support dependent upon being informed by their romantic
partners that they are using PrEP (Govender & Karim, 2018). Both men and women
anticipated that persons who chose the pill-taking option may have difficulty with daily
adherence of PrEP (Govender & Karim, 2018). Men reported worries of side effects and
allergic reactions that could affect men. Men also reported concerns of increased
unfaithfulness with women and felt that PrEP use would provide an opportunity for
higher levels of secrecy and promiscuity among women (Govender & Karim, 2018;
Hannaford et al., 2020). Men felt that women must inform their partners if they were to
begin using PrEP (Govender & Karim, 2018). Young heterosexual men acknowledged
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high HIV-risk behavior, expressed concern about their risk of acquiring HIV, and
embraced the value of PrEP as an HIV prevention method (Hannaford et al., 2020). Men
were typically unsupportive of their female partners taking PrEP and were against its use;
mistrust among sexual partners was commonly reported in South Africa (Hannaford et
al., 2020). Participant acknowledgement of high-risk status was mainly focused on
condom use and engaging in sex with multiple partners of unknown HIV status,
continued high-risk sexual behaviors, and interest in HIV prevention services despite
anticipation of exposure to logistical challenges (Hannaford et al., 2020). In another
study, drivers and apprentices expressed a high degree of likelihood to get more
information about PrEP, talk to their friends about PrEP, and access PrEP if it were free
(Kumar et al., 2013). In another study, 28.3% of all participants and 28.7% of high-risk
participants reported not believing that PrEP works; while a fear of potential side effects
was reported by 18.3% of all participants, and 25.9% of high-risk participants (Ojikutu et
al., 2018). A small portion of all participants (15.4%) reported not liking to take pills
every day as why they were unwilling to use PrEP versus 10.2% of high-risk participants
(Ojikutu et al., 2018). Few participants reported that their reasons for lack of willingness
were not wanting to pay for it and fear that someone would find out that they were taking
PrEP (Ojikutu et al., 2018). Participants who had not seen a health care provider in more
than one year were significantly less likely to be willing to use PrEP (Ojikutu et al.,
2018).
Regarding participant attitudes towards PrEP, 83% reported that they would not
feel anxious about using PrEP and 87% reported that they would not feel embarrassed
about using PrEP (1Roth et al., 2019). Some 79.7% of participants reported being willing
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to take PrEP if their healthcare provider suggested it (1Roth et al., 2019). Participant
willingness to take PrEP if suggested by a healthcare provider increased PrEP uptake
intention by 4.17-fold (95% CI: 1.42–12.24) (1Roth et al., 2019). Over 30% of
participants reported having at least one friend using PrEP; 58% of participants reported
that they would be the first to initiate PrEP use among their friends and 72.9% would
disclose their PrEP use to their sexual partners (1Roth et al., 2019). Four factors were
associated with PrEP intention: participant willingness to pay US$20/month for PrEP
(UOR: 2.24; 95% CI:1.25–3.98), willingness to take PrEP if it were free (UOR: 10.7;
95% CI: 4.27–26.9), willingness to attend quarterly follow-up visits (UOR: 3.24; 95% CI:
1.63–6.45) and willingness to tolerate minor side-effects (UOR: 2.67; 95%CI: 1.49–4.79)
(1Roth et al., 2019). No association between race and ethnicity, and PrEP intention was
found. Participant willingness to take PrEP, even if side-effects were a consequence, was
associated with a 1.98-fold increase in intention to use PrEP (95% CI:1.01–3.90) (1Roth
et al., 2019). Furthermore, men, compared to women, were more likely to anticipate
decreased condom use (40.4%vs. 21.3%, P = 0.02) and more sexual partnerships (29.3%
vs. 6.4%, P < 0.01) with PrEP use (2Roth et al., 2019). Men, compared to women, had
greater odds (aOR, 5.96; 95% CI, 1.51–23.5) of anticipating an increase in their numbers
of sexual partnerships with PrEP initiation similarly to participants who reported
engaging in transactional sex (aOR, 3.02; 95% CI, 1.01–8.97) (2Roth et al., 2019).
Leverage points for increasing PrEP commitment included participant expressions
of fear of infecting family rather than self, self-perceptions of HIV risk, and for PrEP
focusing on cultural beliefs towards medication and physicians (Shneider et al., 2010).
Participants cited cost as a major barrier to PrEP commitment. Not having extramarital
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sex or with sex workers was the main indicator for low HIV-risk perception and
contributed to a lack of initial commitment for PrEP (Shneider et al., 2010). Still,
participants largely believed that PrEP could be affective; however, concerns were raised
about side effects associated with PrEP (Shneider et al., 2010). Concerns about sexual
performance, or lack thereof, after taking the pill was also raised. Increased commitment
to PrEP was realized in drivers with previous sexual risk behavior, history of STI and
potentially non-Muslim religion, and younger age (Shneider et al., 2010). Interest in PrEP
was associated with cost, effectiveness, and the easiness of accessing services and
medication either near participants’ homes or by public transportation (Smith et al.,
2012). Participants reported frequent HIV testing (taking a rapid oral HIV test every three
months) as a benefit of accessing PrEP and would not be a barrier to taking PrEP;
however, differences were recorded among participants regarding whether increased
experiences of HIV stigma would occur and affect the reputation of PrEP takers because
of using PrEP (Smith et al., 2012). Still, most participants reacted positively to the idea of
taking a daily pill to prevent HIV. Convenience of outlets that dispense PrEP was deemed
an important facilitator to potential PrEP uptake and adherence (Smith et al., 2012).
Health department clinics and community pharmacies were reported as ideal places to
pick up PrEP; some participants expressed a willingness to pick PrEP up at hospitals or
hospital clinics with a concern that lines are often too long at these venues (Smith et al.,
2012). Pharmacies located close to public transportation stops were considered most
convenient due to lack of access to cars (Smith et al., 2012). Barriers to PrEP uptake
included side effects, cost, partial effectiveness, low perceived HIV risk, burden of daily
adherence, peer reactions and opinions, and for the MSM groups only, fear of risk
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compensation (decreased use of condoms and other safer sex practices) (Smith et al.,
2012).
Multiple factors contributed to participant retention and adherence in PrEP trials
and programs, including conducting pre-enrollment education and myth reduction
counseling, providing accurate estimates of participant obligations and side effect
symptoms, ensuring participant understanding of the effects of non-adherence, gauging
personal commitment and interest in study outcomes, and developing a strong external
social support network for participants (Toledo et al., 2015). Participants reported
learning of the TDF2 trial, a Phase 3 clinical trial of daily oral TDF/FTC with sexually
active heterosexual men and women in Botswana, via TV, radio, peers, and recruitment
staff (Toledo et al., 2015). Three major concerns were uncovered as barriers to
enrollment to the trial: discouragement from others, side effects, and fear of disease
infection (Toledo et al., 2015). Participants reported negative reactions or discouragement
from peers and family members for participating in the study and revealed that this
increased their apprehension about participating in the study (Toledo et al., 2015). High
levels of community mistrust of trial researchers were reported. Still, most participants
reported having a positive experience with the TDF2 trial with all but one participant
identifying the opportunity to access health services (e.g., HIV testing, health checkups,
health counseling, and HIV prevention) as a reason for seeking enrollment in the trial
(Toledo et al., 2015).
PrEP Efficacy
Three articles discussed PrEP efficacy (Choopanya et al., 2013; Thigpen et al.,
2012; Verguet et al., 2012). Tenofovir efficacy estimate, based on 48 eligible
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participants, was 45.7% (3.1–70.6; p=0.04) (Chooppanya et al., 2020). A confirmation of
HIV infection in 52 participants (17[33%] in the tenofovir group, 35 [67%] in the placebo
group) indicated a 51.8% reduction in HIV incidence (95% CI 15.3–73.7; p=0.01) in the
tenofovir group compared with the placebo group in the intention-to-treat analysis
(Chooppanya et al., 2020). Other research reported once-a-day oral TDF–FTC decreased
the rate of HIV infection by 62.2% for heterosexual adults in Botswana when
administered in tandem with a comprehensive package of HIV-prevention services
(Thigpen et al., 2012). The protective efficacy of TDF-FTC was higher when limited to
participants who reported having taken the medication within the past 30 days and is
consistent with increased efficacy among participants with high adherence to the
medication in other trials of preexposure prophylaxis (Thigpen et al., 2012). Regarding
where PrEP should be deployed, an estimated average of 390 000 HIV infections (95%
UR 190 000 to 630 000) would be prevented, 24% of these in South Africa, after 5 years
if PrEP were deployed nationwide (Verguet et al., 2012). In estimate, regarding per capita
impact, Lesotho would yield the highest impact with 500 HIV infections averted per 100
000, and Somalia would see the smallest impact with 10 HIV infections averted per
100,000 (Verguet et al., 2012). PrEP was estimated to have maximum impact and be
cost-effective in a general population in countries with high HIV burden and low levels
of male circumcision. PrEP is predicted to be most cost-effective in Southern Africa as a
targeted intervention added to existing strategies to control the HIV pandemic (Verguet et
al., 2012). If deployed, South Africa would yield the highest impact with 94 000 HIV
infections averted; Djibouti would yield the smallest impact with 200 HIV infections
averted (Verguet et al., 2012).
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Intervention Strategies & Demonstration Projects
Three articles reported an intervention design (Choopanya et al., 2013; Martin et
al., 2017; Thigpen et al., 2012); one article discussed a demonstration project design
(Berner-Rodoreda et al., 2020). Choopanya et al. (2013) & Martin et al. (2017) used a
randomized, double-blind, placebo-controlled trial that included volunteers from 17 drugtreatment clinics in Bangkok, Thailand. Study participants were randomly assigned (1:1;
blocks of four) to either tenofovir or placebo groups (Choopanya et al., 2013; Martin et
al. 2017). Study participants selected between daily directly observed treatment or
monthly visits and were able to switch at monthly visits (Choopanya et al., 2013; Martin
et al. 2017). Study participants also received monthly HIV testing and individualized
risk-reduction and adherence counselling, blood safety assessments every 3 months, and
were offered condoms and methadone treatment (Choopanya et al., 2013; Martin et al.
2017). Thigpen et al. (2012) randomly assigned HIV-seronegative men and women to
tenofovir disoproxil fumarate and emtricitabine (TDF–FTC) or matching placebo groups
(Thigpen et al., 2012). Monthly study visits were scheduled, and participants received
prevention services (e.g., HIV testing, counseling, medication management, monitoring
for adverse events, risk reduction strategies) (Thigpen et al., 2012). Berner-Rodoreda et
al. (2020) completed a 18-month PrEP demonstration project that was administered in six
health clinics in the Hhohho Region of Eswatini. The project included nurses who offered
on PrEP each morning during scheduled health talks on HIV and TB issues after
receiving off-site training on PrEP delivery followed by a two-day onsite training
(Berner-Rodoreda et al., 2020). Clients were offered PrEP after testing negative for HIV,
consenting to complete a risk assessment, stated they were interested in starting PrEP,
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and identified to be ‘at risk’ based on their reported health behaviors (Berner-Rodoreda et
al., 2020).
Race & Ethnicity
A majority (62%) of the included articles did not report or include racial or ethnic
differences among their sample population; however, almost all these articles focused on
Black study participants. Three articles included participants in India (Kumar et al., 2013;
Schneider et al., 2010; Schneider et al., 2013). The acceptance for PrEP was 87% and
study participants reported a high likelihood of obtaining more information about PrEP, if
provided free of cost, and to chat with friends about PrEP (Kumar et al., 2013). Schneider
et al. (2010) reported low levels of initial commitment towards PrEP. Schneider et al.
(2012) reported an 85.9% PrEP acceptability rate and found that sex with FSWs was
associated with PrEP acceptability. Two articles included Thai participants (Choopanya
et al., 2013; Martin et al., 2017). Once-daily oral tenofovir was found to decrease the risk
of HIV infection by 48. 9% in injecting drug users when provided in tandem with other
HIV prevention services (Choopanya et al., 2013). Martin et al. (2017) found that more
than 60% of participants started PrEP and that participants who had injected heroin or
been in prison were more likely to choose to take PrEP.
Three articles reported racial differences among their sample (1Roth et al., 2019,
2

Roth et al., 2019, Zhang et al., 2019). 1Roth et al. (2019) found that White participants

had a 10.4% intention to use PrEP while persons of color had a 89.6% intention to use
PrEP. 2Roth et al. (2019) found compared with Black participants, white participants had
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lower odds of anticipating decreased condom use with PrEP initiation and Similar
associations were
observed when comparing White participants to Hispanic individuals and persons from
other racial/ethnic groups. Zhang et al. (2019) found that 53 (38%) of 138 respondents
reported awareness of PrEP of which included Black and Latino MSM; MSM had
significantly
greater odds of reporting PrEP awareness compared to other participants (odds ratio
[OR], 5.6, 95% confidence interval [CI], 2.5–13.1) (Zhang et al. 2019).
Discussion
We completed a systematic review for articles that investigate pre-exposure
prophylaxis research among heterosexual men. All included studies either specified
heterosexual men as their target population or this demographic was included in the
recruitment of the studies. To our knowledge, this is the first systematic review that
specifically evaluates previously published literature featuring PrEP research among
heterosexual men and does not include serodiscordant couples.
In our findings, published articles focusing on heterosexual men and PrEP are
scarce. We found only seven articles which investigated only heterosexual men and PrEP.
Furthermore, the low number of papers matching our inclusion criteria, even after
including papers that did not only focus on heterosexual men, is concerning because the
sample sizes of the papers are not generalizable to the larger heterosexual men
population. Because heterosexual sex contributes the largest percentage of annual HIV
incidence worldwide (Myhre & Sifris, 2020), it is imperative that future research both
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includes and focuses on this demographic to ensure that PrEP uptake strategies are not
siloed to highlight only the strategies geared towards MSM, transgender women, and
other sexual and gender minorities. The greatest population health benefits are only
possible if there is enough PrEP coverage for the population accessing it to thwart further
transmission of HIV (Baeten, 2018). Being more inclusive of heterosexual men and HIV
in PrEP studies is vital to enriching the already abundant literature of HIV prevention
strategies and would greatly enhance the generalizability and applicability to a
heterosexual men subgroup who stand to benefit from expanded PrEP knowledge,
uptake, and adherence strategies that have already proven successful for other groups
(Auerbach et al., 2015; Blumenthal et al., 2015; Golub et al., 2013; Holloway et al., 2018;
Storholm et al., 2017; Stutts et al, 2020). Further inclusion of heterosexual men in PrEP
research stands to benefit both the researchers and heterosexual men by creating greater
access and utilization of PrEP for at-risk heterosexual men and by providing an
opportunity for improvements for uptake and adherence strategies to be realized. The
presentation of the findings from heterosexual men and HIV in PrEP studies would
enhance and increase the accessibility of empirical information necessary to developed
informed programming and interventions designed to address and reduce HIV incidence
among heterosexual men and HIV populations and expand upon already established HIV
prevention practices for other populations such as heterosexual men and HIV, FSW, etc.
Still, improvements for access to PrEP should consider both local regulatory issues and
men’s proximity to PrEP providers (Sullivan & Siegler, 2018); PrEP programming
should include comprehensive sexual health services and linkages to PrEP care (Sullivan
& Siegler, 2018).
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The findings of our review also suggest that heterosexual men are willing to use
PrEP as an HIV prevention strategy. Men cited concerns of confidentiality at healthcare
centers, worries of partner infidelity, drug side effects, and being unfairly judged by their
family and peers for using PrEP. HIV stigma reducing campaigns would benefit
communities where these problems persist in tandem with PrEP awareness and
promotion initiatives. Men’s social networks may play a large role in influencing their
behavior choices; these social networks, including peers and family members, should be
leveraged to both promote PrEP, increase awareness, and dispel HIV-related
misconceptions. Still, few included articles were found which utilize the social networks
of heterosexual men.
We found that a gap in the literature exists pertaining to PrEP awareness and
heterosexual men and HIV; MSM eclipsed their heterosexual men counterparts in being
aware of PrEP. Most of the studies included in this systematic review reported low PrEP
awareness among heterosexual men and provides evidence that PrEP advertising
campaigns for this demographic are needed. Heterosexual male-focused advertisements
in different regional settings should target areas where these men are most likely to see
such them such as public transportation stops, supermarkets, barbershops, and other
popular hangout spots; online settings have also been used to identify men willing to use
PrEP (Grov et al., 2016). It is also important for advertisements to encompass side-byside messaging and imagery inclusive of multiple populations to instill the belief in
viewers that PrEP is not just for one specific community of people; community-informed
language to promote PrEP is also needed (Fields et al., 2020). For example, an
advertisement strategically posted at a busy bus/train stop or a TV commercial could
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present the same messaging for multiple populations by having the messaging be
included on images of a cisgendered heterosexual couple, an MSM couple, and a
transgendered couple displayed beside one another or on the same advertisement to
promote PrEP for all persons who are at risk of HIV infection. Strategies such as this may
positively address some of the HIV-related stigma that a few of the studies have
highlighted. Other barriers to PrEP uptake included cost, with men citing having to pay
for the medication as a deterrent to their likeliness of using it. Cost must be addressed and
policies to make PrEP free of cost or at the very least subsidized to a low price point
would benefit heterosexual men and HIV and other populations greatly. Alongside
offering PrEP at a low cost (Coi et al., 2020), more healthcare providers who are willing
to prescribe PrEP more openly are also needed (Krakower & Mayer, 2016). However,
medical/researcher distrust, also found for other at-risk demographics (D’Avanzo et al,
2019; Cahill et al., 2017), was cited as a concern of men in this review and healthcare
providers and researchers must work to gain the trust of at-risk HIV populations to
increase the uptake of PrEP in communities, especially among Black communities.
Like past research findings of willingness to use PrEP among MSM (Beludi et al.,
2021; Bourne et al., 2017; Peng et al., 2019; Ren et al., 2019), a major finding of this
systematic review is that most persons reported being willing to use PrEP. While this
finding is promising, it is imperative for researchers to keep in mind that self-reported
intent to use or willingness to use does not always translate to uptake or maintenance. To
counteract this point, proper HIV prevention programming geared towards actual uptake
of PrEP for heterosexual men and HIV are needed to bridge the gap between intent to use
and actual uptake. Also, the PrEP continuum of care must be considered and addressed;
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the role healthcare providers may play in improving the PrEP continuum of care should
also be considered (Ming et al., 2020). Future research should not focus so heavily on
PrEP awareness; while it is necessary for more heterosexual men and HIV to be made
aware of PrEP, access, uptake, and maintenance are just as important. More attention
must be paid to increasing PrEP uptake, maintenance, and adherence of PrEP for
heterosexual men and HIV through the development of programming and interventions;
however, questions still remain regarding the sustainability of PrEP adherence over time
(Weinstein et al., 2017).
While several included articles discussed intervention strategies and a
demonstration project, we are of the opinion that it is not worthwhile to adapt the
intervention strategies for future intervention. Our reasoning for this is that we believe
PrEP research endeavors should be more concerned with getting persons to initiate and
adhere to PrEP. Studies, such as the ones included in this review, which focus on PrEP
choices and preferences are no longer necessary – unless a novel PrEP method is released
in the future. Because PrEP has been proven to be effective at preventing HIV infection
and has been marketed for a long enough period, PrEP initiation and adherence should be
focal points. Still, the demonstration project discussed by Berner-Rodoreda et al. could be
a promising model to increase PrEP uptake in multiple settings and regions in tandem
with applying how and why individuals make preventative health decisions. We should
consider including this strategy for HIV prevention and apply it to PrEP uptake. Also,
since it has been determined that there is a lack of PrEP awareness, we must consider
what will drive persons to seek PrEP and actually use it. A pertinent question to be
answered include: How can we influence people to use PrEP beyond direct-to-consumer
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advertisements? Perhaps reframing PrEP messaging as “protect yourself while protecting
others” in tandem with making PrEP more accessible and ubiquitous would be a great
way to start. Intervention strategies that use community responsibility health messages
and easier access to PrEP would yield greater uptake of PrEP. The messaging that is
communicated must be a collectively driven response regardless of race, ethnicity,
religion, or political affiliation.
Limitations
This systematic review was subject to several limitations. First, articles matching
the inclusion criteria may have been missed due to researcher error or due to failure of
not searching some databases. Additionally, studies matching the inclusion criteria may
have been published after the database searches had already been completed.
Furthermore, by excluding studies focused on serodiscordant couples, pertinent
information regarding PrEP awareness, uptake, and adherence for heterosexual men may
have been missed. Finally, another limitation of this review is that there was no specified
geographic focus, and thus the findings of this review are not generalizable as what
works in Thailand may not be appropriate or effective in Canada, for example. The
included studies were not stratified by race or ethnicity and further leads to a lack of
generalizability.
Conclusion
Our findings from this systematic review reflect a dearth of literature focused
solely on heterosexual men and HIV regarding PrEP awareness and willingness to use.
Our findings demonstrate that few studies have been published pertaining to solely PrEP
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uptake and adherence for heterosexual men. Results from our review also show that PrEP
awareness is low for heterosexual men and HIV while uptake and adherence is lower.
Still, of the relevant articles found for PrEP and heterosexual men and HIV, it is
encouraging that when surveyed, most heterosexual men report being willing to use
PrEP, providing ample opportunities for researchers to develop and implement
programming and interventions targeted at heterosexual men along the PrEP continuum
of care. To address the disparities in the current literature of PrEP use among
heterosexual men and HIV, an increased focus should be placed on the development of
research and programming that is inclusive of all the stages of the PrEP continuum of
care.
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Main Findings

65 men

PrEP uptake skewed predominantly towards
participants aged 26-35. Fear of becoming
infected with HIV (32%), according to risk
assessment forms, was the greatest reason for
male PrEP initiation; having multiple
partners (18%), not knowing the HIV-status
of a sexual partner (15%) and living in a
serodiscordant relationship (14%) were other
reasons for PrEP initiation. Men who
continued PrEP and who also had an HIVpositive partner on anti-retroviral treatment
(ART) reported coordinating the times for
taking PrEP and ART pills as a useful
adherence tool. Heterosexual men believed
HIV testing to be a major limitation to
accessing PrEP regardless of participants’
HIV risk perception; heterosexual men
believed men usually test when sick or did
not test at all due to an assumption that their
HIV status was the same as their partner’s or
because they feared going to a clinic to test.
Still, men who had begun using or continued
using PrEP reported that taking pill daily
worried them at first but proved manageable
after initiation. Heterosexual men reported
heightened stigma of PrEP due to their

142

confusion about the difference between PrEP
and ARVs; heterosexual men also reported
PrEP pills rattling in the container, having
only one line at health facilities for
prevention and treatment, and evading closeby facilities to avoid being recognized by
family and peers as barriers to PrEP
adherence. Heterosexual men also reported
concerns about PrEP education and
subsequent service delivery in health clinics
because these placed are typically avoided by
men. Heterosexual men recommended PrEP
education be implemented in the community
at various venues (e.g. chief’s residence,
schools, taxi ranks and bus stations, bars,
churches, soccer matches, etc.) to raise
awareness, especially using flyers or other
health education materials. Heterosexual
men suggested the use of advertising about
PrEP through printed media, radio, and
television.
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Participants took the study drug an average
(mean) of 83.8% of days (SD 23.0, median
94.1%, IQR 79.2–98.7); participant
adherence did not differ by treatment group
(p=0.16) or by time on study (p=0·22).
Participants aged 40 years and older adhered
better (median 98.2%, 93·5–99·5) than
younger participants (92.3%, 75.5–98.2;
p<0.0001). Women (95.6%, 81.1–98.9)
adhered better than men (93.8%, 78.8–
98.7%; p=0.04). A confirmation of HIV
infection in 52 participants (17[33%] in the
tenofovir group, 35 [67%] in the placebo
group) indicated a 51.8% reduction in HIV
incidence (95% CI 15.3–73.7; p=0.01) in the
tenofovir group compared with the placebo
group in the intention-to-treat analysis. The
tenofovir efficacy estimate based on the 48
eligible participants was 45.7% (3.1–70.6;
p=0.04); 17 met the adherent criteria (ie,
took the study drug for 71% or more of days
and did not miss more than 2 consecutive
days of study drug)—five in the tenofovir
group and 12 in the placebo group, yielding
an efficacy estimate of 55.9% (95% CI, –
18.8 to 86.0; p=0.11).
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Most men reported not being in support of
PrEP use and expressed that a justification of
vulnerability or exposure to risk of HIV
infection for their women must be present to
accept product use. Urban men who support
PrEP use reported that PrEP use is relegated
to “vulnerable rural women” but not their
female romantic partners. Men desired
information pertaining to the added product
benefit for both women and men, suggesting
a level of support dependent upon being
informed by their romantic partners that they
are using PrEP. Both men and women
anticipated that persons who chose the pilltaking option may have difficulty with daily
adherence of PrEP. Men reported worries of
side effects and allergic reactions that could
affect men. Men also reported concerns of
increased unfaithfulness with women and felt
that PrEP use would provide an opportunity
for higher levels of secrecy and promiscuity
among women. Men felt that women must
inform their partners if they were to begin
using PrEP.
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Young
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South Africa

(South Africa)
HIV-negative
heterosexual
men
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(2020)

Surveillance
Data Review
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31 men

Participants reported being willing to take
PrEP to protect themselves as well as their
sexual partner amidst anticipated stigma and
structural barriers. Men reported a worry of
their female partner becoming sexually
active with persons other than themselves if
she were to gain access to PrEP. Young
heterosexual men also acknowledged high
HIV-risk behavior, expressed concern about
their risk of acquiring HIV, and embraced
the value of PrEP as an HIV prevention
method. Men were typically unsupportive of
their female partners taking PrEP and were
against its use; mistrust among sexual
partners was highly reported. Participant
acknowledgement of high-risk status was
mainly focused on condom use and engaging
in sex with multiple partners of unknown
HIV status, continued high-risk sexual
behaviors, and interest in HIV prevention
services despite anticipation of exposure to
logistical challenges.
4283
PrEP awareness was lowest among
Heterosexual heterosexual persons (7%), highest among
persons,
men who have sex with men (85%), and 26%
4469 MSM, among persons who inject drugs.
and 3435
PWID with
likely PrEP
indications

with an
Emphasis on
the Southern
United States
Kumar S.G.,
Kumar A.G.,
Poluru R.,
Schneider J.A.,
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1,800 truck
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through
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PrEP had an acceptance rate of 87% among
drivers and apprentices. Participants
expressed a high degree of likelihood to get
more information about PrEP, access PrEP if
it were free, and to talk to their friends about
it. When asked if they would accept taking a
pill in near future either to be taken once
daily or one pill a day for 28 days to prevent
HIV infection, 87.3% truckers reported being
likely to get more information and 84.3%
reported an interest in obtaining the
medication if were provided free of cost over
the next 3 years by a healthcare provider;
75.8% of participants reported being likely
pay for it. Of truckers who were likely to
consider PrEP, 42.3% were likely to consider
taking a pill once a day and 57.7% were
likely to consider a pill one day before sex
and then for 28 days. Most truckers, 87%,
were likely to recommend it to their friends,
if necessary.

Awareness of,
usage of and
willingness to
use HIV preexposure
prophylaxis
among men in
downtown
Toronto,
Canada

(Canada) Men
in Toronto

Selfadministered
questionnaire

Martin M.,
Vanichseni S.,
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Men
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Out of 256 participants, very few (11.7%)
men reported awareness of PrEP; more MSM
(14.1%) were aware of PrEP than
heterosexual men (4.9%). Neither MSM nor
heterosexual men participants reported PrEP
usage. Participant willingness to consider
PrEP use was high and associated with highrisk activities such as having multiple sexual
partners. Identifying as MSM was strongly
associated with PrEP awareness (odds ratio
[OR] ¼ 3.55; 95% CI: 1.03, 12.28).
Variables associated with ‘definitely’ or
‘maybe’ being willing to use PrEP included
MSM status (OR ¼ 1.90, 95% CI: 1.06,
3.41), more than one sexual partner in the
preceding six months (OR ¼ 2.43, 95% CI:
1.27, 4.66 for those with 2–4 partners; OR ¼
2.11, 95% CI: 1.08, 4.10 for those with 5 or
more partners) and unprotected anal sex in
the past six months (OR ¼ 2.02, 95% CI:
1.19,3.42).
Findings support the belief that a great
proportion of PWID who are aware of PrEP
may be interested in taking it; most eligible
BTS participants (61%) opted to start openlabel PrEP. Participants who were 30 years
or older (odds ratio [OR] 1·8, 95% CI 1·4–
2·2; p<0·0001), injected heroin (OR 1·5,
1·1–2·1; p=0·007), or had been in prison
(OR 1·7, 1·3–2·1; p<0·0001) during the
randomised trial were more likely to choose

drugs: an
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extension of the
Bangkok
Tenofovir
Study
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Allen W.,
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(U.S.A.) Black
individuals

Crosssectional
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148

868
participants;
340 men

PrEP than participants without these
characteristics. Participants who reported
injecting heroin or being in prison during the
3 months before open-label enrolment were
more likely to return for at least one openlabel follow-up visit than those who did not
report injecting heroin (OR 3·0, 95 % CI
1·3–7·3; p=0·01) or being in prison (OR 2·3,
1·4–3·7; p=0·0007). Participants who
injected midazolam or were in prison during
open-label follow-up were more likely to be
greater than 90% adherent than were those
who did not inject midazolam (OR 2·2, 95%
CI 1·2–4·3; p=0·02) or were not in prison
(OR 4·7, 3·1–7·2; p<0·0001).
Some 14.5% of all survey participants
reported being aware of PrEP; awareness of
PrEP was higher among high risk than lower
risk participants (19.8% vs 11.4%) and
26.0% were willing to use PrEP. Among
high-risk participants, willingness to use
PrEP was higher than among lower risk
(35.1% vs 20.5%). Low risk perception was
the most common reason for lack of
willingness to use PrEP [lower risk (76.8%),
high risk (65.1%)]. One-third of all
participants (28.3%) and 28.7% of high-risk
participants reported not believing that PrEP
works; while a fear of potential side effects
was reported by 18.3% of all participants,
and 25.9% of high-risk participants. A small

1
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131 men
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portion of all participants (15.4%) reported
not liking to take pills every day as why they
were unwilling to use PrEP versus 10.2% of
high-risk participants. Few participants
reported that their reasons for lack of
willingness were not wanting to pay for it
and fear that someone would find out that
they were taking PrEP. Participants who had
not seen a health care provider in more than
one year were significantly less likely to be
willing to use PrEP.
One-half of participants reported willingness
to take PrEP even though only of participants
reported 25% believing they were at-risk for
HIV. Participants who perceived themselves
to be at-risk for HIV had 2.2-fold likelihood
of being willing to take PrEP 95%
confidence interval (CI):1.12–4.35]
compared to participants with no perceived
HIV risk. Regarding participant attitudes
towards PrEP, 83% reported that they would
not feel anxious about using PrEP and 87%
reported that they would not feel
embarrassed about using PrEP. Some 79.7%
of participants reported being willing to take
PREP if their healthcare provider suggested
it. Participant willingness to take PrEP if
suggested by a healthcare provider increased
PrEP uptake intention by 4.17-fold (95% CI:
1.42–12.24). Over 30% of participants
reported having at least one friend using

150
2
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99 men
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PrEP; 58% of participants reported that they
would be the first to initiate PrEP use among
their friends and 72.9% would disclose their
PrEP use to their sexual partners.
Four factors were associated with PrEP
intention: participant willingness to pay
US$20/month for PrEP (UOR: 2.24; 95%
CI:1.25–3.98), willingness to take PrEP if it
were free (UOR: 10.7; 95% CI: 4.27–26.9),
willingness to attend quarterly follow-up
visits (UOR: 3.24; 95% CI: 1.63–6.45) and
willingness to tolerate minor side-effects
(UOR: 2.67; 95%CI: 1.49–4.79).
No association between race and ethnicity
was found for PrEP intention. Participant
willingness to take PrEP, even if side-effects
were a consequence, was associated with a
1.98-fold increase in intention to use PrEP
(95% CI:1.01–3.90).
Men, compared to women, were more likely
to anticipate decreased condom use
(40.4%vs. 21.3%, P = 0.02) and more sexual
partnerships (29.3% vs. 6.4%, P < 0.01) with
PrEP use. Men, compared to women, had
greater odds (aOR, 5.96; 95% CI, 1.51–23.5)
of anticipating an increase in their numbers
of sexual partnerships with PrEP initiation
similarly to participants who reported
engaging in transactional sex (aOR, 3.02;
95% CI, 1.01–8.97).

Cross-Sectional
Study

1

Schneider
J.A., Dandona
R., Pasupneti
S., Lakshmi
V., Liao C.,
Yeldandi V. et
al. (2010)

Initial
commitment to
Pre-Exposure
Prophylaxis
and
circumcision
for HIV
prevention
amongst Indian
truck drivers

India (Truck
Drivers)

In-depth
qualitative
interviews

151
151

90 truck
drivers

Truck-drivers reported low initial
commitment to PREP. Leverage points for
increasing PrEP commitment included
participant expressions of fear of infecting
family rather than self, self-perceptions of
HIV risk, and for PREP focusing on cultural
beliefs towards medication and physicians.
Participants cited cost as a major barrier to
PrEP commitment. Not having extramarital
sex or with sex workers was the main
indicator for low HIV-risk perception and
contributed to a lack of initial commitment
for PREP. Stil, participants largely believed
that PREP could be affective; however,
concerns were raised about side effects
associated with PrEP. Concerns about sexual
performance, or lack thereof, after taking the
pill was also raised. Increased commitment
to PREP was realized in drivers with
previous sexual risk behavior, history of STI
and potentially non-muslim religion, and
younger age.
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Schneider
J.A., Kumar
R., Dandona
R., Kumar P.,
Kumar A.,
Lakshmi V. et
al. (2012)

Social Network
and RiskTaking
Behavior Most
Associated
with Rapid HIV
Testing,
Circumcision,
and
Preexposure
Prophylaxis
Acceptability
Among HighRisk Indian
Men

(India) Indian
truck drivers
and truck
cleaners

Social
network and
risk survey

152
152

1602 truck
drivers and
truck
cleaners

A large majority (85.9%) of participants
reported being likely to accept PrEP,
however, a pericoital option (used at the time
of intercourse) was preferred to a once-daily
PrEP option among 57.5% of participants
likely to accept PrEP and 97.4% of
participants unlikely to accept PrEP. Onequarter of respondents reported intercourse
with female sex workers (FSW) and 5% with
men (MSM). Participants reporting prosocial
network characteristics demonstrated
variable PrEP acceptability (AORs 0.08–
2.22; p < 0.001). Ages ranging from 20-24,
current alcohol use, alcohol use prior to sex,
current drug use, multiple sex partners in the
past 6 months, extramarital sexual partner at
last sex, history of sex with men, and friend
closeness were significantly associated with
increased odds of accepting PrEP ( p < 0.05)
in bivariate analyses. Conversely, lowmiddle- and high-income levels, traveling on
a southeastern route, having many friends,
daily communication with a friend, and
closeness of friend to respondent’s family,
were associated with decreased odds of
accepting PrEP.

Smith D.K.,
Toldeo L.,
Smith D.J.,
Adams M.A.,
Rothenberg R.
(2012)

Attitudes and
program
preferences of
AricanAmerican
urban young
adults about
pre-exposure
prophylaxis
(PrEP)

(USA) AfricanAmerican
young men and
women

Eight mixedgender and
two MSM–
only focus
groups

153
153

77
participants;
42 young
men

Interest in PrEP was associated with cost,
effectiveness, and the easiness of accessing
services and medication either near
participants’ homes or by public
transportation. Participants reported frequent
HIV testing (taking a rapid oral HIV test
every three months) as a benefit of accessing
PrEP and would not be a barrier to taking
PrEP; however, differences were recorded
among participants regarding whether
increased experiences of HIV stigma would
occur and affect the reputation of PrEP
takers because of using PrEP. Still, most
participants reacted positively to the idea of
taking a daily pill to prevent HIV.
Convenience of outlets that dispense PrEP
was deemed an important facilitator to
potential PrEP uptake and adherence. Health
department clinics and community
pharmacies were reported as ideal places to
pick up PrEP; some participants expressed a
willingness to pick PrEP up at hospitals or
hospital clinics with a concern that lines are
often too long at these venues. Pharmacies
located close to public transportation stops
were considered most convenient due to lack
of access to cars. Barriers to PrEP uptake
included side effects, cost, partial
effectiveness, low perceived HIV risk,
burden of daily adherence, peer reactions and
opinions, and for the MSM groups only, fear

of risk compensation (decreased use of
condoms and other safer sex practices).
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Thigpen M.C.,
Kebaabetswe
P.M., Paxton
L.A., Smith
D.K., Rose
C.E., Segolodi
T.M., et al.
(2012)

Antiretroviral
Preexposure
Prophylaxis for
Heterosexual
HIV
Transmission in
Botswana

(Botswana)
HIVseronegative
men and
women

Randomized,
double-blind,
placebocontrolled
clinical trial

154

1219 men
and women;
662 men

Once-a-day oral TDF–FTC decreased the
rate of HIV infection by 62.2% for
heterosexual adults in Botswana when
administered in tandem with a
comprehensive package of HIV-prevention
services. The protective efficacy of TDFFTC was higher when limited to participants
who reported having taken the medication
within the past 30 days and is consistent with
increased efficacy among participants with
high adherence to the medication in other
trials of preexposure prophylaxis.

Toledo L.,
McLellanLemal E.,
HendersonF.L.,
Kebaabetswe
P.M. (2015)

Knowledge,
Attitudes, and
Experiences of
HIV PreExposure
Prophylaxis
(PrEP) Trial
Participants in
Botswana

(Botswana)
Heterosexual
men and
women

In-depth
interviews

155
155

53
interviews;
24 men

Multiple factors contributed to participant
retention and adherence in PrEP trials and
programs, including conducting preenrollment education and myth reduction
counseling, providing accurate estimates of
participant obligations and side effect
symptoms, ensuring participant
understanding of the effects of nonadherence, gauging personal commitment
and interest in study outcomes, and
developing a strong external social support
network for participants.
Participants reported learning of the TDF2
trial via TV, radio, peers, and recruitment
staff. Three major concerns were uncovered
as barriers to enrollment to the trial:
discouragement from others, side effects, and
fear of disease infection. Participants
reported negative reactions or
discouragement from peers and family
members for participating in the study and
revealed that this increased their
apprehension about participating in the
study. High levels of community mistrust of
trial researchers were reported. Still, most
participants reported having a positive
experience with the TDF2 trial with all but
one participant identifying the opportunity to
access health services (e.g., HIV testing,
health checkups, health counseling, and HIV

prevention) as a reason for seeking
enrollment in the trial.
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Verguet S.,
Stalcup M.,
Walsh J.A.
(2012)

Where to
deploy preexposure
prophylaxis
(PrEP) in subSaharan
Africa?

(Sub-Saharan
Africa) Adults
in 42 subSaharan
African
countries

Deterministic,
compartmental
model of HIV
transmission
stratified by
gender

156

Heterosexual
adults;
number of
men not
reported

An estimated average of 390 000 HIV
infections (95% UR 190 000 to 630 000)
would be prevented, 24% of these in South
Africa, after 5 years if PrEP were deployed.
In estimate, regarding per capita impact,
Lesotho would yield the highest impact with
500 HIV infections averted per 100 000, and
Somalia would see the smallest impact with
10 HIV infections averted per 100,000. PrEP
was estimated to have maximum impact and
be cost-effective in a general population in
countries with high HIV burden and low
levels of male circumcision. PrEP is
predicted to be most cost-effective in
Southern Africa as a targeted intervention
added to existing strategies to control the
HIV pandemic. If deployed, South Africa
would yield the highest impact with 94 000
HIV infections averted; Djibouti would yield

the smallest impact with 200 HIV infections
averted.

Uptake of HIV
Preexposure
Prophylaxis
Among
Commercially
Insured
Persons—
United States,
2010–2014

(USA)
Commercially
insured persons

Retrospective
database
analysis

3558
participants;
3363 men

Zhang H.L.,
Murthy B.,
Johnston B.,
Mortiboy M.,
Wu J., Samsa
G.P., et al.
(2019)

Public
Awareness of
HIV PreExposure
Prophylaxis in
Durham, North
Carolina:
Results of a

(USA)
139
respondents

Survey

62
heterosexual
persons; 86
men
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Wu H.,
Mendoza M.,
Huang Y.A.,
Hayes T.,
Smith D.K.,
Hoover K.W.
(2017)
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Male PrEP users increased from 82.0% in
2010 to 97.5% in 2014. Throughout the 5year study period, participants who reported
living in the West showed an increasing
trend in PrEP uptake and accounted for
>40% of PrEP users in 2014. Each year,
most participants (>97% of PrEP users) lived
in a metropolitan area. The prevalence of
persons prescribed PrEP among the US
population with commercial health insurance
increased significantly from 3.3 per million
in 2010 to 75.4 per million in 2014. When
stratified by sex, male PrEP prevalence
increased significantly overtime; the largest
increase occurred in 2014 with 151.2 persons
prescribed PrEP per one million.
More than one-third (38%) of 138
participants reported being aware of PrEP.
MSM reported significantly greater odds of
reporting being aware of PrEP compared to
other respondents (odds ratio [OR], 5.6, 95%
confidence interval [CI], 2.5–13.1). Being
male, having a non-heterosexual orientation,
health insurance status, and having tested for

Community
Survey

HIV in the past were significantly associated
with greater odds being aware of PrEP.
Participants who believed that HIV is
treatable (OR, 2.2, 95% CI, 1.0–5.1) or that
condoms reduce the risk of acquiring HIV
(OR, 2.7, 95% CI, 0.9–8.8) were more likely
to report being aware of PrEP. Participants
who reported believing stigma affects HIV
testing (OR, 2.1, 95% CI 0.9–4.8) or that
stigma affects HIV treatment (OR, 2.6, 95%
CI, 1.1–6.3) were also more likely to report
being aware of PrEP. No significant
association between awareness of how to
protect oneself from HIV with being aware
of PrEP was found.
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CHAPTER 5
DISCUSSION
The final chapter of this dissertation recaps the findings for each aim of the
study and provides a discussion of the results from the three included manuscripts. This
chapter also presents a conclusion of the findings and discusses the strengths and
limitations of the research. The chapter concludes with a section each on the implications
for public health practice and directions for future investigations. This dissertation
proposed three aims of which were successfully achieved and are described throughout
this chapter. This dissertation aimed to evaluate the awareness of PrEP for heterosexual
Black men and assess their readiness and intent to use PrEP, examine the factors which
may increase interest and use of PrEP among heterosexual Black men, and conduct a
systematic review of strategies to promote PrEP and to create a set of recommendations
for future research inquiries on how to increase the uptake of PrEP among heterosexual
Black men.
Summary of Findings
The major goal of this dissertation was to explore the awareness of, willingness to
use, and uptake of PrEP among heterosexual Black men also referred to as men who have
sex with women (MSW). This dissertation also had three specified aims. This dissertation
evaluated the awareness of PrEP for heterosexual Black men and assessed their readiness
and intent to use PrEP using two cross-sectional surveys in the USA and Tanzania. The
surveys were administered to men at places they frequent such as barbershops in
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Brooklyn and social camps in Dar Es Salaam. A systematic review was also conducted to
identify past research that has focused on heterosexual men and PrEP. Collectively, the
three included papers investigated factors which may increase interest and use of PrEP
among heterosexual Black men globally in all three papers included in this dissertation.
The systematic review was conducted of research inquiries regarding PrEP among
heterosexual men. All three included papers in this dissertation were guided by the Social
Cognitive Theory and the Protection Motivation Theory as both theories place emphasis
on the role which influential persons in an individual’s social environment can play in the
adoption of behaviors. This dissertation also posed to answer three research questions
regarding the awareness of, willingness to use, and uptake of PrEP among heterosexual
Black men. Questions of how aware are heterosexual Black men of PrEP as an HIV
prevention method, are heterosexual Black men willing to use PrEP to prevent HIV
infection, how many heterosexual Black men have used PrEP were all answered in this
dissertation. The results of the Tanzania and Brooklyn PrEP papers for this dissertation
revealed that the participants in both studies were mostly unaware of PrEP as an HIV
prevention method; however, both studies found that the participants were willing to use
PrEP after being informed of it. The systematic review produced similar results for
heterosexual men globally. Consequently, because of low awareness, there was also very
low usage or uptake of PrEP in all three studies, if any. Below, the result of each paper is
presented summarily.
Regarding the selected dependent variables for both the Brooklyn and Tanzania
studies, all variables were selected due to their relevance to the outcome variables. To
keep the analysis consistent across both studies, the equivalent dependent variables in
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each study were selected. Age, education, and having ever tested for HIV were included
in both studies; however, because marital status was reported in the Tanzania study but
not in the Brooklyn study, living with sexual partner was substituted for marital status in
the Brooklyn study. In both papers, variables pertaining to participants discussing
HIV/PrEP within their social networks and their beliefs about their social network’s
attitudes towards PrEP were also included due to their high relevancy to the outcome
variables. For example, it was deemed relevant that including whether men had discussed
HIV with their friends or family, barber, and sexual partners was relevant to the outcome
of whether they believe their network of family and friends would be interested in PrEP.
The same logic is followed for the Tanzania study; whether participating men believed
their close friend had ever had an HIV test, how likely they are to discuss PrEP with other
camp members, and how they believed their sexual partner would react to them using
PrEP were all relevant to the outcome variable.
The results of the Brooklyn PrEP study found that most participants (82%) had
never heard of PrEP prior to their participation in the survey and consequently, more than
half (55.3%) of men reported never having used PrEP or knowing anyone that had while
37.4% of participants were not sure. Only 6.8% reported PrEP use by them or someone
that they knew. When asked how interested they believe people in their network of
friends would be in learning more about PrEP, 45.1% of men reported somewhat
interested while 28.2% reported very interested, and 26.7% not interested. The findings
of the study are consistent with those of past research in the U.S. which found limited
awareness and awareness of PrEP but an interest in PrEP (Ajai et al., 2019; Iniesta et al.,
2018; Jayakumaran et al., 2016). This study was unique in that it included Black
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heterosexual men in barbershops in Brooklyn; this demographic s not been typically
included in PrEP studies in New York City. Based on the literature, MSM have mostly
been the focus of PrEP studies in the city (Franks et al., 2018; Garnett et al., 2018;
Goedel et al., 2016; Rucinski et al., 2013. A highlight of the study is that it provides
evidence that barbershops are worthwhile venues to engage and target Black men and
that men perceive that their family and friends would be interested in learning more about
PrEP. The paper also provides evidence that barbers are valuable agents for providing
HIV prevention materials and acting as a bridge between community HIV organizations
and health departments. Barbershops have previously been used to promote hypertension
detection (Hess et al., 2007), blood pressure reduction (Victor et al., 2018), and prostate
cancer education (Hart & Bowen, 2003). Since there is great stake in barbershops as
places of not only hair services, but also a space of extended conversation and
congregation for Black men, it is imperative that barbershops be more implemented as
spaces which may reduce HIV stigma and increase HIV prevention and treatment
services uptake through promotion in these spaces.
The results of the Tanzania PrEP study found that most men, (85.6%) reported
having never heard of PrEP prior to the survey. The same number of men (85.6%)
reported knowing “nothing at all” regarding PrEP. Still, 71.5% of men reported being
likely to take PrEP if it were offered to them. Thirty-six percent (36%) of men reported
that a reason that would make other men not want to take PrEP is not knowing where to
get it from. Nearly 40% of men stated that they believed they would use PrEP before
sexual intercourse either every time or every other time. More than half of men (56.8%)
reported being likely to inform their sexual partner that they were using PrEP. Slightly
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over one-third of men (36.4%) believed that their sexual partner would react positively if
they were informed that they were using PrEP. Lastly, almost three-fourths of men
(74.5%) reported that they are likely to discuss PrEP with other camp members. Camps
provided a space for participating men to discuss HIV testing with one another and also
served as a venue for strong friendships to form among the men. Participating men
expressed that they had friends in the camp who encouraged them to test for HIV and
vice versa. Men also reported that they would likely encourage their close friends in the
camp to use PrEP.
The results of the systematic review found that heterosexual men are willing to
use PrEP as an HIV prevention strategy; however, in certain environments (e.g., health
centers/clinics in sub-Saharan Africa) there are barriers to access which must be
addressed. Men cited concerns of confidentiality at healthcare centers, worries of partner
infidelity, side effects, and being unfairly judged by their family and peers for using
PrEP. HIV stigma reducing campaigns would benefit communities where these problems
persist in tandem with PrEP awareness and promotion initiatives. Men’s social networks
seem to play a large role in influencing their behavior choices; these social networks,
including peers and family members, should be leveraged to both promote PrEP, increase
awareness, and dispel HIV-related misconceptions. Still, few included articles were
found which utilize the social networks of heterosexual men.
We found that a gap in the literature exists pertaining to PrEP awareness and
heterosexual heterosexual men; MSM eclipsed their heterosexual male counterparts in
being aware of PrEP across the board. Most of the studies included in the systematic
review reported low PrEP awareness among heterosexual men.
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Interpretation of Findings
While PrEP awareness and use have both seen global increases in the past decade
among certain populations (e.g., MSM and transgender persons) (Mosley et al., 2018;
Schueler et al., 2019), the same increases have not been reported for heterosexual men.
Furthermore, there is a dearth of research surrounding the inclusion of heterosexual men
in research focused on PrEP in any capacity. Per the results of the systematic review
included in this dissertation, there are few papers which have solely investigated
heterosexual men and PrEP without the inclusion of other populations (e.g.,
serodiscordant female partners and/or pregnant partners). While past research has found
using serodiscordant (Ngure et al., 2016; Psaros et al., 2014) and/or pregnant partners of
heterosexual men (Pintye et al., 2018) to be effective strategies to target, identify, and
recruit heterosexual men, this strategy as a major flaw of only being able to identify and
target heterosexual men who are currently engaged in sexual relationships with female
partners. Due to this, single heterosexual men, those who are not currently engaged in
sexual relationships, as well as heterosexual men who are either childless and/or not
engaged in a relationship with a partner currently living with HIV are excluded by this
research strategy. Furthermore, this strategy has been mostly relegated to sub-Saharan
Africa. Still, in other world regions, heterosexual men have been mostly omitted from
PrEP research. In the U.S., for example, there are few past studies that have investigated
PrEP for heterosexual men in any capacity. Understandably, the vast majority of HIV
incidence occurs among MSM in the U.S. (Sullivan et al., 2021); however, to achieve
zero new infections (Haghdoost & Karamouzian, 2012), heterosexual men must be
included in HIV prevention strategies as well as treatment as prevention (TasP). This

164

dissertation has successfully identified the current literature surrounding PrEP and
heterosexual men using a systematic review. This dissertation also contributes two
manuscripts to the current body of literature that focuses on the awareness and uptake of
PrEP among groups of heterosexual men in the U.S. and Tanzania in social settings such
as barbershops and social camps.
Inquiry into heterosexual men’s awareness of PrEP was also a means of
investigating the sociocultural beliefs and notions about PrEP from their perspectives.
Continued conversations about PrEP among heterosexual men require targeted
communications about what PrEP is, how it works, and the necessity of the drug for atrisk heterosexual men. Continued normalization of the conversations regarding HIV
treatment, prevention, and services, specifically regarding PrEP, are tantamount to
reducing the incidence rates of HIV among heterosexual men. Globally, conversations
about PrEP may be influenced by greater advertising and easier access to PrEP for
heterosexual men in both resource limited settings (i.e., social camps in Dar Es Salaam)
and resource sufficient settings (i.e., Brooklyn, NYC).
Though most men in all three papers self-reported a lack of awareness or
awareness of PrEP, when surveyed, men expressed interest in learning more about the
drug and in the Brooklyn and Tanzania studies, men reported believing their friends and
family would be interested in learning more about PrEP. Men also acknowledged that
though they knew very little about the drug, they would be interested in using it which
further provides supporting evidence for an expansion of PrEP advertising and
promotion. Past research has used Facebook as an advertising tool for HIV prevention
(Jones et al., 2015; Jones et al., 2017) and this strategy should be employed for PrEP
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across all social media platforms. The idea is that as men become better educated on the
benefits of PrEP and how their sexual behaviors may be putting them at risk, they will be
more likely to seek and use PrEP, especially if the conversation surrounding the drug has
been normalized in their community and among their friends and family. Regarding the
self-reported perspectives of men’s attitudes towards PrEP, some men expressed a worry
that their female counterparts would become more promiscuous if they were to gain
access to PrEP. These reports are somewhat contradictory because those men also
believed PrEP to be a useful HIV preventive tool for themselves and other men. Due to
this, PrEP education and advertisement must also include information promoting gender
equality and inclusivity. Past research has stressed the importance of gender equality and
the role it plays in HIV prevention (Albertyn, 2003; Peacock et al., 2009). A similar issue
found in the systematic review, some men reported being suspicious of researchers and
their intentions when approached about PrEP; this fear must be validated and respected,
but also addressed in a culturally sensitive matter (dependent on the region and
environment of the targeted men) to address any researcher/medical distrust (Ball et al.,
2013; Sauermilch, 2020) Thabathe et al., 2018). Participating men also voiced concerns
of PrEP use potentially resulting in their partners being unfaithful. This finding is
consistent with other studies among MSM where men were apprehensive about the
availability of PrEP potentially encouraging their partners to be more promiscuous (Eaton
et al., 2017; Golub, 2019; Mowlabocus, 2019). Collectively, these reports of concerns of
infidelity suggest a need to further examine male sexual beliefs in tandem with PrEP
availability and use.
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The examination of awareness and use of PrEP for heterosexual men provides
pertinent insight into the lack of research investigations for this population and offers
guidance into what must be addressed for heterosexual men going forward to have PrEP
be more attractive and more widely accessible to heterosexual men. Better access to PrEP
and its uptake may have a direct effect of lessening the HIV incidence rates of
heterosexual men in multiple regions globally. The examination of PrEP for heterosexual
men also provides insight on where interventions should be targeted as well as how they
should be promoted. It is important to highlight that both the Brooklyn and Tanzania
papers were conducted in urban settings where space available for men to congregate was
limited; however, urban settings provide an opportunity to reach a larger amount. Still,
past research has also identified opportunities to reach heterosexual men in rural settings
for HIV prevention (Bwambale, et al., 2008; Walton et al., 2004).
Implications of Findings
To fully understand the extent to which heterosexual men are aware of PrEP,
whether they have used the drug, and what barriers persist which limit its uptake,
heterosexual men in both urban and rural settings must be targeted globally. It is
imperative to tailor future investigations towards cultural similarities as well differences
in included settings – there is no one size fits all approach that will satisfy the needs of
heterosexual men in both rural or urban settings. The findings of the included research
found that awareness of PrEP is severely lacking among heterosexual men in the global
settings assessed. More conversations/advertisements and access to PrEP is necessary to
increase its uptake. Identifying and addressing possible cultural beliefs that may hinder
the uptake of PrEP must also be considered. Culturally inclusive approaches may be able
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to dispel misconceptions and misinformation about PrEP as well as barriers to its uptake
including fear, embarrassment, or other relevant stigmas. Community conversations and
campaigns organized and spearheaded by trusted community leaders in spaces where
heterosexual men are likely to frequent should be considered. Such conversations require
cooperation among heterosexual men, community leaders, and HIV prevention and
service deliverers – including clinicians and health providers who prescribe PrEP.
The educational achievement of heterosexual men is also noteworthy. Men who
have achieved high levels of education more aware of PrEP and its benefits compared to
men with less education; this finding is supported by past research findings for men and
HIV testing (Gage et al., 2005; Mitchell et al., 2013; Stephenson et al., 2015. Still,
despite the uncovered lack of PrEP awareness among heterosexual men, a vast majority
of participating men cited being interested in the drug and believed that their family and
peers would be willing to accept information about it as well. According to the results of
the included studies, the absence of awareness of PrEP was the major hindrance to its
uptake followed by lack of access – specifically in Tanzania where, at the time of data
collection, PrEP had not yet been approved for use by the government. It is expected that
as heterosexual men become more aware of PrEP and as access to the drug increases
more heterosexual men will use the drug considering that most men in the included
studies expressed positive attitudes towards PrEP. One of the only poor perspectives
reported in the included studies was men citing a worry of their female partners becoming
promiscuous because of gaining access to PrEP. Perhaps this is a result of cultural norms;
however, the correcting of this misinformation is necessary for public health practitioners
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to address this claim and to dispel the notion that PrEP use equates to an increase in
sexual partners.
Though self-reported willingness to use PrEP and the desire of heterosexual men
of wanting more information and access to PrEP does not necessarily translate to actual
uptake of PrEP, this finding is encouraging and signifies that there may be a significant
number of heterosexual men who may be also interested in the drug in different
environmental settings around the world. Pertinent health communication channels,
including direct verbal communication with a health care provider is essential to the
translation of willingness to use for heterosexual men in all settings. Information
regarding PrEP and other health prevention materials may be most effective if it is
developed and endorsed by health experts that is then disseminated to heterosexual men.
Past research has found that persons typically had a positive outlook on patient-provider
communication channels and there were many health benefits to be reaped from the
channels for patients (Apollo et al., 2008; Hauseman et al., 2012; Marelich & Murphy,
2010. Simply put, health experts are often trusted by patients and their families
(Alrubaiee, 2011); one of the main challenges that must be addressed for this relationship
to work is that confidentiality concerns must be taken seriously. However, in the
systematic review, one article discussed a distrust of researchers and some participants
being apprehensive about participating in the research. It is imperative that future
research aim to build trust and rapport within the communities they desire to work in to
reduce the stigma associated with HIV research, including PrEP. Still, men reported a
willingness to discuss HIV prevention services with their barbers in Brooklyn and PrEP
with their peers in Tanzania – these finding signals that trust among men and persons
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they deem trustworthy are important factors for disseminating and reinforcing HIV
prevention services uptake. Barbers are typically viewed as community leaders and are
often entrusted with very personal details of their clienteles’ lives; some barbers
sometimes act as a proxy counselor of sorts (e.g. mental health, family, marriage, etc.)
and are often positioned to offer advice to their clientele that will be respected and taken
seriously. This relationship should be leveraged to target and identify Black heterosexual
men for PrEP and other HIV prevention services. Social camps, as described in the
Tanzania study, operate much of the same ways that barbers do in a barbershop; the main
differences between the two is that a service is not being rendered in the camps and the
leaders were voted on by camp members. Social camps still have a similar structure of
the barbershop where men convene to find support among their peers for multiple issues
including HIV prevention.
Since men reported a desire of wanting to be better informed of PrEP, an
intervention for heterosexual men may be appropriate to inform as many men as possible
to normalize and promote PrEP, HIV testing, and linkage to care. With the increased
global availability and widespread use of internet, smartphones, and mobile phone apps,
communities may benefit from social media and/or electronic dissemination of
information which promotes what PrEP is, where it can be accessed, and how to properly
adhere to it. TV and radio should also be leveraged as mediums to promote PrEP;
advertising via commercials may be an effective strategy for health communication.
Posters, billboards, and written materials may also be leveraged – the key to using these
mediums is that they should be strategically advertised in places of high foot traffic
and/or high visibility for heterosexual men. One study from the systematic review noted
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that participants desired PrEP related information and access to be as convenient as
possible which meant places that were either on their route of commute or near their
homes. This finding is important to consider increasing the uptake of PrEP among
heterosexual men.
Like past research of PrEP among other populations such as heterosexual men,
this dissertation revealed low levels of PrEP awareness among heterosexual men,
especially Black men. Men’s low awareness and subsequent low uptake of PrEP are
attributed to lack of PrEP access and availability but can mostly be attributed to a lack of
PrEP knowledge. This finding is not unique in that few heterosexual men have used PrEP
considering that most men in all three papers reported a lack of awareness of the drug.
Simply put, for heterosexual men to use PrEP, they must first be made aware of what it is
and why the drug may be beneficial to their lives. A lack of awareness may be a
hindrance to the uptake of PrEP and low uptake results in few heterosexual men using
PrEP.
Usefulness of Barbershops & Social Camps for Intervention Development
The results of this dissertation revealed that both barbershops and social camps
may be worthwhile venues to engage and focus on heterosexual Black men for men.
Considering that, in the study one, 25.8% of men reported using health education
materials provided by their barbershop and 20.98% reported having talked to their barber
HIV, there is ample opportunity to increase the health education advertising and
promotion of PrEP at barbershops. It is encouraging, from a health promotion standpoint,
that the participating barbershops were willing to not only allow HIV education materials
but were also willing to openly discuss it with their clientele. This presents a unique
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opportunity for this to be leveraged to normalize discussing both HIV prevention and
treatment. This openness of barbers and barbershops may benefit men in other settings
outside of Brooklyn and should be investigated; there is great opportunity for barbershops
to partner with health clinics and health departments to increase the number of men who
use health education materials provided to them by their barbers. As a result of this
partnership, barbers and barbershops could be used as tools to get men to move beyond
awareness and towards uptake of PrEP if they were trained to provide linkage to HIV
prevention services. Doing so may result in a greater uptick in men feeling comfortable to
be more open to HIV and prevention messaging.
In addition, in study two, 99.80% of men reported having a close friend in the
camp, 72% reported having had a close friend encourage them to test for HIV, and
74.46% who reported being likely to discuss PrEP with other camp members, this
presents an opportunity for the camp structure to be leveraged, where social camps are
available, to both increase awareness of PrEP and move men to action to use PrEP since
they already discuss very private and sensitive topics in the camps. Social camps may
also be able to collaborate with health clinics to offer camp members health education
materials and HIV prevention services, including PrEP. The men in the study had widely
been tested for HIV and were familiar with the process, this could also be leveraged by
health clinics to have an increased presence at the camps and could employ a few camp
members to serve as liaisons for the clinic.
Given the results of study 1 & 2, to fully take advantage of men’s willingness to
use PrEP, an intervention strategy that leverages men’s environmental factors and
intrapersonal factors to move them towards uptake and adherence of PrEP would be
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beneficial in barbershops, social camps, or in any social setting where men often frequent
such as other social clubs, churches, etc. A randomized controlled trial design for the
intervention would work best. In the treatment group, barbers or camp leaders would be
trained to discuss HIV prevention education, including PrEP, to interested men, and they
would offer health education materials to them as well. A trained PrEP navigator would
also be present to assist with any questions or concerns the barbers or camp leaders are
unable to address and who would consult with the men to offer them PrEP services at a
local health clinic or health department; men would have the option of making an
appointment with this person to be seen later at a clinic or health department or be
provided contact details to schedule an appointment later. The PrEP navigator will offer
to attend the appointment with each man, for support. In the control group, men receive
health education materials offered to them by barbers, camp leaders, or other designated
leaders and would be provided with the contact information of an establishment for them
to schedule an appointment to further discuss HIV prevention, including PrEP, and to
initiate PrEP. Demographic and behavioral information (e.g., age, marital status,
education, number of sexual partners, condom use, beliefs about HIV, perceived HIV
risk, HIV prevention efficacy, etc.) would be collected at baseline and men would be
given a unique identifier. At one and three month follow up, men would be surveyed
about their self-reported interest and use of PrEP; men’s unique identifier would then be
used to confirm whether they had scheduled an appointment for HIV prevention services
and if they had initiated PrEP. At 6-moth endpoint, men would be surveyed again to
confirm PrEP initiation and adherence.
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Conclusion
Both awareness and uptake of PrEP remain low globally for heterosexual men,
especially among Black men. To increase awareness and uptake of PrEP, mass
advertising campaigns alongside greater accessibility of PrEP is needed, especially in
regions where PrEP has not yet been approved for use by local governments. This
dissertation found that there are significant gaps in awareness of PrEP among
heterosexual men that is exacerbated by misinformation and medical mistrust in the
environments where heterosexual men reside. Heterosexual men would benefit greatly
from increased advertisement and greater accessibility to PrEP since increased awareness
may increase interest in PrEP which may in turn produce a greater likelihood of using
PrEP if it is available. One essential element of increasing uptake of PrEP is the gaining
of community buy-in; Black heterosexual men must feel that PrEP is a worthwhile
prevention tool that they should personally invest in. As Black heterosexual men become
more educated about PrEP and empowered to use it, interventions which aim to address
barriers surrounding PrEP (e.g., geographical, structural, cultural etc.) may successfully
decrease the HIV incidence rate among Black heterosexual men globally.
It is imperative to highlight the necessity of including sociocultural factors while
developing interventions which include PrEP and Black heterosexual men to both
improve PrEP awareness and to aid in a reduction of structural barriers for its uptake. We
must also take into the consideration that in some regions, specifically sub-Saharan
Africa, there has been an over-researching of certain communities for HIV prevention
and treatment and these communities may have grown fatigued from this. There has also
been incidences of researcher malpractice in HIV research (Bernstein, 2015) that has led
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to a deterioration of trust among multiple groups. Due to this, changing the opinions of
some communities regarding research may not be an easy task; however, researchers
must account for the impact of these histories and do the work to ensure that researcherparticipant trust is recovered. To complete this task, communication with the
communities being researched must be strong and transparent.
Study Limitations
This dissertation is subject to several limitations. First, neither the Brooklyn nor
the Tanzania study were focused solely on PrEP. The Brooklyn study’s aim was to
investigate the effectiveness of using barbers to disseminate HIV prevention information
and the Tanzania study was focused on HIV self-testing. Due to this limitation, it is
difficult to determine whether participating men would have engaged in the study had it
been focused on only PrEP. Second, while PrEP was available at the time of recruitment
in Brooklyn, this was not the case in Tanzania. While surveying men about PrEP in
Tanzania, the questions were strictly hypothetical because PrEP had not yet been
approved for use in the country. Third, in the Tanzania study, PrEP was explained to men
via a brief paragraph that was read to them by a survey administrator in Kiswahili that
was translated from English. The possibility exists that the translation may not have been
100% accurate. Fourth, the Brooklyn data were secondary data that were collected
without the inclusion of the author of this dissertation; the author cannot verify the
protocols followed to gather the data from participants and is also unable to speak to the
study quality (including whether female survey administrators were used). Fifth, in the
Tanzania study, two female research team members were used to administer surveys to
men and may have caused men to respond to sexual and personal survey questions
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inaccurately because of fear of judgment, embarrassment, or discomfort. We are unable
to assess the degree to which this may have been the case, but its occurrence is possible.
There is also the possibility of social desirability bias. Men in both the Tanzania and
Brooklyn studies may have responded to survey items in a manner that they believe
would be most favorable to their family or their peers and may have also either under- or
over-reported their health beliefs and behaviors rather than selecting or reporting
responses that are accurately reflective of their true beliefs and behaviors. Furthermore,
participating men may have under- or over-estimated their beliefs and behaviors due to a
lack of memory or boredom regarding the survey items. Another limitation of the two
studies is that cross-sectional surveys, such as the ones used with closed-ended questions,
may have a lower validity rate than other question types. There are also potential data
errors associated with the administration of the survey. One data error is the non-response
for some men for some survey items. In both surveys, some men opted to not respond to
some of the survey items and in turn created bias that may have affected the study results.
We are unable to distinguish whether this is the result of survey answer options being
unclear or misinterpreted.
In the systematic review, there is a lack of scope for the included articles because
the number of articles matching the inclusion of heterosexual men were low. The
systematic review also suffered from a lack of concrete methodological steps and
standards; the aim of the review was to identify and present the articles which matched
the inclusion criteria and were not subjected to quality assessments. Due to the lack of
quality assessment, it is difficult to fully interpret the evidence uncovered in the
systematic review. Lastly, a major limitation of this research is that the results of the
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Brooklyn and Tanzania studies cannot be used as a one-size fits all strategy for all
countries and regions since no one environment for heterosexual men is the same. It must
also be kept into consideration that because PrEP is also not approved for use in all
countries, governmental access barriers exist.
Study Strengths
Although the limitations of this dissertation have been thoroughly documented,
the strengths of this research must also be highlighted. First, it must be noted that we
were able to compile a list of articles which investigate PrEP in relation to heterosexual
men and their knowledge/awareness and uptake/use of PrEP without the inclusion of
heterosexual men’s sexual partners. This is noteworthy due to the dearth of literature
surrounding this niche. Previous studies, specifically in sub-Saharan Africa, have used
the sexual partners (mostly expectant mothers) to target heterosexual men for HIV
prevention research, including PrEP; such a strategy is not without issues. In this
dissertation, we have been able to identify men who may be at risk for HIV but who may
also be single, married, or cohabitating with sexual partners. Second, with overall results
of the research finding that heterosexual men were mostly unaware of PrEP, this
dissertation highlights an increased need for PrEP advertisement and education
campaigns as well increased availability and accessibility in all included regional
settings. Through this research, we were able to explore the perceptions, beliefs, attitudes,
and barriers to PrEP uptake for heterosexual men and have highlighted the gaps in PrEP
research for heterosexual men. We were also able to successfully show that venues where
heterosexual men socialize such as barbershops and social camps are valuable places to
target heterosexual men for PrEP education and linkage to services. We have uncovered
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that Black heterosexual men are indeed interested in PrEP and believe that their network
of peers and family would likely be interested in learning more about the drug, thus
providing evidence that heterosexual men should be better included in PrEP research
globally. The systematic review provides an overview of the published papers on PrEP
for heterosexual men and includes multiple study designs and methodologies.
Implications for Public Health Practice
The findings of this dissertation suggests that Black heterosexual men are willing
to use PrEP and believe that their peers may also be interested in PrEP – the caveat to
these findings is that Black heterosexual men felt this way only after they had been made
aware of PrEP and its health benefits. The first step to increasing PrEP use among Black
heterosexual men is that the men must first be made aware of the drug. Without knowing
what PrEP is and how to obtain it, there is a low chance that Black heterosexual men will
use it. The barriers to PrEP uptake for Black heterosexual men must be addressed and
cultural appropriateness must be adhered to so that optimal interest and uptake of PrEP
may be achieved. Culturally sensitive campaigns that acknowledges patient-doctor or
researcher-participant mistrust must also be adhered to with the aim of empowering
Black heterosexual men.
Since most Black heterosexual men reported a willingness to use PrEP, the drug
should be made more accessible to this group. If Black heterosexual men are more aware
of PrEP and more knowledgeable of its benefits, more Black heterosexual men will be
likely to use the drug, and uptake will increase. It is important to acawareness and
address the sociocultural barriers to HIV prevention; like how the social camps in
Tanzania select a camp leader, community leaders must be identified, engaged, and
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trained to provide buy-in from their peers for interventions; doing so may entice other
men to engage in HIV prevention measures, including PrEP. Involving male community
leaders will also provide substantiality to the project and improves the potential approval
of men. Community leaders may also provide pertinent feedback for public health
practitioners to follow to increase the uptake of PrEP among heterosexual men instead of
relying on heterosexual men’s sexual partners. To achieve all the recommendations,
clinicians, doctors, healthcare professionals, and all person involved in PrEP research for
Black heterosexual men must be properly trained in cultural competence for their
specified environment and reliable sources to disseminate health information into the
targeted communities is also needed.
Future Directions
The findings from this dissertation can be used to increase both the awareness and
uptake of PrEP using mass media campaigns or intervention strategies. To address the
low awareness of PrEP among Black heterosexual men and its uptake globally,
researchers must employ a regionally appropriate approach and would benefit from
evidence-based strategies that have been successful with other demographics. The
importance of using culturally appropriate venues cannot be overstated. This dissertation
provided evidence that barbershops in Brooklyn and social camps in Tanzania can be
used as venues to target men; culturally appropriate venues (e.g. sporting events, bars,
etc.), dependent on the country of interest, should be used to target Black heterosexual
men. Furthermore, future investigations should aim to address the stigma and
misinformation associated with HIV prevention and PrEP to gain more buy-in for
prevention strategies. Future investigations should also be age appropriate and employ
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different strategies to target younger men and older men. Researchers may want to review
the literature of what strategies have been successfully used to target heterosexual men
and serodiscordant couple and redesign these strategies to fit the personal preferences of
Black heterosexual men. Still, it is important to note that serodiscordant research tends to
focus more on women even though they are targeting men.
Since PrEP research continues to advance, researchers should utilize the most upto-date PrEP methods, including offering both the once-a-day tablet and long lasting
injectable to find out which is most attractive to Black heterosexual men. Researchers
must also consider that, according to the results of this research, the cost of PrEP and
access to it matters greatly; these two matters must be addressed. Future research should
be concerned about the barriers to initiation and maintenance of PrEP.
One of the most concerning findings of this research is that PrEP was approved
for use in 2012 and over 9+ years later, research is still being conducted on its awareness
and intent to use; Most of the studies found in the systematic review as well as the two
original included papers were focused on willingness to use. More progress is needed
towards increased uptake and overcoming barriers to access. An effective strategy would
be to target young Black heterosexual men since this demographic consistently has the
highest risk for acquiring HIV. It is important to target the social networks of Black
heterosexual men as well.
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APPENDIX A
SURVEY QUESTIONS
The following list of questions were used to survey participating men.
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•

•
•
•

D7.
Were you born in the United States?
D8.
Where were you born?
D9.
In what country were you born?
D10. Do you consider yourself to be Hispanic/Latino?
D11. What do you consider to be your race? You may choose one or more
options.
D12. What is the highest level of education that you have completed?
D13. Are you currently enrolled in school?
D14. What best describes your current employment status?
D15. What was your personal income last year from all sources before taxes?
D16. Do you currently have any health insurance or other medical coverage
such as Medicaid, Medicare or private insurance?
D17. Are you currently living together with your wife, girlfriend, or other sex
partner?
D18. In what year were you born?
D21. Where do you live or stay most of the time?
D22. How often does it happen to you that you do not have enough money to
afford the kind of food you should have?
D23. How often does it happen to you that you do not have enough money to
afford the type of medical care you should have?
D26. Have you ever spent at least one night in jail or prison?
D27. In the past three months, how often did you use alcohol?
D28. In the past three months, how often did you use marijuana or hashish?
D29. In the past three months, how often did you use any other drugs that were
not prescribed by a doctor, such as crack, heroin, cocaine, amphetamines, or other
drugs?
D30. Have you had more than five sexual partners in the last 90 days, or fewer
than five sexual partners? A sexual partner is someone that you have had either
vaginal, anal, or oral sex with. Please press the HELP button on the right for
definitions of what we mean when we talk about vaginal, anal, and oral sex.
D31. How many women did you have sex with in the last ninety days?
D32. Thinking back over the past ninety days, did you have any regular
partners?
D33. How many regular partners did you have?
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•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•

D34. Thinking back over the past ninety days did you have any casual partners?
A casual sexual partner is someone with whom you have sex occasionally.
D35. How many casual partners did you have?
D36. Thinking back over the past ninety days did you have any one time
partners? A one time partner is someone with whom you have had sex one time
and with whom you don't plan to have sex again.
D37. How many one time partners did you have?
D38. What was the HIV status of your regular partners?
D39. Did you have any vaginal sex with your regular partners in the last 90
days?
D40. About how many times did you have vaginal sex with your regular
partners in the last 90 days?
D41. Of these times, was there at least one time when you did not use a
condom?
D42. In the last ninety days, how often did you use a condom with your regular
partners during vaginal sex?
D43. Did you have any anal sex with your regular partners in the past 90 days?
D44. About how many times did you have anal sex with your regular partners in
the last 90 days?
D45. Of these times, was there at least one time when you did not use a
condom?
D45W372.
In the last ninety days, how often did you use a condom with your
regular partners during anal sex?
D46. In general, how confident do you feel that you could convince all of your
regular sexual partners in the next ninety days to use condoms if you wanted to?
D47. Overall, how favorable do you feel about always using condoms with your
regular sexual partners in the next ninety days?
D48. Overall, do you think that it is more likely or unlikely that you will always
use condoms with your regular sexual partners in the next ninety days?
D49. What was the HIV status of your casual partners?
D50. Did you have any vaginal sex with your casual partners in the last 90
days?
D51. About how many times did you have vaginal sex with your casual partners
in the last 90 days?
D52. Of these times, was there at least one time when you did not use a
condom?
D53. In the last ninety days, how often did you use a condom with your casual
partners during vaginal sex?
D54. In the last ninety days, how often did you use a condom or other barrier
method such as a dental dam or saran wrap with your casual partners during oral
sex?
D55. Did you have any anal sex with your casual partners in the past 90 days?
D56. About how many times did you have anal sex with your casual partners in
the last 90 days?

227

•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•

D57. Of these times, was there at least one time when you did not use a
condom?
D58. In the last ninety days, how often did you use a condom with your casual
partners during anal sex?
D59. In general, how confident do you feel that you could convince all of your
casual sexual partners in the next ninety days to use condoms if you wanted to?
D60. Overall, how favorable do you feel about always using condoms with your
casual sexual partners in the next ninety days?
D61. Overall, do you think that it is more likely or unlikely that you will always
use condoms with your casual partners in the next ninety days?
D62. What was the HIV status of your one-time partners?
D63. Did you have any vaginal sex with your one-time partners in the last 90
days?
D64. Was there at least one time when you did not use a condom during vaginal
sex with your one-time partners?
D65. In the last ninety days, how often did you use a condom with your onetime partners during vaginal sex?
D66. Did you have any anal sex with your one-time partners in the last 90 days?
D67. Was there at least one time when you did not use a condom or other
barrier method during anal sex with your one time partners?
D68. In the last ninety days, how often did you use a condom with your onetime partners during anal sex?
D69. In general, how confident do you feel that you could convince all of your
one-time sexual partners in the next ninety days to use condoms if you wanted to?
D70. Overall, how favorable do you feel about always using condoms with your
one-time sexual partners in the next ninety days?
D71. Overall, do you think that it is more likely or unlikely that you will always
use condoms with your regular one-time partners in the next ninety days?
D72. Have you ever been tested for HIV?
D73. Was this in the past year?
D74. Has a healthcare provider ever told you that you have HIV?
D75. Pulling out the penis before a man climaxes or cums keeps a woman from
getting HIV during sex.
D76. A woman cannot get HIV if she has anal sex with a man.
D77. Showering, or washing ones genitals or private parts, after sex keeps a
person from getting HIV.
D78. A woman cannot get HIV if she has sex during her period.
D79. A natural skin condom works better against HIV than does a latex
condom.
D80. Having sex with more than one partner can increase a person’s chance of
being infected with HIV.
D81. Using Vaseline or baby oil with condoms lowers the chance of getting
HIV.
D82. Homosexuals, bisexuals, and drug addicts are the only people who get
HIV/AIDS in my neighborhood.
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•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•

D83. You can tell if a woman has HIV by looking at her.
D84. Having another sexually transmitted disease like Chlamydia can increase
your chances of getting HIV.
D85. If you are a man with HIV, then that means that you have probably had
sex with other men.
D86. If a man only has anal sex with women, he is not going to get HIV.
D87. A man is not at risk for HIV if he only has unprotected sex during a
'quickie'.
D99. HIV is a problem in my community.
D100. People who live in my neighborhood are at risk for HIV.
D101. HIV/AIDS is not that serious anymore.
D105. Black men and women in our community are at increased risk for
HIV/AIDS because of our sexual behavior.
D112. People like me do not get HIV infections.
D113. I am very healthy so my body can fight off an HIV infection.
D114. I am worried that I might get an HIV infection.
D161. In the last ninety days, have you used any health education materials on
HIV that were provided by your barbershop? This could include brochures,
resource guides, or other materials.
D162. In the last ninety days, did you talk with any of your sexual partners about
HIV? This means talking to them about the problem of HIV or about ways to
prevent the spread of HIV.
D163. In the last ninety days, did you talk with any of your friends about HIV?
D164. In the last ninety days, did you talk with any of your family about HIV?
D165. In the last ninety days, did you talk with anyone else about HIV?

PrEP Items:
• Q_1. (HeardPrEP) Have you ever heard of PrEP before today?
• Q_2. (UsedPrEP) Have you or anyone that you know of ever used PrEP?
• Q_3. (InterestPrEP) How interested do you think people in your network of
friends and family would be interested in learning more about PrEP?
• Q_4. (HIV) What other kinds of health topics do you think that people in your
network of friends and family would benefit most from - HIV prevention and
treatment, PrEP prevention?
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